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Abstract and Layout of Thesis 
Inspired by nature’s use of self-assembled systems to carry out virtually all biological 
processes, chemists have taken to building simplified synthetic systems that mimic the 
biotic world. Although transition metal-ligand interactions are rarely used for the 
purpose of biological self-assembly, they have several advantages over other weak non-
covalent interactions, such as pronounced directionality and significant strength. These 
particular attributes have allowed chemists to construct a comprehensive library of 
self-assembled polygons and polyhedra, using different transition metal-ligand motifs. 
Many of these supramolecular assemblies possess cavities of defined shape and size, 
which are able to accommodate guest molecules. It has further been realised that 
isolation of guest species from the bulk phase can lead to many interesting functions, 
such as containment, sensing and catalysis. Herein, a new self-assembly strategy has 
been used to construct novel cyclometalated Pt cages and assembly of the first known 
[Ir(ppy)2]-based capsule has also been achieved. 
Chapter 1 includes an introduction to metallosupramolecular assemblies, followed by a 
comprehensive review of three-dimensional architectures with accessible cavities, 
their synthetic strategies and applications.  
Chapter 2 reports on the construction of novel Pt(II)-based trigonal prisms using an 
unusual, kinetically controlled protocol. By exploiting asymmetric cyclometalated 2-
phenylatopyridine based platinum corner units that possess both labile and non-labile 
cis-coordination sites, trigonal prismatic stereoisomeric architectures have been 
selectively prepared by altering the sequence of addition of ditopic 4,4′-bipy (4,4′-
bipyridine) and tritopic tpt (2,4,6-tris(4-pyridyl)-1,3,5-triazine) molecular structural 
components using a template free method. Collision-induced-dissociation mass 
spectrometry experiments were used to differentiate between the structural isomers 
due to their significantly different fragmentation profiles.  
Chapter 3 describes the synthesis and characterisation of the first molecular capsule 
based on an [Ir(ppy)2]+ 90° metallosupramolecular acceptor unit. Initial work focused 
on pyridine-based donor ligands from which an Ir2L2 metallamacrocycle was 
assembled. However, when the highly conjugated tpt “panels” were used, due to 
postulated constraints in the dihedral angle, self-assembly of the Ir6tpt4 octahedral was 
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unsuccessful. The constraints in the dihedral angle were eliminated by swapping 
pyridine for nitrile-based ligands and following the development of a method to resolve 
rac-[(Ir(ppy)2Cl)2] into its enantiopure forms, homochiral Ir6tcb4 (tcb = 1,3,5-
tricyanobenzene) octahedral capsules where realised. Photophysical studies on the Ir-
capsules have shown that the ensemble of cooperative, weakly coordinating ligands can 
lead to luminescence not present in the comparative mononuclear analogues. X-ray 
crystallographic analysis revealed that the Ir capsules possess cavities large enough to 
accommodate 4 triflate counterions. Through a series of titration experiments the 
ability of the capsules to act as anion sensors was also exposed. 
Further exploration into the host-guest chemistry of the Ir6tcb4 capsule is reported in 
Chapter 4. Subsequent experiments have shown that self-assembly is highly dependent 
on the counterions associated with the system. While a number of different anions 
(OTf-, BF4-, ClO4-, PF6-) facilitate the formation of the same octahedral scaffold, when 
triflimide was employed as a bulkier counterion, no capsule was observed. On 
subsequent addition of smaller counterions, such as triflate, the same Ir6tcb4 cage 
assembles, demonstrating that the anions also act as templates. Kinetic stability 
experiments, undertook by monitoring the rate of scrambling of the Δ and Λ-[Ir(ppy)2]+ 
components within the preformed ensembles, show that the Ir capsules are up to 
1.4×104 times more stable than their mononuclear analogues. The counter anions were 
also observed to play a crucial role in the capsule’s stability with measured scrambling 
half-lives ranging from 4.7 mins with tetrafluoroborate to as long as 4.5 days with 
triflate. In contrast, the rate of ligand exchange in simple mononuclear complexes, as 
ascertained using EXSY NMR experiments, was found to be approximately independent 
of the associated anion. 
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CD Circular Dichroism 
CID Collision-Induced Dissociation (MS) 
COSY Correlated Spectroscopy (NMR) 
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C^N Bidentate ligand coordinating through a carbon and a nitrogen atom 
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DOSY Diffusion-Ordered Spectroscopy (NMR) 
dppp 1,3-(diphenylphosphino)propane 
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en ethylene diamine 
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Et2O diethyl ether 
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EXSY Exchange Spectroscopy (NMR) 
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h hour(s) 
HOESY Heteronuclear Overhauser Effect Spectroscopy (NMR) 
HPLC High Performance Liquid Chromatography 
i, i + 4 Hydrogen bonding between 2 amino acids separated by 4 residues 
i, i + 7 Hydrogen bonding between 2 amino acids separated by 7 residues 




LR-FAB Low Resolution Fast Atom Bombardment 






MS Mass Spectrometry 
MSn Tandem MS with n stages of ion separation 
min minute(s) 
MLCT Metal-to-Ligand Charge-Transfer 
nESI nano-Electrospray Ionisation 
NIR Nitrogen Inversion/Rotation 
NMR Nuclear Magnetic Resonance 








PyH+ Pyridinium cation  
RNA Ribonucleic Acid 










TLC Thin-Layer Chromatography 
TON Turnover-Number (catalysis) 
tpt 2,4,6-tris(4-pyridyl)-1,3,5-triazine 
Δ-TRISPHAT- Δ-tris(tetrachloro-1,2-benzenediolato)phosphate(V) 
UV Ultraviolet (light) 
Vis Visible (light) 
VT Variable Temperature (NMR) 
XRD X-Ray Diffraction 
Ф emission quantum yield 
  
NB: Conventional abbreviations for units and physical quantities are not included. 
Abbreviations used in the experimental sections that are not listed above are defined 
therein. 
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General Remarks in Experimental Data 
Unless stated otherwise, all reagents and solvents were purchased from commercial 
sources and used without further purification. Dry DCM, CHCl3 and THF were obtained 
by passing the solvent (HPLC grade) through an activated alumina column on a 
PureSolv™ solvent purification system (InnovativeTechnologies, Inc., MA). All reactions 
were carried out under a nitrogen atmosphere, unless stated otherwise. Column 
chromatography was carried out using Geduran® Silica 60 (particle size 40-63 μm, 
Merck, Germany) as the stationary phase, and TLC was performed on precoated silica 
gel plates (0.25 mm thick, 60 F254, Merck, Germany) and observed under UV light. All 
chemical reactions involving Ag(I) complexes were carried out in the absence of light 
whenever possible. 
All 1H, 13C and 19F NMR spectra were recorded as stated on either the Bruker AV 500 or 
AV 400 instrument at a constant temperature of 298 K, unless otherwise stated. All 
DOSY experiments were performed on Bruker AV 400 (Topspin 2.1) using bipolar 
gradient pulses for diffusion with two spoil gradients (ledbpg2s.compensated) pulse 
sequence. The sequence was carried out under automated conditions where the 
duration of the magnetic field pulse gradient (δ) was 1.5 ms and the diffusion time (Δ) 
was 100 ms. Typically in each pulse field gradient NMR experiment, a series of 16 
spectra on 32 K data points were collected and the eddy current delay (Te) was set to 5 
ms in all experiments. The pulse gradients (g) were incremented from 2 to 95% of the 
maximum gradient strength in a linear ramp. The temperature was set and controlled 
at 298 K with an air flow of 400 L h-1 in order to avoid any temperature fluctuations due 
to sample heating during the magnetic field pulse gradients. The data was processed 
using Bruker Topspin 2.1.  
Chemical shifts (δ) are reported in parts per million and referenced to residual solvent 
peaks (CD2Cl2: 1H δ 5.32 ppm, 13C δ 54.0 ppm; CDCl3: 1H δ 7.26 ppm, 13C δ 77.2 ppm; 
C2D2Cl4: 1H δ 6.00 ppm, 13C δ 73.8 ppm; CD3NO2: 1H δ 4.32 ppm, 13C δ 62.8 ppm). 
Coupling constants (J) are reported in hertz (Hz). The J value given per chemical shift, 
unless stated otherwise, refers to J-J spin coupling through three bonds (J3). Standard 
abbreviations indicating multiplicity were used as follows: m = multiplet, t= triplet, dd 
= doublet of doublets, d = doublet, s = singlet, bs = broad singlet. 
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Mass spectrometry (MS) was performed on Q-Tof Ultima or Q-Tof 2 (MicromassWaters 
Corporation, Manchester, UK) mass spectrometers, using a nESI source, controlled 
using Masslynx v2.3 software. All the scans in the experimental are for positive ions. 
The samples were dissolved in DCE, TCE or MeNO2 at 50-100 µM. Prior to analysis, 
instruments were calibrated using a solution (2 mg mL-1) of sodium iodide in 50:50 
water/isopropanol. Collision induced mass spectrometry measurements were 
performed with argon as the collision gas. nESI voltages were adjusted between 1.0 and 
2.0 kV to optimize spray quality, while the cone voltage was typically set to 36 V. Source 
temperature was set at 80 °C. Energy of collision with inert gas was set to 1.6z eV 
(where z is the charge state of ion). nESI tips were prepared in-house from borosilicate 
glass capillaries (Kwik-Fil, World Precision Instruments Inc., Sarasota, FL, USA) using a 
Flaming/Brown Micropipette puller (Model P-97, Sutter Instrument Co., Novato, USA). 
Platinum wire (0.125 mm, 99.95% purity, Goodfellow Cambridge Ltd., Huntingdon, UK) 
was used to apply the potential to solutions. Data were analysed using MassLynx 
software (v4.1 Waters Corporation). Predicted isotopic distributions were calculated 
using Molecular Weight Calculator Version 6.48. FAB spectrometry was carried out by 
the MS services at the University of Edinburgh. 
UV-Vis measurements were recorded on a JASCO V-670 spectrophotometer. Data was 
collected over a wavelength range of 270-600 nm, at a scan speed of 400 nm min-1, UV 
bandwidth of 1.0 nm and near IR bandwidth of 4.0 nm. Samples were measured at RT 
and at given concentrations using a cuvette (Starna Ltd.) with a 10 mm path length. 







Metallosupramolecular Capsules: design, 







I am greatly thankful to both Dr. Paul Lusby and Dr. Christopher Campbell for proof-
reading this and the following three chapters.  




With over a 4-billion year head start, nature has developed highly efficient biological 
processes that rely primarily on weak intermolecular interactions. The weak, 
supramolecular interactions, when functioning in unison, are key in the spontaneous 
construction of highly specific assemblies. The ease and efficiency of self-assembly within 
nature has inspired chemists to build nano-sized artificial systems using abiotic strategies 
which mimic those found in the biological world. Initial construction primarily focused on 
conventional covalent chemistry to construct large molecules with complimentary 
hydrogen bonding motifs on the periphery that would self-assemble into discrete nano-
sized architectures. However, due to the linear nature and the relative weakness of a 
single hydrogen bond, lengthy multi-step syntheses of the subcomponents with multiple 
binding sites were often required. The hydrogen-bonded assemblies were also only 
compatible by non-hydrogen bonding solvents and as a result the construction was often 
difficult and time consuming. Transition metal-ligand bonding, on the other hand, is far 
more versatile and with a large number of metals and ligands to choose from, with an 
array of different bonding angles and strengths, the number of possible assemblies is 
potentially limitless. Since the assembly of the first metallosupramolecular macrocycle 
just over 20 years ago, a vast collection of polygons and polyhedra has emerged. Initially 
assembled for their unique topographies, the focus has now changed to engineering and 
utilising these three-dimensional assemblies for various applications. 
This opening chapter comprises a thorough review into discrete three-dimensional 
metallosupramolecular assemblies with accessible cavities, their different synthetic 
strategies and their many uses, in particular catalysis. The chapter also touches on the 
redox and photophysical properties of transition metals and how these qualities could 
potentially be incorporated and utilised within the supramolecular framework of the 
capsules. 




Supramolecular assemblies have evolved in biology over billions of year to function as 
recognition, transformation and translocation devices. Nature has utilised non-covalent 
molecular interactions in the form of electrostatic, hydrogen bonding, π-π stacking, 
hydrophobic and dispersion forces for molecular recognition and self-assembly of 
complex architectures. These intermolecular interactions are generally weaker than the 
conventional covalent bond making supramolecular assemblies potentially less stable 
than conventional molecular structures, kinetically more labile and geometrically more 
flexible. However, cooperatively, these complementary intermolecular links can form 
thermodynamically robust and dynamically rigid aggregates.[1]  
The double-stranded helix of DNA relies on complementary base pairings to form 
three-dimensional supramolecular structures. Valinomycin, a naturally occurring 
antibiotic, transports potassium cations across the mitochondrial membrane. It too 
relies on multiple supramolecular interactions to bind K+ within its macrocyclic 
structure for transportation through the hydrophobic environment of the membrane.[2] 
Enzymes, nature’s nanoreactors, rely on relatively weak yet highly selective substrate 
recognition to promote fast reactions with high turnover numbers under mild 
conditions.[3] These highly proficient molecular recognition devices have fascinated and 
inspired the scientific community for many years, but only recently with advances in 
synthetic chemistry have artificial supramolecular architectures and devices started 
being produced.[4] 
Although there are many reported organic-based three-dimensional supramolecular 
structures in the literature[5] this chapter will focus primarily on polyhedral 
architectures, with accessible cavities, assembled using metal-ligand coordination.[6] 
The use of these discrete assemblies as molecular containers and catalysts will also be 
discussed. 
 
1.3 Three-dimensional self-assemblies 
Self-assemblies are generally high order molecular structures formed by spontaneous, 
thermodynamically driven, enthalpically favoured rearrangement of smaller 
aggregates. In recent years non-covalent self-assemblies have gained great interest in 
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chemistry due to their aesthetically appealing architectures and potential simplicity in 
construction. Learning from nature, chemists started building biomimetic capsules 
initially using hydrogen-bonding interactions.[7] Hydrogen-bonded nano-clusters are 
fairly unstable and are therefore less prevalent in the literature. Their instability is 
generally due to a fine balance between entropic losses, due to size, versus enthalpic 
gains due to cooperative intermolecular interactions. The linear nature of hydrogen 
bonding also restricts the size of these clusters and building complexities soon became 
apparent. The focus thus changed to involve metal coordination. 
Metal-ligand coordination is very attractive in the field of supramolecular assemblies 
due to three key factors: 
(i) Intermolecular bonding strengths between metal centres and coordinative 
ligands can be tailored to range from very labile, almost dispersion-like, to 
very robust, covalent-like. 
(ii) The well-defined geometries of metal complexes with the use of protective 
groups allow for angles smaller than the linear nature of H-bonding or 
hybridised s and p orbitals in covalent-bonds to be obtained. The 90° angle 
is readily accessible in square planar as well as octahedral and trigonal 
bipyramidal geometries. 
(iii) It is generally easier and requires fewer steps to synthesise metal 
complexes relative to the large highly-specific ligands required in the 
synthesis of hydrogen-bonded systems. 
 
Initial work on metallosupramolecular capsules used either square planar Pd(II) or 
Pt(II) geometries. The metal centres were exploited for their 90° angle using labile 
multitopic ligands while blocking of the remaining concomitant sites with kinetically 
inert mono- or bi-dentate auxiliaries. This method was successfully used by Fujita’s 
group to originally build a molecular square[8] and soon after, in 1995, the first metal-
directed three-dimensional cage. Stoichiometrically mixing the highly versatile exo-
tridentate triangular 2,4,6-tris(4-pyridyl)-1,3,5-triazine “panels” (tpt)[9] with the cis-
protected ethylenediamine palladium “connectors”, [(en)Pd(NO3)2] in an M3:L2 ratio, in 
water, led to the assembly of a discrete M6L412+ octahedral supramolecular structure 1 
with Td symmetry (Figure 1.1).[10] The presence of twelve accompanying nitrate 
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counteranions makes this capsule fully soluble in water, a property that has been 




Figure 1.1. M6L4 prism 1 and bowl 2 reported by Fujita.[11] 
 
By altering the N-donor sites on the tpt “panels” from para- to meta-, supramolecular 
bowl 2 could be self-assembled (Figure 1.1).[12] Interestingly, assembly 2 has also been 
prepared under solvent-free conditions.[13] Using a pestle and mortar, 90% isolated 
yields were obtained after 10 min of grinding, as opposed to 81% when heated at 70 °C 
in water for 30 min. The specific design of molecular polytopic “panels” of different 
geometries has led to the discovery of a large number of metallosupramolecular cages 
by Fujita’s group.[11] The key to success for all these three-dimensional assemblies is 
the 90o angle and the dynamically rigid “panels” which ensure the assembly processes 
are convergent, preventing the formation of polymeric structures. The substitution of 
palladium(II) for the more kinetically stable platinum(II), in analogous two-
dimensional assemblies, resulted in the formation of an oligomeric mixture. However 
when heated to 100 °C for several days, the oligomeric mixture converged into a 
discrete cage-like assembly which was far more kinetically robust than its palladium 
analogue 1.[14] 
Not all metallosupramolecular assemblies require the capping of the concomitant sites 
on the metal centres. For example, Shionoya’s group have successfully synthesised a 
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identical tris-monodentate ligand.[15] Using “naked” Hg(II) as the metal cation led to the 
formation of an M6L8 capsule that was coordinatively saturated. However, further 
addition of Hg(II) resulted in the reassembly of the M6L8 cage into a M6L4 cage 
constructed with unsaturated Hg(II) ions at the vertices.[16] This process was also 
demonstrated to be reversible by removal of Hg(II) from the system using [2.2.2]-
cryptands. Other assemblies using unsaturated octahedral metal cations have also been 




Figure 1.2. Self-assembly of M12L24 and M24L48 molecular spheres (where M2+ = Pd or 
Pt). The different angles (θ) in the di-topic ligand (L) were achieved through alterations 
of the central connector group. The corresponding assembly was obtained when L was 
mixed with M2+ in a 2:1 ratio. Reproduced from reference 18b.  
 
Fujita and co-workers further demonstrated that the number of metal-acceptor sites 
does not have to be limited to two. By subtle alterations in the ditopic ligand 
coordination angle (θ), through the design of different central connector groups, Fujita 
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and co-workers used 4-coordinate Pd(II) or Pt(II) metal centres to assemble discrete 
molecular spheres as large as M24L48 (see Figure 1.2).[18] 
Crowley has also utilised all four acceptor sites on Pd(II) metal centres, which when 
mixed with a 2 mol eq of either a ditopic pyridine ligand or a di-1,2,3-triazole “click” 
ligand an M2L4 cage or quadruply stranded helicate formed.[19] The “naked” square 
planar configuration of Pd(II) has also been used to build octahedral prisms using tris-
N-donors based on a cyclotriveratrylene scaffold[20] and amide linked ligands.[21] 
Stang and co-workers have developed an alternative strategy for the formation of 
multicomponent supramolecular assemblies which use 3 ditopic bis-Pt(II) “clips” with 
2 tritopic N-donor ligands to assemble prism 3 (Figure 1.3).[22] The usually kinetically 
robust Pt(II)-pyridine bond was labilised by placing anthracene trans and PEt3 ligands 
cis to the N-donor sites, which allowed the assemblies to form at RT. Monitoring the 
formation of the supramolecular entities, Stang observed initial formation of oligomeric 
species followed by self-correction which led to the formation of a single discrete 
product. Following on from the synthesis of cage 3, Stang and co-workers constructed a 
plethora of discrete self-assembled architectures using a similar Pt(PEt3)2 motif.[23] 
Interestingly, the same group also demonstrated that when mixing multiple 
components in a single pot self-sorting occurred and resulted in the formation of only 
discrete homoleptic structures at the exclusion of less stable disordered assemblies.[24] 
The self-sorting processes were observed to rely on the thermodynamic preferences of 
the subcomponents, whereby the size of the ligands directed self-selection. In 2009, 
Mukherjee also reported on a very similar assembly where the Pt and N groups were 
interchanged to give 3 N-donor clips with 2 PEt3 labilised tritopic tris-Pt(II) ligands.[25] 
 






Figure 1.3. “Clip” strategy used in directing the self-assembly of 3 by Stang and co-
workers.[22] 
 
An alternative method, based on host-guest interactions, was first used by Fujita’s 
group, to direct the self-assembly of more than two component metallosupramolecular 
systems.[26] 
Host-guest chemistry involves the binding of a relatively small molecule or ion with 
divergent binding sites, the guest, to a larger framework with convergent binding sites, 
the host, via supramolecular interactions. Unlike self-assemblies, host-guest complexes 
are generally driven by solvophobic effects, where the encapsulation of the guest 
results in more favoured solvent-solvent interactions.[27] In nature, enzymes are 
probably the most famous host-guest systems that catalyse specific reactions by 
selective encapsulation of the reactive species, driven by supramolecular interactions 
and hydrophobic effects.[3] 
Within the field of supramolecular coordination chemistry guests have been widely 
used to template the assembly of discrete architectures. In 2003 Fujita’s group 
synthesised a prism-like cage 4 using a three-component Pt(II) system (Figure 1.4).[26] 
Initially when mixing the three components in a stoichiometric ratio of 2:3:6, a mixture 
of homoleptic Pt4L4 square, octahedral cage 1 and prism 4 was formed. This problem 
was resolved by incorporating a hydrophobic triphenylene template, which at elevated 
temperatures in aqueous conditions effectively drove the formation of a hydrophilic 
environment around itself with the self-assembly of 4. Cage 4 showed high kinetic 
stability at RT, even after removal of the aromatic template. Assembly of the Pd(II) 
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analogue was also attempted but due to the labile nature of Pd(II) other 
supramolecular assemblies formed when the guest molecule was omitted. 
 
 
Figure 1.4. Self-assembly of trigonal prism 4 by Fujita’s group. Reaction: a) without 
template; b) with triphenylene as template.[26] 
 
Template-free synthesis of a trigonal prism was also achieved by adding bulky methyl 
groups in the ortho-position on a bis-pyridine ligand (see Figure 1.5).[28] This 
modification prevents homoleptic cis-coordination of the pyridine tectons due to a 
steric clash between the bulky methyl groups. By altering the length of the pillar 
ligands, Fujita and co-workers were able to lengthen the cage to allow the 
incorporation of multiple aromatic guests to form symmetrical[29] and dissymmetrical 
stacks.[30] 





Figure 1.5. Stabilised stack of multiple pyrene based molecules within a trigonal prism 
of varying height. The height was adjusted using different pillared ligands of varying 
length as depicted above. [29] * 3 other non-pyrene aromatic molecules were 
encapsulated in the stack.[28] R = OC2H4OCH3. 
 
Recently, Stang and co-workers presented the self-assembly of a heteroleptic Pt(II) 
three-component tetragonal prism without the need for a template.[31] On mixing three 
different subunits, cis-Pt(PEt3)2(OTf)2, 5a and 5b in a ratio of 8:4:2 a single product 5c 
was formed (Figure 1.6). This spontaneous self-organisation of more than two different 
components, without the use of templates, is the first of its kind. The exclusive 
formation of 5c without oligomerisation of the sub-units is down to the different 
electronic properties of the bis-carboxylate and tetrakis-pyridine ligands, 5a and 5b, 
respectively. Having two carboxylate donor groups bound in a cis conformation at the 
Pt centre was computed to be energetically disfavoured due to electrostatic repulsion 
between the two negatively charged groups. Although cis-bispyridine coordination 
around a square planar metal centre is common and energetically favoured, self-
reorganisation occurs to maximise site occupancy, giving rise to one carboxylate and 
one pyridine at each metal centre. 





Figure 1.6. Three-component self-assembly of box 5c. Under thermodynamic control, 
driven by the separation of charge at the metal centres.[31] 
 
The charge separation strategy has also been used by Mukherjee’s group in the 
template-free synthesis of a trigonal prism,[32] analogous in geometry to 4, as well as 
Severin’s group using arene “capped” Ru corner units.[33] Severin and co-workers have 
also used the arene “capped” Ru motif to assemble trinuclear metallamacrocycles that 
were linked together using dynamic covalent chemistry to form tetrahedral capsules.[34] 
Often, metal-ligand interactions are either too kinetically inert, hindering the self-
sorting process, or too weak, where the entropic factors for self-assembly outweigh the 
enthalpic gains. A number of different strategies have been applied to kinetically “lock” 
or “unlock” metallosupramolecular interactions, these are summarised in a 
comprehensive review by Thomas.[35] The following strategies used to tune the metal-
ligand bond affinities are all worth bearing in mind when building three-dimensional 
metallosupramolecular structures: 
(i) Choice of metal: As shown above, Pd(II) and Pt(II) complexes both have 
the same square planar geometry but differ in their affinity to bind ligands. 
Pt(II) complexes are generally more kinetically stable and form more robust 
supramolecular complexes, however as the Pt-pyridine bond is nearly 
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irreversible at RT, templates are often used in tandem to help energetically 
favour the self-assembly of a targeted scaffold. Likewise, the Pt-N bond can 
also be labilised using electron withdrawing groups in the cis- and trans- 
position on the metal. Within the 1st row transition metals, Fe(II), Ni(II), 
Zn(II) and Co(II) all favour octahedral coordination, however their affinities 
for ligand coordination all differ and as a consequence different assemblies 
are obtained.[36] 
(ii) Choice of ligand motif: Thus far, all of the above examples have contained 
pyridine-based ligands. Although they are the most common monodentate 
ligands in the self-assembly of metallosupramolecular capsules, not too 
labile and not too inert, other ligands have been used in order to control the 
lability of the M-L bond. Metal-nitrile interactions are far weaker than those 
for pyridine but cooperatively self-assembly of discrete squares[37] and 
capsules[38] is still possible. Metal-phosphorous bonds are more kinetically 
inert but paired with the [Ru(tpy)Cl] motif (tpy = 2,2′,6′,2″-terpyridine)[39] 
or “naked” coinage metals (Cu(I), Ag(I) or Au(I))[40] spontaneous assembly 
of polygons and tetrahedra was respectively accomplished. Replacing labile 
pyridine ligands, that were used to drive discrete self-assembly, with 
kinetically irreversible acetylide ligands was demonstrated by Michl and co-
workers as a useful technique for “locking” metallosupramolecular 
architectures.[41] Bidentate ligands, which generally form even stronger 
interactions than their monodentate counterparts, are also common in the 
field of metallosupramolecular assemblies. Examples that feature bidentate 
ligands will be discussed in the following part of this chapter. 
(iii) Trans- and cis- influence and effect: The stability of metal-ligand bonds 
can be tuned simply by altering the ligand trans to the activated metal 
coordination site. σ-donor, weak-field ligands such as pyridine or amines, 
will stabilise, while σ-donor/π-acceptor, strong-field ligands such as carbon 
monoxide groups will labilise trans-ligands.[42] Re(I)-amine complexes are 
fairly inert at RT but with carbon monoxide ligands coordinated to the 
“capped” trans sites on the metal centre supramolecular assembly is 
achievable as demonstrated by Hupp and co-workers with their Re(I)-
linked Zn-porphyrin boxes.[43] In the same manner but to a lesser extent, cis-
effects can also be utilised to alter the binding affinity of metal complexes as 
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demonstrated by Stang and co-workers, who frequently use bulky, electron-
withdrawing PPh3 groups in the cis position to labilise Pt N-donor 
interactions.[44] 
(iv) Solvent, counterions, additives and light: If metal-ligand bonds are 
relatively inert, performing the self-assembly in weakly coordinating 
solvents, such as THF or CH3CN, or even under light[45] can help weaken the 
supramolecular interactions and enhance the rate of self-sorting. 
Conversely placing the supramolecular assembly in a non-coordinating 
solvent would lead to an inherent increase in stability. Likewise, counterion 
choice can dramatically alter the outcome of self-assembly. For example 
using weakly coordinating anions such as NO3- in organic solvents may 
allow for self-corrections to take place. Whereas replacement of NO3- 
counterions for PF6- may result in a mixture of different products and 
oligomers.[46] Coordinating additives such as 2,2,2-trifluoroethanol (TFE) 
have also been used by Fujita’s group to temporarily labilise the Pt-pyridine 
bond within the self-assembly of their Pt molecular nano-spheres. 
Following the thermodynamically controlled self-assembly of Pt12L24, TFE 
was removed rendering this cuboctahedron kinetically inert.[47] 
(v) Cooperative and chelate effects: Analogues to Velcro and DNA, a number 
of “seamed” supramolecular systems are stable primarily due to the 
combined strength of their individual intermolecular interactions.[48] Alone, 
these metal-ligand interactions are often readily reversible but 
cooperatively, stable aggregates are formed.[49] The entropic cost often 
heavily outbalances the enthalpic gains of a single intermolecular 
interaction. However, if several supramolecular interactions are present the 
combined enthalpic gain outweighs the relatively unchanged entropy of the 
system. Chelation is also an enthalpically favoured effect, giving rise to a 
greater number of M-L interactions without increasing the number of 
aggregates associated with the system. 
 
Following on from the pioneering work by Saalfrank and co-workers,[50] Raymond’s 
group developed a cooperatively stabilised tetrahedral M4L6 capsule 6 using octahedral 
metal centres with the chelating effect of bis-bidentate catechol ligands (Figure 1.7).[51] 
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Utilising the octahedral geometry of either Ga(III), Al(III), In(III), Fe(III), Ti(IV), or 
Ge(IV) with rigid naphthylene-amide-linked bis-catecholate ligands and a template, a 
racemic mixture of homochiral assemblies (Δ,Δ,Δ,Δ or Λ,Λ,Λ,Λ) were obtained. The Δ (or 
Λ) handedness in chirality at the metal centre would determine, due to geometric 
constraints, the homochiral geometry of the entire structure. Using chiral S-nicotinium 
cations resolution of the two enantiomers was possible.[52] Due to the cooperative 
nature of metal-ligand binding (24 metal-ligand interactions in total) assembly 6 is 
very robust and does not undergo racemisation even when boiled in water. Unusually 
for metallosupramolecular chemistry, this cage structure is anionic with a 12- charge; 
the presence of the 12 countercations make it water soluble, however, its large 
aromatic “panels” create a hydrophobic environment within the centre of the cage.  
 
 
Figure 1.7. Tetrahedral homochiral [M4L6] capsule 6 synthesised using 6 bis-catechol 
ligands with 4 Ga(III) cations. Five of the six bis-catechol ligands have been removed for 
clarity.[51]  
 
Symmetric [M4L4] clusters have also been constructed by Raymond[53] using tris-
bidentate ligands and octahedral Ti(IV) or Sn(IV) metal centres and Saalfrank et al. 
using Fe(II).[54] Saalfrank et al. have also created a unique chiral indium Δ,Δ,Λ,Λ-[In4L4] 
assembly which interestingly forms from a racemic mixture of homoconfigurational 
(Δ,Δ,Δ,Δ)/(Λ,Λ,Λ,Λ)-fac-[In4(HL)4](ClO4)4 (L = tris(5,5-dimethyl-2,4-dioxohexyl)amine) 
stereoisomers by a simple deprotonation reaction.[55] An alternative method for the 
synthesis of pure homochiral clusters was reported by Cui who used chiral ligands to 
direct the exclusive formation of (Δ,Δ,Δ,Δ) or (Λ,Λ,Λ,Λ)-fac [M4L4] clusters with Fe(III) or 
Ga(III) metal centres.[56] 
≡ 
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Moving away from tris-catecholate and other oxygen based bidentate ligands, in 2008 
first Lindoy[57] and then Nitschke[58] reported on the synthesis of novel Fe4L6 
tetrahedrons. Cage 7, reported by Nitschke and co-workers, is formed from the in-situ 
condensation of 4,4′-diaminobiphenyl-2,2′-disulphonic acid and 2-formylpyridine to 
give the tris-bidentate N-donor ligands (Figure 1.8). The reversible nature of imine 
condensation gives cage 7 a unique assembly/disassembly switchable property, 
triggered by the pH of the aqueous solution.  
 
 
Figure 1.8. pH reversible assembly/disassembly process for cage 7 with cyclohexane 
as guest (not shown).[58] Five of the six ligands have been removed for clarity. 
 
The “on/off” switchable property of cage 7 has led to molecular-recognition studies on 
the stabilisation of reactive species and capture of greenhouse gases, gold compounds 
and fullerenes (see section 1.4.2). Following on from the synthesis of cage 7 the 
Nitschke group has constructed a comprehensive library of other three-dimensional 
architectures all incorporating reversible bis-, tris- or tetrakis-bidentate imine-pyridine 
ligands.[59] The dynamic nature and sensitivity of these imine capsules to terminal 
amine group modification[60] and different anions and metals have been further 
demonstrated.[36] Exchanging Fe(II) for the more kinetically labile Co(II) and using a 
slightly modified bidentate ligand than the one used for the synthesis of 7 resulted in 
the self-assembly of a tetrahedral cage.[61] However, substituting the OTf- counterions 
for ClO4- led to a complete geometric reassembly into a pentagonal antiprismatic 
structure. This pentagonal structure was also recently assembled using Fe(II) metal 
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centres with functionalised methoxy ligands for enhanced water solubility.[62] The self-
assembly, although in equilibrium with the tetrahedral conformation during synthesis, 
is cooperatively “locked” at RT when isolated. 
The same group also demonstrated the true capability of self-assembly with the 
formation of cube 8. Using a staggering 62 subcomponents with 2 different metals in 





Figure 1.9. Cube 8 assembled in a single step from 62 subcomponents. Twenty of the 
twenty-four ligands have been removed for clarity.[63]  
 
Recently, Schmittel and co-workers also used Schiff base condensation with the 
tetrahedral geometry of Cu(I) to develop capsule 9.[64] Employing the site occupancy 
maximisation principle, with the use of bulky substituted phenanthroline ligands for 
steric control, only heteroleptic coordination was observed within the ground state 
(see Figure 1.10a).[65] This concept was used to build a trigonal prism with 3 bis-ditopic 
pyridine-aldehyde ligands and 2 tris(phenanthroline-Cu(I)) units before capping the 
ends with 2 trifunctional amine aggregates via a Schiff base condensation reaction to 
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form capsule 9 (see Figure 1.10b). Capsule 9 is unique in the fact that it contains one 





Figure 1.10. a) Illustration of how site occupancy maximisation principle with a bulky 
substituted phenanthroline ligand can be used to favour heteroleptic coordination. M+ = 
Cu+ or Ag+. b) Capsule 9 with 1 large (red) and 2 small (blue) cavities.[64] 
 
Metallo-structures using unsaturated octahedral metal centres have also been 
assembled by Ward, who with his team has built up a vast array of photo-active 
polyhedral cages using ligands with two bi-dentate pyrazolyl-pyridine N-donors 
attached to a central fluorescent aromatic group.[66] By altering the geometry of the 
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ligands through substitution of the central aromatic groups many different M2:L3 
topologies were shown possible; [M4L6] tetrahedra, [M8L12] cubes, [M12L18] truncated 
tetrahedral and [M16L24] tetra-capped truncated tetrahedral. The preference for the 
formation of one assembly over a range of others was rationalised to be driven by 
secondary aromatic interactions, which were accessible due to a degree of flexibility in 
the ligands. The truncated tetrahedral [M12L18] cage 10 is a good example where 
extensive naphthyl (electron-rich) and pyrazolyl-pyridine (electron-poor) π-stacking 
interactions give rise to a high-order assembly (see Figure 1.11).[67] The formation of 6 
stacks, each of which contains 6 π-π interactions, enthalpically outweighs the 
entropically disfavoured gain in size, driving the exclusive formation of 10. 
 
 
Figure 1.11. X-ray crystal structure of the truncated tetrahedral [Co12L18] cage 10 with 
the grey carbon atoms for the 6 π-stacks are highlighted in red, green, blue, yellow, 
orange and pink, N atoms in light blue and Co in dark blue.[67] 
 
The octahedral geometry of Ru(II) was also exploited by Therrien in the synthesis of 
metallo-prisms[68] and boxes[69]. Arenes were used as inert “capping” ligands to “block 
off” three of the six coordination sites on the Ru(II) metal centres. The assembly of the 
three-dimensional scaffolds followed the directional “clip” strategy, where ditopic 
10 
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chloro-, oxalate-, benzoquinone- or thiolato-bridged arene-Ru(II) dimer “clips” 
spontaneously assembled with tris- or tetrakis-monodentate ligands to form the 
corresponding cationic prisms. By structurally altering the arene, bridging and 
“panelled” ligands of the Ru(II) “clips” different physical and chemical properties can be 
targeted, such as fluorescence detection of nitroaromatics as demonstrated by Stang’s 
group.[70] In 2011, Therrien and co-workers reported the successful synthesis of a 
series of water soluble trigonal prisms 11a-11c with different sized pores (see Figure 
1.12).[71] Using bridged ligands of varying width (12a-12c), the pore size was altered 
while keeping the cavity volume constant. Cages 11a-11c were used as potential drug 
delivery agents in a study to investigate the rate of guest release relative to the pore 
size. Unsurprisingly, out of the 3 cages, 11a had the largest pores and the fastest guest 
release and 11c the smallest pores and the slowest release. This work is a good 
illustration how selective alteration of the ligands can fine-tune the necessary chemical 
and physical properties targeted in an assembly. 
 
 
Figure 1.12. Water soluble Ru(II) prisms 11a-11c constructed from 3 different 
corresponding bridging ligands, 12a-12c, using the “clip”-strategy.[71] 
 
In a similar manner, Jin and co-workers assembled trigonal prisms using the Ir(III) 
cyclopentadiene motif.[72] Self-assembly occurred in the presence of tpt driven by C-H 
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activation of terephthal-bis-aromatic imine ligands with [Cp*IrCl2]2 to give a ditopic 
dinuclear Ir precursor. The Ir cages were similar in size and shape to 11 and 
encapsulation of aromatic guests such as Pt(acac)2, pyrene, and coronene was also 
demonstrated. 
Rhenium(I) is also known to form octahedral organometallic structures with 
moderately labile properties. Slone and Hupp took inspiration from nature to build the 
first Re-linked supramolecular Zn-porphyrin square 13 (Figure 1.13).[73]  
 
 
Figure 1.13. Re-linked supramolecular porphyrin square 13.[73] 
 
The Zn-porphyrin square is assembled using Re(I) metal corner linkers functionalised 
using strongly trans-labilising CO ligands. These molecular squares, and ultimately 
boxes,[74] have no charge associated with them, which has rendered their use as 
potential molecular sieves.[75] The molecular square 13, although described as a two-
dimensional shape, is as such three-dimensional due to the large Zn-porphyrin ligands 
and possesses properties that are usually associated with cage-like assemblies (see 
section 1.4.3). Initial attempts to synthesise a molecular box using Re as corner linkers 
was unsuccessful but utilising the vacant coordination sites on the Zn in the porphyrin 
scaffold led to the synthesis of box 14 (Figure 1.14).[74] The supramolecular structure 
was assembled using a 2:1 ratio of Zn-porphyrin trimers with Sn-porphyrin dimers in 
organic solvents. The large size of the cavity can accommodate multiple guests and its 
size, along with its asymmetry, can be adjusted by simply altering the R″ groups on the 
Sn-porphyrin bridging ligands.[76] 





Figure 1.14. Rigid Zn-porphyrin box 14 as reported by Hupp. TIPS = triisopropylsilyl, R 
= OC6H13, R′ = OC4H9, R″ = 4-tert-butylbenzoate.[74] 
 
Other Zn-porphyrin based assemblies have also been built by Osuka[77] and Aida[78], 
who both reported on two isomeric box conformations with interesting light harvesting 
properties. 
14 
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Hupp’s Zn-porphyrin metallo-assembly 14 and Nitschke’s Fe8Pt6L24 cube 8 are 
examples where more than one metal can be used to make a supramolecular capsule. 
The introduction of a second metal into a supramolecular array could potentially lead 
to unique magnetic, photoluminescent or electrochemical properties that could be 
accessed without the potentially tedious multistep covalent synthesis of organic 
ligands. By using metal centres with orthogonal binding motifs, assemblies with 
reduced symmetry are more easily accessible. The design principles in self-assembly of 
heterometallic cages tend to be very similar, whereby ligands with two orthogonal 
metal-binding sites are used, one soft and one hard.[70, 79] The hard donor site, such as a 
catechol, will fully saturate the available coordination sites of a hard metal cation, such 
as Ti(IV) or Ga(III), leaving the soft donor site, such as pyridine, to coordinate to a soft 
metal cation, such as Pd(II) or Fe(II). Reversibility in the soft donor site is still key to 
ensure self-correction and the formation of a discrete assembly can ensue. Ti(IV) and 
Pd(II) have been used in an analogous manner by Shionoya’s group to construct a 
unique supramolecular assembly with an interconvertable structure.[80] After extensive 
comparative 1H NMR studies on the thermodynamic stability of Ti(IV) complexes, 
Shionoya’s team came up with a TiHL2(acac) (L = 4(3-pyridyl)catechol, acac = 
acetylacetonate) complex which converted into TiL3 by selective-ligand exchange in the 
presence of H2L and a strong base. By altering the basic conditions and component 
fraction this system was also shown to be reversible. This led to the development of a 
macrocyclic structure 15 that under analoguos conditions in the presence of 
PdCl2(CH3CN)2 converted into a three-dimensional assembly 16 (Figure 1.15). 
Changing the pH with a strong acid, cage 16 could be interconverted back into 15. The 
stepwise reaction pathway to 16 is under kinetic control, this was demonstrated when 
no single product was formed on mixing all 3 components in a single pot. The 
interconvertable property of cage 16 could potentially be applied as an “on/off” trigger. 
This stepwise ligand exchange strategy used in the self-assembly of capsules 16 has 
been further exploited by Shionoya, who has construct larger capsules with a further 
reduction in symmetry.[81]  





Figure 1.15. Ti(IV)Pd(II) complex with a switchable geometry between macrocycle 15 
and cage 16.[80] 
 
A similar ligand exchange strategy has also been used by Mirkin and co-workers 
dubbed the “weak-link” approach. The weak-link approach uses cis-bidentate chelating 
ligands, which contain one kinetically locked bond, such as M-PPh2, and the other a soft 
interaction, such as M-O or M-S, which can be broken on addition of suitable exogenous 
ligands. Addition of stronger coordinating ligands transforms the bidentate motif 
around the metal into a trans-monodentate interaction, expanding the assembly and 
producing two newly available binding sites per metal centre. Mirkin’s group 
constructed a Rh linked macrocycle, 17, where the bidentate phosphine and oxygen 
bridged ligands could be expanded by the addition of CO or CH3CN (see Figure 1.16).[82] 
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The expanded forms of the macrocycle 18 and 19 could then be homocoupled to form 
cylindrical capsules 20 and 21 by preferential substitution of the CO or CH3CN using 2 
dinitrile or diisocyanide bridging ligands, respectively. Mirkin’s group have also 
reported other expandable macrocycles and prisms,[83] which have been utilised, using 
this weak-link approach, as exogenously triggered allosteric catalysts.[84] 
 
 
Figure 1.16. Using the weak-link approach macrocycle 17 was expanded using CO or 
CH3CN to give 18 and 19, respectively, from which cylindrical capsules 20 and 21 were 
assembled.[82] 
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All examples within this chapter were demonstrated to converge either under 
thermodynamic control into discrete three-dimensional assemblies (e.g. Fujita’s 
prisms) or under a step-wise approach (e.g. Shionoya’s Ti(IV)-Pd(II) cages), where a 
degree of kinetic control was introduced. The key strategies used to direct self-
assembly of discrete entities are summarised below: 
(i) Metal choice: Choosing a metal cation with a complimentary coordination 
and binding affinities for the chosen ligands is a prerequisite to successful 
self-assembly. For example, Nitschke demonstrated how moving across the 
1st row divalent TMs produced different outcomes in self-assembly when 
the same ligand was used.[36] This was as a result of subtle differences in the 
coordination sphere and binding strength of the different metal cations. The 
reversibility in the metal-ligand bond is also essential for self-correction 
when targeting thermodynamic ground state products. Make the bond too 
robust or too labile and a mixture of oligomers will result. 
(ii) Ligand design: Pre-self-assembly, ligands are often designed with pre-
determined geometric information so when used in spontaneous 
assemblies steric hindrance prevents the formation of undesired 
coordination. The ligand geometry is often constrained with the use of 
alkynes and aromatic linkers in order to “lock” the ligand in a desirable 
conformation. In many instances the rigidity of the ligand has also allowed 
for stereochemical information to be transferred between metal centres, 
eradicating the formation of different stereoisomers.[51, 85] Using bulkier 
ligands can not only alter the ligand preference in multi-component systems 
but altogether prevent cis-coordination, as exemplified by Fujita when 
building multi-component prisms.[28] Hupp’s group also used bulky axial 
ligands in the design of their box to prevent binding of the “scaffold” ligands 
to the inner cavity.[74] Coding the ligands with pre-determined geometrical 
information, along with accurate aggregate ratios, is often necessary in 
order to prevent oligomerisation occurring. 
(iii) Maximisation of site occupancy: In most examples, which are under 
thermodynamic control, self-assembly is driven by maximisation of site 
occupancy with entropic and enthalpic considerations, whereby the 
smallest discrete assembly, which satisfies all donor/acceptor sites at a 
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given stoichiometry, is often preferentially formed. Depending on the 
number of acceptor and donor sites and the stoichiometry used within the 
system the size of the smallest discrete assembly sometimes turns out to be 
quite large, for example a triple rhomboid assembled by Stang.[86] 
Maximisation of site occupancy has also been referred to as “avoidance of 
valence frustration” by Nitschke.[87] 
(iv) Guest-templating: As mentioned earlier, guest-templating has been used 
alongside thermodynamic control to kinetically “lock” supramolecular 
structures, however, it is more commonly used to pre-organise aggregates. 
When maximisation of site occupancy is not energetically favourable 
enough, a complimentary template can be used to lower the ground-state 
energy minima to a particular discrete self-assembly.[26] Demonstrated by 
Raymond’s group in the synthesis of tetragonal prism 6,[56] chiral guests can 
also be used as templates to selectively favour the formation of one 
enantiomer over the other, or as Nitschke has demonstrated using anions, 
one structure over another.[61]  
(v) Charge separation: Asymmetry can be introduced into a supramolecular 
capsule using di- carboxylate and pyridine ligands in tandem.[31-32] Due to 
repulsive electronic effects of the carboxylate ligands around cis-protected 
square planar metal centres, only one carboxylate and one pyridine ligand 
is preferentially bound. 
(vi) Secondary inter-ligand interactions: Although very tricky to pre-engineer 
within a particular self-assembly, secondary inter-ligand interactions are 
common within large supramolecular cages,[66] which are often formed with 
a degree of serendipity. The multiple secondary interactions may lead to a 
cooperative effect, which enthalpically favours and stabilises higher-order 
systems at an entropic expense. 
(vii) Site-selective ligand exchange: Known by Stang as the “clip” strategy or 
by Mirkin as the “weak-link” approach, site-selective ligand exchange is a 
powerful technique in the directional stepwise construction of capsules that 
contain a reduced-degree of symmetry. The spectrochemical series is often 
used in this fashion, to kinetically drive the formation of desired assemblies 
by substitution of labile ligands (e.g. NO3-) for more kinetically inert 
aggregates (e.g. N-donors). However, extensive NMR analysis into the 
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dynamic metal-ligand exchange influenced by both the structure and 
properties of the metal and ligands and their combination under external 
stimuli is often required to build successful systems.[81] 
 
From a growing catalogue of three-dimensional metallo-assemblies these examples 
were chosen due to the variety of different construction strategies used to direct and 
“lock” the supramolecular scaffolds. These self-assembled cages were also chosen due 
to their potential to act as catalysts, containers, sensors and transporters. 
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1.4 Functional metallosupramolecular capsules  
1.4.1 Background 
Initially built purely for aesthetic reasons, the focus of supramolecular design has 
evolved to build self-assemblies that fulfil specific applications including guest 
recognition, containment of reactive and unstable species, mediation of stoichiometric 
and catalytic reactions and drug carriers for biological applications.[6c, 88] 
The systems to be discussed in this section all have one common key requirement 
which is that the metallosupramolecular assemblies are capable of encapsulating ionic 
or molecular guests.  
Pioneering work in the field of host-guest chemistry was led by Cram who along with 
Lehn and Pederson received the 1987 Nobel Prize for their development and use of 
molecules with structure-specific interactions of high selectivity. Working primarily 
with covalently constructed architectures, Cram used host systems as containers to 
facilitate guest encapsulation and stabilise reactive and unstable aggregates by limiting 
the degrees-of-freedom of the guest within their cavities.[89] 
The receptor properties of metallosupramolecular capsules were observed and the 
potential implications acknowledged by Fujita with the synthesis of the first capsule 
1.[10] Soon after, both Raymond[51] and Ward[90] also observed guest recognition of ionic 
species within the well-defined cavities of their respective capsules. From these studies 
the idea of using metallosupramolecular three-dimensional assemblies as molecular 
scale, size specific containers began to flourish. Their ease of synthesis and, through 
simple ligand and metal substitutions, adjustable dimensions and properties, were the 
main factors favouring the use of metal based self-assemblies as molecular vessels 
rather than the original covalent assemblies reported by Cram. In the same practical 
manner as a flask can be used in everyday life to contain, combine and store matter, 
these molecular capsules can be used to separate and sense materials by selective guest 
encapsulation, effectively concentrate multiple species and stabilise reactive entities by 
protecting them from the bulk-phase. The microenvironment of the well-defined 
internal cavity, due to restricted space, also has the potential to conformationally pre-
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organise one or multiple guests such that unique phenomena, not usually present in the 
bulk solution, are observed. 
1.4.2 Metallosupramolecular capsules as containers 
Four years on from constructing their first three-dimensional self-assembly, Fujita’s 
group began utilising cage 1 for specific applications.  
In 2000 the group reported the “ship-in-a-bottle” synthesis of the short lived cyclic 
silanol trimer 22 by enclathration in 1 (Figure 1.17).[91] 
 
 
Figure 1.17. Stabilised cyclic silanol trimer 22 within cage 1.[91] 
 
The size specific dimension and hydrophilic cavity of 1 was ideal for encapsulation and 
stabilisation of three short lived phenylhydroxymethylsilane molecules hydrolysed 
from their methoxy derivatives prior to polymerisation in water at 100 °C. Without 1 
further polymeric condensation took place. Additionally, the condensation and 
isolation of a specific number of trialkoxysilanes was controlled by altering the cavity 
size and shape of the supramolecular hosts.[92] This “cavity-directed synthesis” 
approach illustrates how supramolecular assemblies can be tailored to encapsulate a 
certain number of guests at orientations which favour specific reactions. This system is 
a direct mimic of the biological world where the exact product formed is pre-
determined by the information encoded within the cavity size, shape and electronic 
properties of the enzyme.  
Cage 1 has also been used to stabilise the coordinatively unsaturated 16-electron 
[Cp′Mn(CO)2] (Cp′ = methylcyclopentadienyl) complex 23 in order to solve a long 
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running debate over its coordination, which turned out to be pyramidal and not planar 




Figure 1.18. Cage 1 stabilisation of unsaturated complex 23 used to solve a long 
running debate over its conformation.[93] 
 
In biology the formation of DNA duplexes under aqueous conditions is a highly efficient 
and specific process which is partly catalysed by the pre-organisation of base pairs 
within hydrophobic pockets of enzymes and partly driven by co-operative enthalpic 
interactions. Synthetic recognition of unstable mononucleotide duplex base pairs in 
water has only recently been achieved. Fujita and co-workers reported the successful 
stabilisation of mononucleotide duplexes in water within the hydrophobic cavity of 
molecular prism 4.[94] This minimal nucleotide base pairing using artificial systems has 
potentially opened new synthetic routes to the synthesis of larger man-made ribosome-
like transcriptional devices. 
The bowl shaped assembly 2 is a more accurate representation of nature’s enzymes 
where the hydrophobic pocket is open to bind organic molecules with no constraints 
on size. 2 has also been used to stabilise biological structures, such as oligopeptides as 
α-helices up to 17 residues long.[95] In proteins, hydrophobic cavities selectively direct 
the formation of α-helical secondary peptide structures through favoured 
intermolecular host-guest interactions and hydrogen bonding between the i and i + 4 
residues of the peptide chains. However, outside the protein environment these 
polypeptides unfold due to entropic forces which outweigh the enthalpically favoured 
intramolecular hydrogen bonding. Bowl 2 is the correct size and shape for 
enclathration of i, i + 4 and i, i + 7 residues of oligopeptides, stabilising the formation of 
α-helices (Figure 1.19).[95c] π-π interactions between host and guest and the 
hydrophobic environment of this artificial enzyme is believed to be the driving force for 
this process. 





Figure 1.19. Directed formation of an α-helical secondary peptide structures within 2. 
Reproduced from Ref 95c. 
 
Raymond and co-workers have also demonstrated a wide use of applications with their 
anionic tetrahedral cage 6. Water solubility, structural integrity and the ionic nature of 
6 were observed to drive encapsulation of small cationic[51] and neutral[96] aggregates 
analogous with Fujita’s cages, however, the shape, size and electrostatic properties of 6 
were very different. In 2000, Raymond utilised 6 as a host for the quantitative 
formation and protection of unstable phosphonium cations in aqueous solvents.[97] 
Iminium cations were also stabilised in the same fashion by electrostatic driven 
interactions between the highly anionic cavity of host 6 and the positively charged 
cations.[98] 
With a growing interest for guest encapsulation Raymond, in collaboration with 
Bergman, ran extensive experiments to establish the characteristics and mechanism for 
guest exchange within 6.[51, 96, 99] They discovered that encapsulation depends on the 
size, charge, hydrophobicity and enthalpy of desolvation of the guests and although the 
different metal centres at the vertices have little conformational effect on the assembly, 
the encapsulated species are found to significantly distort the shape and size of the 
internal cavity. The encapsulation process is endothermic and driven entropically by 
desolvation of the guests through enclathration in the hydrophobic environment of the 
host. Furthermore, as the guests are generally too large to move freely in and out of the 
cavity, the process for guest ingress and egress was observed to occur via the expansion 
of the capsules pores and not by the rupture of the M-L bonds. 
Ac-AEAAAEAAWAEAFAAE-NH2 
2 
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Cage 6 has also been utilised for reaction studies of nitrogen pyramidal inversion. 
Nitrogen inversion/rotation (NIR) within amines involves lone pair migration across 
the tetrahedral structure. Previously, solution NMR analysis was used to quantify the 
inversion free-energy barrier associated with NIR processes but due to experimental 
difficulties only results for amines with high inversion energy barriers were obtained. 
The constrained local environment of host 6 made the perfect tool for controlling the 
rate of nitrogen inversion, which along with NMR analysis was used to produce free-
energy diagrams for the NIR process of monoprotonated diamines.[100] 
Cage 7 has also been used by Nitschke’s group to stabilise reactive aggregates.[101] 
White phosphorous (P4) is highly air-sensitive and reacts with oxygen explosively to 
form H3PO4, driven by the formation of strong P-O bonds. In the presence of 7 within an 
aqueous solution, P4 is encapsulated within the perfectly sized cavity by hydrophobic 
interactions (Figure 1.20). The stabilisation of P4 is due to the constrained nature of the 
pocket which is too small for the larger P4O10 to form in the presence of oxygen. 
Following on from the success brought about with cage 7, Nitschke and co-workers 
went on to selectively encapsulate larger fullerenes from fullerene soot using a 
porphyrin-based cubic assembly[102] and linear Au molecules in tube-like capsules, for 
which encapsulation was reversible by switching the solvent.[103]  
 
 
Figure 1.20. White phosphorus stabilised within cage 7, unable to react with O2 due to 
the constrained environment of the cavity. 
 
Using guest-templating or steric constraints to direct the construction of Pt(II) self-
assemblies at elevated temperatures, as discussed in the previous section,[26] led to the 
synthesis of trigonal prismatic cages of varying height (see Figure 1.5). Encapsulation 
of up to as many as 5 pyrene guests held together within a stack by their aromatic π-π 
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interactions was observed by Fujita and co-workers.[29] Other planar metal complexes 
and aromatic guests have also been stabilised as stacks and investigated for their 
unique spin crossover properties,[104] electron transport,[105] formation of metal ion 
arrays[106] and encapsulation of discrete polarised aromatic stacks.[107] 
Likewise, Therrien’s group have constructed a series of Ru-based trigonal prisms 
(analogous to 12) that show an affinity for aromatic guest encapsulation through π-π 
interactions.[108] Host-guest chemistry studies revealed that using a large aromatic 
molecule, such as methyl 4-(pyren-1-yl)butanoate, results in the formation of a stable 
carciplex-like complex, where the guest is permanently bound. 
Thus far, we have demonstrated how the constrained, size-specific cavity of 
metallosupramolecular capsules can be utilised to stabilise reactive species, 
intermediates and unusual products, constrain or increase the energy barrier for the 
rearrangement of guests for in-situ studies, selectively bind and extract aggregates from 
the bulk phase and permanently encapsulate guests to form non-covalently bonded 
interlocked systems. Incarceration of guest molecules is generally driven by 
hydrophobic effects in water, however, secondary intermolecular interactions are often 
observed in the form of Coulombic forces, π-π stacking and hydrogen-bonding.  
Hydrophobically driven encapsulation within supramolecular assemblies has also been 
used to increase the effective molar concentration of reactive aggregates as a means to 
lower the reaction free-energy barriers for the formation of new products under mild 
conditions. The similarities between three-dimensional self-assemblies and enzyme 
active sites have led to the exploitation of supramolecular cages as novel reaction 
vessels for unique site-selective reactions and rearrangements. 
 
Metallosupramolecular Capsules                                                                                       Chapter 1  
34 
 
1.4.3 Metallosupramolecular capsules as reaction mediators 
In 1997, Rebek et al. were the first group to successfully exploit the enzyme-like 
properties of a three-dimensional supramolecular assembly. They demonstrated how 
their hydrogen bonded capsule could function as a microreactor for the purpose of rate 
enhancement in a Diels-Alder reaction between two compatible species.[109] Driven 
primarily by π-π interactions within a weakly-polar organic solvent the two guest 
molecules were complementary in size and shape for encapsulation within the host. 
The encapsulation effectively increased the molar concentration of the reactive species 
as well as pre-organising both molecules into their reactive conformations. Although, 
successful in increasing the rate of reaction by an impressive 200-fold the capsule had 
to be used in stoichiometry quantities as product inhibition was an issue. The product 
was complimentary in size and shape to the internal cavity of the host enthalpically 
favouring the formation of the newly formed host-guest complex and preventing the 
cage from acting as a true catalyst. 
The issue of product inhibition was explored by Fujita’s group who created a system 
where the previously reported cage 1 was recyclable after facilitating the Diels-Alder 
reaction between 1,4-naphthoquinone and 2-methyl-1,3-butadiene.[110] The water-
soluble nature of the cage allowed the reaction to be run in an aqueous solution which 
gave rise to entropically driven encapsulation of the reactive species within the 
hydrophobic environment of the cavity of cage 1. The effective molar concentration and 
pre-organisation led to a 113-fold rate enhancement for Diels-Alder reactions under 
stoichiometric conditions. The orthogonal solubility properties of the host and guest 
allowed the formed product to be isolated from cage 1 using an organic solvent and 
cage 1 to be reused as a molecular flask within a new reaction. 
The orthogonal solubility properties between the host and guest were utilised to a 
greater extent in a Wacker-type oxidation process for styrenes (Figure 1.21).[111] Using 
a two phase system, host 1 was used to mediate the phase-transfer of styrene from the 
organic to the aqueous phase where oxidation into acetophenone occurred in the 
presence of Pd(II) as co-catalyst. The formed product was readily auto-excluded from 
the cavity of cage 1 due to an increase in water-solubility, which allows the cage to 
actively function as a catalyst with a turnover-number (TON) ca. 13. The catalytic cycle 
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Figure 1.21. Two Phase Wacker-type oxidation of styrenes using cage 1 in the 
presence of a Pd(II) co-catalyst. O2 is used to re-oxidise Pd(O).[111] 
 
The pre-organisation capability of these molecular cages has also been shown to 
selectively facilitate the formation of unique regio- and stereo- selective products under 
cycloaddition reactions.  
In solution, anthracene generally reacts with dienophiles to give the 9,10-adduct, 
however in the presence of cage 1 the 1,4-adduct was observed to form when using N-
cyclohexylmaleimide (Figure 1.22).[112] The sterically constrained environment of the 
cavity facilitates pre-organisation of the relatively inert species into the most space 
saving orientations, which happens to be the ideal conformation to form the 1,4-endo-
adduct via Diels-Alder reaction. 




Figure 1.22. Diels-Alder reaction between N-cyclohexylmaleimide and 9-
hydroxymethyl anthracene within cage 1 leads solely to the formation of the unusual 
1,4-adduct.[112] 
 
The geometrically constrained environment of the cavity of capsule 1 has been 
demonstrated by Fujita to promote other unusual, energetically disfavoured regio- and 
stereo- selective [2+4] cycloaddition reactions. Facilitating reactions by means of 
increasing the effective concentration of species using Cage 1 has not been limited to 
the [2+4] Diels-Alder cycloadditon, the group have also demonstrated rate 
enhancements in the photochemical [2+2] dimerisation reaction between 
heteromolecules. Originally reporting on the cross-coupling of homo-olefins,[113] Fujita 
went on to demonstrate that cross-photodimerisation between two different entities in 
the presence of cage 1 was also possible.[114] Dimerisation between two different olefins 
is a challenging task as the two species are often very similar in their reactivities and 
form a mixture of homo- and hetero- dimers. Within the hydrophobic cavity of the cage 
selective encapsulation of 5-ethoxy-1,4-naphthoquinone and acenaphthylene in a 1:1 
ratio was observed to occur, due to the size and steric constraints of the cavity. 
Photoirradiation of the complex led to the exclusive formation of the endo dimer in 
92% yield. Fujita also went on to demonstrate that the outcome of a cycloaddition 
reaction can be controlled by either heating or photoirradiating the reaction mixture, to 
give either the [2+4] or the [2+2] cycloaddition product, respectively.[115] Other 
photochemical cycloadditions,[116] radical additions[117] and rearrangements[118] have 
also been observed using cage 1 as a molecular reaction vessel.  
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Complete encapsulation of the reactive aggregates within molecular flasks is not crucial 
for reactions to take place. The bowl-shaped supramolecular assembly 2 has been used 
as a more efficient alternative to 1 in the photodimerisation of naphthoquinones, which 
led to a 98% exclusive yield of the syn-isomer.[113] However, as for capsule 1, 
complimentary π-π and CH-π interactions between product and bowl 2 inhibit 
exclusion of product from the “reaction chamber” and the microreactor had to be used 
stoichiometrically to reach the reported yields.  
Nature’s enzymes that effectively increase reaction rates with high turnover numbers 
tend to selectively facilitate uninhibited access with complementary host-guest 
interactions to specific aggregates only. The complex structure of enzymes promotes 
efficient pre-organisation of guest entities, reducing the energy barrier to regio- and 
stereospecific reactions. The enzymatic cycle is completed with auto-exclusion of the 
product from the enzymes’ open pockets, a crucial step if high turnover numbers are to 
be achieved. 
Although the reported yields for the above reactions were high, product inhibition still 
remained a major problem when exploiting self-assemblies as catalysts. Fujita et al. 
have addressed this problem by successfully achieving product repulsion within the 
hydrophobic “open” cavity of 2 due to disfavoured product conformation. The enzyme-
like hydrophobic pocket of 2 was the perfect host for the Diels-Alder reactions between 
N-phenylmaleimide and 9-hydroxymethyl anthracene, but rather than the 1,4-adduct 
being the major product when cage 1 was employed, the 9,10-adduct was exclusively 
formed in 99% yield (Figure 1.23).[112] This was achieved using catalyst loading at 10 
mol % with an observed TON c.a. 10. The pocket-shape of 2 was observed to be 
complimentary in shape to the reactive species, pre-organising the aggregates in 
reactively favoured orientations. The geometry of the formed product possessed a 
“kink” at the 9,10-position leading to a disruption to host-guest π-stacking interactions 
as a result of a less complementary fit. Unlike the kinetically “trapped” environment of 
1, the reduced enthalpic interactions between the 9,10-adduct and 2 were over 
powered by the entropically favoured solvation effects, which effectively led to auto-
exclusion. The destabilised “empty” cavity was re-stabilised by inclusion of further 
reactants, completing the catalytic cycle.  
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Recently, Mukherjee’s group reported near identical results for the Diels-Alder reaction 
using a triimidazole modified bowl assembly as catalyst.[119] 
 
 
Figure 1.23. Catalytic cycle in the Diels-Alder reaction between N-phenylmaleimide 
and 9-hydroxymethyl anthracene in the presence of bowl 2.[112] 
 
Around the same time as Fujita, Raymond and Bergman also demonstrated the catalytic 
potential of prism 6 by successfully creating a catalytic cycle for the 3-aza-Cope 
rearrangement of enammonium cations (Figure 1.24).[120] In aqueous solutions the 
electrostatic attraction between the anionic host 6 and the cationic enammonium guest 
formed a host-guest complex where the constrained environment of the host’s cavity 
pre-organised the guest into a chair-like conformation. The chair-like geometry of the 
cation reduced the entropic cost for the [3,3]-sigmatropic rearrangement and reaction 
occurred under mild conditions. Once formed the iminium cation was preferentially 
replaced by an ammonium cation and hydrolysed within the bulk phase to the 
corresponding aldehyde, leaving prism 6 to be reused in the catalytic cycle. This system 
avoids product inhibition and efficient catalysis was achieved with a modest 13 mol % 
loading of catalyst. The aza-Cope rearrangement was also observed to obey the 
Michaelis-Menten model of enzyme kinetics, accelerating the reaction by a remarkable 
850-fold (for R = iPr, R′ = H) in the presence of 6.[120b] 
 





Figure 1.24. Catalytic cycle in the Aza-Cope rearrangement of enammonium cation 
within the cavity of host 6. R = iPr, R′ = H.[120] 
 
Further catalytic cyclisation reactions with high catalytic efficiency were achieved by 
Raymond, Bergman and co-workers, who reported on impressive rate accelerations by 
up to a factor of 106 in the Nazarov cyclisation of pentadienols, comparable for the first 
time to those observed by enzymes.[121] The origin of the enzyme-like efficiency was put 
down to pre-organisation and stabilisation of the transition state as well as the 
increased basicity of the alcohol group. Inspired by enzymatic processes, the group 
successfully mimicked the action of terpene synthases in the cyclisation of 
monoterpene (±)-citronellal.[122] Under physiological pH, only the deprotonated 
product was observed when 6 was used as catalyst. However, in an aqueous solution, 
out with the hydrophobic cavity of the capsule, the hydrated form was observed as the 
major species. The success was attributed to the conformational control and 
hydrophobic environment provided by 6 in analogy to terpene synthases. Cage 6 has 
also been used as a highly efficient catalyst in the hydrolysis of acetals to ketones 
(>95% yields with 5 mol % of 6)[123] and orthoformates to formate esters, unusually 
under basic condition.[124] 
Recently, the full potential for these enzyme-like cage assemblies to act as 
environmentally benign catalysts was demonstrated in a Knoevenagel 
condensation.[119, 125] A reaction most commonly achieved with enzymes, Fujita and co-
workers successfully used cage 1 (see Figure 1.1) to catalyse the dehydration of various 
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aldehydes with Meldrum’s acid in a neutral homogenous aqueous solution (Figure 
1.25).[125] Surprisingly, the reaction proceeded to give near stoichiometric yields with a 
catalytic loading of only 1 mol %. The spontaneous egress of product due to an 
unfavoured conformation is believed to be the driving force in this highly efficient 
catalytic cycle. Interestingly, no catalytic effects were observed with bowl 2. This was 
attributed to the stabilisation of charge of the intermediate species by the cationic 
Pd(II) centres located around every portal of cage 1. 
 
 
Figure 1.25. Proposed mechanism for the catalytic Knoevenagel 
condensation of an aldehyde with Meldrum’s acid in the presence of cage 1.[125] 
 
Thus far, Fujita’s and Raymond’s supramolecular three-dimensional metallo-
assemblies have been used as catalysts that have successfully facilitated a number of 
different regio- and stereoselective reactions in catalytic cycles with high rate 
enhancements and modest TONs. Another challenge in replicating the biological 
functionality of enzymes was to introduce chirality into the synthetic molecular flasks 
so that within a catalytic cycle the formation of one enantiomer of the product would be 
favoured over the other. 
In order for self-assemblies to act as stereoselective catalysts, chiral information has to 
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1 by replacing the bidentate ethylenediamine ligand of 1a for (1R, 2R)-N,N′-dialkyle-
1,2-diaminocyclohexane, 1b and 1c (Figure 1.26). Applying 1b as a chiral microreactor 
in the asymmetric [2+2] photoaddition of 3-methylfluoranthene and N-
cyclohexylmaleimide resulted in enantioselectivity of 50% ee (Figure 1.27).[126] The 
relatively modest enantiomeric excess was surprising as the chiral information was 
bestowed on the outer periphery of the cage, with little known presence in the inner 
cavity. For that reason it was hypothesised that the chiral auxiliaries imposed a minor 
geometric deformation in the triazine “panels” resulting in a chiral environment within 
the cavity of the cage. This system however still had the same limitations of product 















Figure 1.27. Asymmetric [2+2] photoaddition of 3-methylfluoranthene and N-
cyclohexylmaleimide within cage 1b.[126] 
 
As discussed previously, tetrahedral cage 6 is chiral due to the stereogenic 
tris(bidentate) Ga(III) metal centre. In the presence of a chiral cation, the resolution of 
the Λ and Δ homochiral enantiomers was possible.[52] Chiral information transfer from 
6 to substrate has recently been achieved by Raymond’s group in the previously 
reported aza-Cope rearrangement (see Figure 1.24).[127] The aza-Cope rearrangement 
of emmonium cations (with different R-groups on the terminal olefin), in the presence 
of homochiral prism 6, gave rise to chiral product at 78% ee with corresponding yields 
of 49%. 
Hupp and co-workers took a different approach to chiral catalysis by incorporating an 
active achiral Mn-porphyrin catalyst (see Figure 1.28) for oxidation reactions within 
the chiral environment of the Zn-porphyrin square 13 and box 14. Chirality was 
introduced through the R″ ligands axial to the Zn-porphyrin centres. Initially using 
square 13, although an enhancement in catalytic lifetime, up to 100-fold, was observed 
no enantiomeric preference was visible for the epoxidation of styrenes.[128] This was 
believed to be due to the large torsion angles in the porphyrin “panels” of the square. 
Within 14 the porphyrin “panels” are far more rigid due to the geometric constrains of 
the box shape. In the presence of the imbedded Mn-porphyrin catalyst methyl p-tolyl 
sulphide was successfully oxidised into the corresponding sulfoxide with a modest 12% 
ee (Figure 1.29a).[76] As the active catalytic site is embedded within the constrained 
cavity of 14, the size selective nature of the catalyst was also demonstrated in the 
preferential epoxidation of the less bulky (Z)-stilbene (Figure 1.29b). 








Figure 1.29. Box 14 (see Figure 1.14) used with a Mn-porphyrin catalyst (see Figure 
1.28) to catalyse a) the chiral oxidation of p-tolyl sulphide and b) the size selective 
epoxidation of (Z)-stilbenes. TIPS = triisopropylsilyl, R = OC6H13, R′ = OC4H9, R″ denotes 
the different groups coordinated to the Sn-porphyrin ligand for reactions a) and b).[76] 
b) 
a) 
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This concept of incorporating an organometallic catalyst within the cavity of a 
molecular capsule has also been used to enhance reaction rates by increasing both the 
effective molar concentration of the reactive species around the active site, and 
selectivity, which is controlled by the well-defined cavity. First reported in a 
collaborative project between Raymond’s and Bergman’s group,[129] the size 
constrained chiral environment of host 6 with an encapsulated Ir(III) complex, was 
used to enhance the size and diastereomeric selectivity of C-H bond activation of 
various aldehydes. However, this system was stoichiometric and not catalytic due to 
cavity inhibition of the product. Recently, a catalytic cycle using an encapsulated Au(I)-
phosphine complex within 6 for the hydroalkoxylation of allenes was accomplished.[130] 
Formation of the heterocyclic product was increased from 11 to 48% with the 
encapsulation of the CH3PAu(I) catalyst within 6, likewise, the reaction rate was 
accelerated 8-fold with reported TONs as high as 67. The size- and shape-selective 
capability of 6 has also been used in tandem with a Rh(I) catalyst in selective 
isomerisation of allylic alcohols.[131] 
Reaction rate enhancement and high TONs, site- and stereoselectivity and life-time 
durability are the main criteria by which the success of a catalyst is determined. In 
order to build a successful three-dimensional supramolecular catalytic system the 
following key points should be taken into consideration: 
(i) Concentration of reactive species: Primarily driven by solvophobic 
forces, increase in the effective molar concentration of reactive aggregates 
within the host’s cavity is the key concept for supramolecular cage catalysis. 
The hydrophobicity of the guest is often the driving factor in the majority of 
examples. 
(ii) Pre-organisation: The constricted shape and size of the host’s cavity 
guided by intermolecular host-guest interactions facilitates the highly 
selective pre-organisation of guests into reactive conformations. Often 
unusual regio- and stereo- selective reactions occur as a result. The size and 
shape of the cavity is pre-determined through the selective use of specific 
ligands and metals. 
(iii) Auto-exclusion of product(s): The product, if not emitted from the host’s 
cavity, will inhibit any further reactions and greatly reduce the TON. 
Repulsion of the product has been achieved through unfavoured sterics, 
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repulsive electrostatic forces and increased solubility of product within the 
bulk phase. Without auto-exclusion the catalytic system has to be used in 
stoichiometric quantities. 
(iv) Chirality: Both chiral templates and ligands have been used in the 
construction of chiral capsules, although in many cases, the chiral 
information is bound to the cage periphery with little chiral influence 
within the cavity. Chiral information transfer from host to guest is readily 
used and highly efficient within enzymes but has only recently been 
demonstrated possible with abiotic assemblies, however, to date the 
number of synthetic systems with high ee’s remains limited.  
(v) Charge: The charge, which is often overlooked, has also been demonstrated 
crucial in some cases for stabilising ionic intermediates and facilitating 
auto-exclusion of product.[121, 125, 132] 
 
Thus far, metallosupramolecular three-dimensional scaffolds have been shown to 
function as molecular-sized containers and reaction vessels, analogous to nature’s 
enzymes. Despite the fact that the first abiotic metal-based capsule is nearly two 
decades old, it is only recently that advances in utilising these assemblies for other 
application have started to emerge.  
1.4.4 Other applications 
The notion that a chiral environment does not have to be covalently linked to the active 
catalyst has also been explored by Feringa et al. who have reported on the use of DNA 
linked Cu(II) assemblies in the asymmetric catalysis of a number of different 
reactions.[133] Enzyme-like catalysis analogous to Feringa’s DNA based system has yet to 
be achieved with artificial self-assemblies however the arene ruthenium cage 24 
reported by Therrien et al. has shown exactly this sort of potential.[134] Functionalised 
pyrene guest 25 (where R = propan- or butanoate) has been demonstrated to bind to 
the chiral host’s cavity with a protruding “arm”, capable of linking to an active catalyst 
(Figure 1.30). Although cage 24 is not proven to be chiral, an earlier reported trigonal 
prism has shown the presence of chirality in the form of a helical Bailer twist that 
persisted in solution without isomerism.[135] 





Figure 1.30. Aromatic guest 25 encapsulated within cage 24. An R group capable of 
linking to an active catalyst extends outside the cavity of the host.[134] 
 
Therrien and co-workers are also paving the way in utilising metallo-capsules as water-
soluble drug delivery systems.[136] Incorporating cisplatin or M(acac)2 (where M = Pd or 
Pt), potent anti-cancer drugs, into highly charged capsule 24 has facilitated “Trogen 
Horse-like” drug uptake into cancer cells.[134] Cage 24 was observed to be moderately 
cytotoxic towards human ovarian A2780 cancer cells, however, encapsulation of either 
the Pt/Pd complexes, or recently developed pyrenyl guests,[137] resulted in a significant 
increase in activity. The potential to functionalise the pyrenyl derivatives with better-
targeting groups for specific diseases, as well as enhanced selectivity, site-specific 
activity and solubility is currently being investigated by the group. 
Preliminary investigations into drug delivery of cisplatin by supramolecular assemblies 
has also recently been undertaken by Crowley and co-workers.[19b] Following the self-
assembly of a water-soluble host 26, two cisplatin molecules were preferentially 
encapsulated within the host’s cavity, stabilised by hydrogen-bonding between the 
amines and the endohedral pyridines (Figure 1.31). The encapsulation of cisplatin was 
shown to be reversible by disassembly of cage 26 with the addition of competing DMAP 
ligands.  






Figure 1.31. a) Spontaneous self-assembly and encapsulation of two cisplatin guests 
within cage 26, b) X-ray crystal structure of 26 with two cisplatin guests and c) DMAP 
triggered disassembly.[19b] C atoms are highlighted in grey, N in light blue, metals in 
dark blue and Cl in green. 
 
The group have recently demonstrated further potential for 26 by successfully 
functionalising ferrocene groups in the exo-position on the ligands using “click” 
chemistry.[138] The 1,2,3-triazol “click” moiety and ferrocene groups did not hinder self-
assembly or encapsulation of cisplatin. Functionalising 26 or similar assemblies with 
biological targeting groups using this “click” chemistry approach could potentially lead 
to the next generation of very specific drug delivery systems. 
Fujita and co-workers have also appended functional groups to the ligands of their 
M12L24 nano-capsules, but instead of sitting on the periphery the groups were attached 
in the endo-position to control the environment within the cavity. Using oligo(ethylene 
oxide),[139] perfluoroalkyl,[140] methyl methacrylate[141] and azobenzene[142] groups 
reversible La(III) absorption, fluorocarbon encapsulation and stabilisation, more 
efficient radical polymerisation and the control of the cavities hydrophobicity and guest 
uptake using light was respectively achieved. Recently, a glucose lined interior for these 
nano-spheres was also developed to favour the encapsulation of Si(OCH3)4 and 
Ti(acac)2(biphen) (acac = acetylacetonate, biphen = 2,2′-biphenoxide), that underwent 
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condensation reactions to form monodisperse SiO2 and TiO2 nanoparticles, 
respectively.[143] 
 
1.5 Redox and optically active supramolecular assemblies 
Thus far, the transition metals incorporated within the scaffold of supramolecular 
capsules have solely played a passive structural roll, however, transition metals are 
also known for their highly active redox and photochemical properties. In nature, 
chlorophyll in plants is probably the best known molecule for harvesting solar energy, 
which through a series of complicated processes transforms the captured light, via 
electrical energy transfers, into chemical energy. Envisaged by Ward,[66] utilising the 
metal centres within supramolecular assemblies for other applications, such as light 
harvesting redox-catalysis, is potentially the focal point and the next big challenge 
within the field of metallosupramolecular cage assemblies, yet to-date it has remained 
relatively unexplored.  
Redox catalysis using metallo-capsules has been achieved by the likes of Su and co-
workers, who reporting on C-H bond activation of various hydrocarbons using a Cu(I) 
cage as catalyst.[144] Although Cu(I) plays a critical role in the catalytic cycle, the only 
purpose the cage motif serves is in modulating the modest catalytic activity, controlled 
by the different associative counterions. Jung’s group have also developed a water 
soluble capsule, [((CH3)4en)Pd)3(L)2](BF4)6 (L = 1,3,5-tris(isonicotinoyloxyethyl) 
cyanurate), capable of catalysing Suzuki-Miyaura C-C cross-coupling reactions without 
the aid of phosphine or other additives.[145] The reaction rates were enhanced when a 
single water molecule was encapsulated within the cavity, consistent with water-
assisted effects of the Suzuki-Miyaura cross-coupling reactions. However, like the 
former example, the three-dimensional structure was to little advantage, as catalysis 
only occurred on the periphery of the cage.  
Photoactive supramolecular capsules, both organic and metal containing, have also 
made an appearance in the literature. Mimicking the antenna modulus used for light-
harvesting in biological systems, porphyrin-based self-assemblies have been 
extensively investigated by the Hunter,[146] Anderson[147] and Kobuke groups.[148] The 
first porphyrin-based three-dimensional capsules were however not assembled until 
Metallosupramolecular Capsules                                                                                       Chapter 1  
49 
 
2004, when first Osuka[77] and soon after Aida[78] demonstrated the light-harvesting 
capability of metallosupramolecular boxes using porphyrin motif 27 (Figure 1.32). 
Other metal-ligand motifs that are inherently luminescent have also been used to 
construct optically active cage assemblies. The [Re(CO)3Cl] unit 28, reported in the self-
assembly of 13, was used by Hupp and co-workers to assemble supramolecular 
squares using 4,4′-bipyridine and [M(dppp)(OTf)2] (M = Pd, Pt; dppp = 1,3- 
(diphenylphosphino)propane).[149] The Re-squares were the first reported 
metallamacrocycles to possess photo-excitable metal-to-ligand charge-transfer (MLCT) 
transitions. Sun and Lees subsequently constructed a large array of luminescent Re-
base squares and triangles.[150] These metallamacrocycles were utilised as anion and 
small aromatic molecule sensors due to their high sensitivity to guest binding. Alkoxy 
linked Re “clips” 29 have also been used with tetratopic pyridine ligands to assemble 
luminescent Re-based boxes.[151] These assemblies were however only luminescent 
when cooled to 77 K (λmax = 628 nm), due to irradiative quenching of the postulated 
3MLCT transitions. The first Ru(II)-based luminescent macrocycles were reported by Xu 
and Hong, who used a [Ru(tpy)Cl] moieties 30 (tpy = 2,2′,6′,2″-terpyridine) to assemble 
molecular squares and triangles.[39] The metallamacrocycles displayed ground-state 
absorption at 470 nm, indicative of MLCT transitions, with emission bands blue-shifted 
to 550 nm, relative to the mononuclear analogue at 635 nm. The two assemblies were 
used as sensors for 1,4-dimethoxybenzene and anisole, functioning by alterations to the 
luminescence quenching pathways and triggering an enhancement in emission 
intensity on guest binding. Using similar arene-Ru(II) “clips” 31 to those used by 
Therrien (see Figure 1.12), Stang and co-workers assembled a series of luminescent 
squares[152] and trigonal prisms.[70, 153] Both MLCT within the Ru(II) “clips” and 
inter/intraligand π→π* transitions between the highly conjugated pyridine-based 
ligands give rise to the observed luminescence, which is retained within the self-
assembled scaffolds. The Ru capsules were used to detect explosive nitroaromatics, 
which dramatically quenched the fluorescence on encapsulation within the cavity. 
These assemblies were also shown to exhibit greater cytotoxicity in vitro then that of 
cisplatin. Nitroaromatic detection has also been achieved by Mukherjee’s group using 
Pt-based prisms[25, 154] assembled using the inherently luminescent M-acetylide motif 
32 (where M = Pd(II) or Pt(II)).[155] The same group also incorporated the M-acetylide 
motif 32 into a modified version of the Pt “clip” used by Stang (see Figure 1.3). The 
modified Pt “clip” was used with a linear ditopic N,N′-bis(4-
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pyridylidene)ethylenediamine receptor ligand to assemble a luminescent rectangular 
assembly that was used as a sensor for 3d transition metal cations.[154] When a Mn(II), 
Fe(III), Ni(II) or Cu(II) cation was bound within the cavity of the molecular rectangle a 
reduction in luminescence intensity was observed due to quenching of the 
photoinduced electron transitions by the partially filled d-orbitals of the transition 
metals. A bis(acetylide) Pt(II) moiety has also been used to construct Pt-based squares 
and rectangles that display long lived phosphorescent lifetimes, with exceptionally high 
quantum yields.[156] The source of the luminescence within these conjugated systems is 
believed to be due to a combination of 3MLCT excited state and π→π* intraligand 
localised transitions. 
Perhaps the most studied Ru(II)-based fluorophores are the polypyridyl Ru(II) 33 
complexes.[157] However, possibly due to the kinetic lability of the Ru-pyridine bond, 
there have been very few reported supramolecular assemblies incorporating this 
moiety.[158] Likewise, [Ir(ppy)2]+ 34 complexes are known to be highly luminescent,[159] 
yet, as for [Ru(bpy)3]2+, very few examples of their use as supramolecular assemblies 
have appeared in the literature.[160] 





Figure 1.32. Various metal-ligand motifs used within supramolecular assembly that 
display photophysical activity. 
 
Examples where the metallosupramolecular-capsules have been utilised for optically 
active applications have however remained limited. Light has been used as a trigger to 
control conformational changes of supramolecular assemblies and vice versa where a 
conformational change has resulted in a dramatic change in light emission. Recently, 
Clever and co-workers reported on photochromic bis-monodentate pyridyl 
dithienylethene ligands that with “naked” Pd(II) cations formed an M2L4 assembly.[161] 
Irradiating the capsule with light of a given wavelength the ligands undergo a 
conformational change, expanding or contracting the size of the capsule’s cavity. This 
light-triggered expansion/contraction was used to control guest uptake/release of a 
dodecafluorododecaborate anion. Shionoya and co-workers have also observed optical 
activity with their earlier reported Hg6L8 assembly.[16] Interestingly the fluorescence 
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was coupled with the assembly’s conformation change and could be turned “on” and 
“off” with the addition of excess Hg(II) or [2.2.2]-cryptand, respectively, due to 
structural alterations into the non-fluorescent Hg6L4 capsule. The only known example 
in the literature where a supramolecular “flask” plays a photo-mediated role is in the 
photochemical oxidation of adamantane.[162] Using cage 1, Fujita and co-workers were 
able to encapsulate 4 adamantane molecules per host and with photoirradiation in air 
regio-selective oxidation was achieved at 24% yield. Extensive mechanistic studies 
revealed that following excitation of cage 1 a single electron was transferred from one 
adamantane molecule to the electron-poor tpt “panels”. The adamantane radical was 
subsequently quenched with either residual water or oxygen to give the oxidised 
products 1-adamantylhydrogenperoxide or 1-adamantanol (Figure 1.33). 
 
 
Figure 1.33. Photochemical oxidation of adamantane in the hydrophobic cavity of 1 in 
water.[162] 
 
Alternative strategies in the construction of redox and optically active assemblies have 
used inherently photoactive ligand motifs, such as anthracene,[163] coumarin,[164] 
naphthyl[66] or aniline[165], or by functionalising the acceptor and/or donor building 
blocks of a supramolecular scaffold with photoactive groups. 
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Stang and co-workers have demonstrated that post-self-assembly modification was 
possible with a hexagonal prism, assembled using the charge separation strategy with 
hexatopic pyridine “panels” and ditopic carboxylate “pillars”.[166] Following self-
assembly with maleimide-functionalised “pillars”, post synthetic covalent modification 
introduced ferrocene groups to the periphery of the cage, thereby bestowing redox 
activity on the system. Functionalisation of the self-assembly building blocks using 
ether or carboxylate linkers with various other groups has also been used by Stang 
with a plethora of different polygons and polyhedra[167] and Fujita with the M12L24 
nano-spheres reported earlier.[168] 
 
1.6 Conclusion and project targets 
Inspired by nature, biological mimicry together with a bottom-up engineering approach 
has been used by chemists to constructing nano-sized containers and catalysts dubbed 
“molecular flasks” and “microreactors”. As discussed in this chapter, the use of 
transition metal complexes to construct molecular capsules has been of great 
advantage due to 3 key factors: i) accessibility to a wide range of well-defined bonding 
angles, ii) an array of tailored bond strengths and iii) general ease in synthesis relative 
to conventional covalent chemistry. Since the synthesis of the first 
metallosupramolecular capsule in 1995, the field has been rapidly expanding and with 
recent innovations now includes more complex heteroleptic and heterometallic 
supramolecular architectures. Orthogonality in metal-ligand interactions has given 
access to kinetic step-wise control in the construction of three-dimensional assemblies 
with reduced symmetry and well-defined cavities. Finally, host-guest chemistry has also 
played a crucial role in both the synthesis, through the use of templates, and ultimately 
the utilisation of the capsules as hosts for stabilising aggregates and mediating unique 
and catalytic reactions. Constructing these molecular capsules for a purpose other than 
their unique topographies is the current focus within the literature. In particular, these 
capsules have shown potential use within the field of environmentally benign catalysis, 
opening the door to the next generation of “greener” enzyme-like reaction mediators. 
However, to-date, the metal centres and ligands generally play a structural role and 
have not been fully exploited for their potential photo-active and electrochemical 
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properties. Recently, examples where the metal centres and ligands serve a purpose 
besides maintaining the capsule’s architectural integrity have started to emerge.  
More often than not the specific functions of metallosupramolecular capsules reported 
in the literature appear to have been discovered serendipity, such as catalysis which 
tends to be very specific towards only a small number of reagents. The design and 
construction of capsules that are complimentary in conformation and electrostatic 
properties to specific guests or a purposeful function still remains a major challenge. 
However, one cannot forget that this is still a relatively new area of research in the field 
of supramolecular chemistry. With the growing number of unique designs, synthetic 
methods and applications so will develop the interest and intellectual understanding 
into how these metallosupramolecular capsules can be constructed to fulfil specific 
tasks and processes. 
The aim of this project is to initially develop new metallosupramolecular capsules via a 
kinetically controlled approach, straying away from conventional thermodynamic one 
pot self-assembly reactions (Chapter 2). Secondly, the well-established optically-active 
cyclometalated [Ir(ppy)2]+ unit will be used to assemble the first luminescent capsule of 
this nature (Chapter 3), which will be thoroughly investigated for its host-guest 
chemistry coupled with its inherent photo-active properties (Chapter 4). 
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Demonstrated herein is a kinetically controlled approach to self-assembly, in which the 
sequence of addition of pre-engineered molecular structural units leads to the 
stereoselective formation of discrete metallosupramolecular cages. Using either a 
phenylpyridine or a diphenylpyridine cyclometalated Pt corner unit two different sets of 
structural isomers were kinetically assembled by selective addion of the ligands. The 
kinetically stable cage isomers were characterised by their distinctly different 1H NMR 
spectra and mass spectrometry collision-induced dissociation pathways. 
 
  




The reversibility of noncovalent and metal-ligand interactions has been widely 
exploited to synthesise a plethora of supramolecular and coordination-based 
assemblies under thermodynamic control.[1] Occasionally, entrapment in local energy 
minima leads to the formation of metastable products, which are often converted into 
lower-energy products upon prolonged reaction times.[2] In contrast, self-assembled 
products in nature almost always arise according to the most expedient reaction 
pathway, that is, are kinetically selected.[3] Herein, supramolecular structural isomers 
were constructed following a kinetically controlled, sequence dependent pathway, 
which is scarcely found in the literature.[4] 
The use of platinum(II) (and other third-row transition metals) is particularly well-
suited to a kinetic approach to self-assembly, not just because Pt–ligand bonds can be 
kinetically inert, but also because the metal ion can be conveniently tuned to produce a 
vast range of different ligand-exchange labilities. For instance, assemblies that utilise 
bis(phosphine) ligands as corner protecting groups often readily assemble at room 
temperature,[5] while those that exploit neutral N-donor bidentate ligands, such as 
ethylene diamine, typically require several hours at elevated temperatures to reach 
equilibrium.[6] Furthermore, the mechanism of labilisation, that is, the trans effect, is 
such that it is possible for a single metal centre to possess cis exchangeable sites with 
dramatically different kinetic properties. Recently a metallosupramolecular trigonal 
prism that possesses an unsymmetrical cyclometalated C^N corner protecting group 
was prepared within the Lusby group, which was assembled in two steps by treating 
[L1Pt(DMSO)] (where H2L1 = 2,6-diphenylpyridine) sequentially with 4,4′-bipy (4,4′-
bipy = 4,4′-bipyridine) and tpt·3CSA (where tpt = 2,4,6-tris(4-pyridyl)-1,3,5-triazine 
and CSA = (+)-camphor-10-sulfonic acid; see Scheme 2.1, steps a and b).[7] The isolation 
of a single isomeric product cis-[(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6 from a possible 
fourteen products, as indicated by the 1H NMR spectrum of the hexa-PF6- salt (Figure 
2.1a), led us to question, was this selectivity a result of each Pt centre possessing one 
labile and one inert exchangeable site, or was the selectivity thermodynamic in origin? 
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2.3 Results and Discussion 
2.3.1 2,6-diphenylpyridine Pt(II) cages 
In order to answer whether the formation of cis-[(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6 was 
occurring under thermodynamic or kinetic control, the sequence in which 4,4′-bipy and 
tpt were added to [L1Pt(DMSO)] was reversed. [L1Pt(DMSO)] was first treated with a 
third of an eq of tpt at RT in CH2Cl2 to give [(L1Pt)3(tpt)] (Scheme 2.1, step c), which 
was then treated with 4,4′-bipy·2CSA, and after metathesis with NH4PF6, the hexa-PF6- 
salt was isolated in 99% yield (Scheme 2.1, step d).  
 
 
Scheme 2.1. Sequence specific control over the formation of metallosupramolecular 
stereochemical isomers. Conditions: a) 4,4′-bipy, CH2Cl2, RT, 18 h, 77%; b) (i) tpt·3CSA, 
CH2Cl2, RT, 1 h; (ii) NH4PF6, 97%; c) tpt, CH2Cl2, RT, 18 h, 85%; d) (i) 4,4′-bipy·2CSA, 
CH2Cl2, RT, 3 h; (ii) NH4PF6, 99%. 
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The 1H NMR spectrum of this product (Figure 2.1b) also indicated the formation of a 
single species, yet there were clear differences between the spectra of the two isomers, 
in particular, for resonances HA-E. The product from route 1 was assigned as cis-
[(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6, in which the tpt ligand is coordinated cis to the 
nitrogen of 2,6-diphenylpyridine, and the product from route 2 was assigned as trans-
[(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6, in which the tpt ligand is coordinated trans to the 
nitrogen of 2,6-diphenylpyridine. This absolute assignment was made on the basis that 
a) the resonance of the ortho-proton of tpt (HC) is more deshielded in the trans-to-
nitrogen coordination site in comparison to the ortho-proton 4,4′-bipy (HB), and b) the 
large and small relative separations between the resonances of HA and HB, and between 
the resonances of HC and HD. 
 
 
Figure 2.1. 1H NMR spectra (500 MHz, C2D2Cl4, 298 K) of a) cis and b) trans-
[(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6. The assignments correspond to the lettering shown 
in Scheme 2.1. 
 
To corroborate the structural assignment of the isomers in solution, analysis was 
undertaken using nanoelectrospray mass spectrometry (nESI-MS). While samples of 
the presumed cis and trans isomers both showed identical peaks that matched the 
predicted isotope pattern for the intact 3+ (1360 m/z) and 2+ (2114 m/z) charged 
cages (see section 2.5.3), their collision-induced dissociation (CID) pathways differed 
significantly (see Figure 2.2). For instance, MS2 experiments showed that with 
increasing kinetic energy, the isolated intact 3+ charged cage [[(HL1Pt)6(4,4′-
bipy)3(tpt)2](PF6)3]3+ of the cis isomer initially fragments to give ions at 1308 and 1464 
m/z, which then fragment further to a dominant species at 1152 m/z (see Figure 2.2a).  
 





Figure 2.2. Partial nESI spectra with increasing collisional energy of the +3 intact 
prism (1360 m/z) to illuminate the CID pathways (see insets) for a) cis and b) trans-
[(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6. 
 
Although, the singly charged peak at 1152 m/z unambiguously corresponds to 
[[(HL1Pt)2(4,4′-bipy)]PF6]+, and thus supports the assignment of the cis isomer, in 
which the weaker trans-to-phenylato Pt-tpt bond undergoes selective dissociation at 
lower potential, the peaks at both 1308 (+2) and 1464 (+1) m/z could correspond to 
more than one different structure with the formulas of [[(HL1Pt)4(4,4′-
bipy)2(tpt)](PF6)2]2+ and [[(HL1Pt)2(4,4′-bipy)(tpt)]PF6]+, respectively. However, MS3 
experiments of both the species at 1308 and 1464 m/z showed the predominant 
appearance of the +1 ion at 1152 m/z ([[(HL1Pt)2(4,4′-bipy)]PF6]+). This finding 
suggests that the ions at 1308 and 1464 m/z correspond to tpt coordinated with two 
and one [(HL1Pt)2(4,4′-bipy)] unit(s), respectively, and that initial fragmentation of the 
cage results from cleavage of Pt-tpt bonds from adjacent panels (Figure 2.2a, inset). 
When the isolated 3+ ion from the trans isomer was subjected to the same CID 
experiment, a signal at 1308 m/z was also observed at low voltage (Figure 2.2b), yet 
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the different charge state (+3) indicates that the initial fragmentation involves the loss 
of a single 4,4′-bipy ligand to give [[(HL1Pt)6(4,4′-bipy)2(tpt)2](PF6)3]3+ (see section 
2.5.3). At higher potential, this peak diminishes with a concomitant appearance of a +2 
ion at 866 m/z, which unequivocally corresponds to [(HL1Pt)3(tpt)]3+. This observation 
fits with a preferential, low-energy dissociation of the weaker Pt-4,4′-bipy bond from 
the trans isomer (Figure 2.2b, inset). 
2.3.2 2-phenylpyridine Pt(II) cages 
To ascertain whether a kinetic self-assembly strategy could be used if the labile 
coordination site isn’t initially masked, we decided to also investigate the sequential 
addition of tpt and 4,4′-bipy to both [(L2Pt)2Cl2] and [(L2Pt)Cl2]Bu4N, where HL2 is the 
bidentate C^N ligand 2-phenylpyridine (Scheme 2.2). The 1H NMR spectrum of a 
mixture of [(L2Pt)2Cl2] and 0.5 eq of 4,4′-bipy (Scheme 2.2, route 1, step a) showed the 
appearance of several new peaks after 5 min (Figure 2.4b); these peaks differed from 
those of the [(L2Pt)2Cl2] starting material (Figure 2.4a). However, the gradual 
disappearance of these initial peaks and the concomitant appearance of a new set of 
signals, which converged to a single species after 24 h at 45 °C, was observed (Figure 
2.4c). Based on the relative chemical shifts, and in particular the significant differences 
of HE and HF in the initial and final compounds (which is caused by shielding by the 
coordinated 4,4′-bipy ligand), it appears that trans-[(L2Pt)2(4,4′-bipy)Cl2] is the initial 
kinetic product, which rearranges into the thermodynamically (and kinetically) more-
stable cis-[(L2Pt)2(4,4′-bipy)Cl2] (illustrated in Figure 2.3).[8] After halide extraction 
using AgX (where X = (+)-camphor-10-sulfonate), treatment with tpt, and then anion 
exchange with NH4PF6, cis-[(L2Pt)6(4,4′-bipy)3(tpt)2](PF6)6 was isolated in virtually 
quantitative yield (Scheme 2.2, route 1, step b). 
 
Figure 2.3. Reaction diagram for the rearrangement of [(L2Pt)2(4,4′-bipy)Cl2] from the 











Scheme 2.2. Kinetically controlled synthesis using an “unmasked” corner protecting 
ligand. Conditions: a) 4,4′-bipy, C2H2Cl4, 45 °C, 24 h; b) (i) AgX (where X = (+)-camphor-
10-sulfonate), C2H2Cl4, RT, 3 h; (ii) tpt, C2H2Cl4, RT, 24 h; (iii) NH4PF6, 98% (starting 
from [(L2Pt)2Cl2]); c) tpt, C2H2Cl4, 45 °C, 24 h; d) (i) AgX (where X = (+)-camphor-10-
sulfonate), C2H2Cl4, RT, 3 h; (ii) 4,4′-bipy, C2H2Cl4, RT, 24 h; (iii) NH4PF6, 77% (starting 
from [(L2Pt)2Cl2]). 
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The 1H NMR spectrum of this product (Figure 2.4d) again suggested the formation of a 
single isomer. When the sequence of addition of 4,4′-bipy and tpt to [(L2Pt)2Cl2] was 
switched (Scheme 2.2, route 2) a single, yet different product was obtained. A 
comparison of the 1H NMR spectra of the two isomers showed significant differences 
(Figure 2.4d and 2.4e), particularly in resonances HA–F.  
 
 
Figure 2.4. 1H NMR spectra showing the kinetic self-assembly reaction starting from 
[(L2Pt)2Cl2] (500 MHz, C2D2Cl4, 298 K). a) [(L2Pt)2Cl2] only; b) trans-[(L2Pt)2(4,4′-
bipy)Cl2]; c) cis-[(L2Pt)2(4,4′-bipy)Cl2]; d) cis-[(L2Pt)6(4,4′-bipy)3(tpt)2](PF6)6; e) trans-
[(L2Pt)6(4,4′-bipy)3(tpt)2](PF6)6. The assignments correspond to the lettering shown in 
Scheme 2.2. 
 
The nESI mass spectra of cis and trans-[(L2Pt)6(4,4′-bipy)3(tpt)2](PF6)6 showed 
identical peaks at 1208 and 1884 m/z, which matched the predicted isotope patterns 
for the intact +3 and +2 charged prisms, respectively (see section 2.5.3). However, in 
contrast to the analogous experiments with cis and trans-[(HL1Pt)6(4,4′-
bipy)3(tpt)2](PF6)6, the CID of the cis and trans isomers of [(L2Pt)6(4,4′-
bipy)3(tpt)2](PF6)6 showed mainly peaks that did not correspond to any sensible 
combinations of L2Pt, 4,4′-bipy, tpt, and PF6-. Instead, the dominant CID pathway for 
both cis and trans-[[(L2Pt)6(4,4′-bipy)3(tpt)2](PF6)3]3+ involves fluoride abstraction 
from the PF6- counteranions. With the cis isomer, the disappearance of the 1208 m/z 
peak is initially accompanied by a dominant species at 1093 m/z, which corresponds to 
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the formula [[(L2Pt)4(4,4′-bipy)2(tpt)F]PF6]2+ (Figure 2.5a). In an analogous manner to 
cis isomer of [(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6, it appears that the initial fragmentation 
pathway involves the cleavage of the weaker Pt-tpt bonds from adjacent panels (also 
supported by a smaller intensity ion at 1311 m/z, which corresponds to [[(L2Pt)2(4,4′-
bipy)(tpt)]PF6]+), a route that is either promoted or stabilised by abstraction of fluoride 
from one of the PF6- counteranions (Figure 2.5a, inset). MS3 experiments show that the 
disappearance of this 1093 m/z ion results from the dissociation into a low-intensity 
ion at 873 m/z, which matches [(L2Pt)2(4,4′-bipy)F]+, and subsequent MS4 experiments 
show that this fragments into a singly charged ion at 505 m/z, by loss of the neutral 
[(L2Pt)F] from [(L2Pt)2(4,4′-bipy)F]+. For the trans isomer, the fragmentation pathway 
appears to first involve loss of a single 4,4′-bipy, again either promoted or stabilised by 
fluoride abstraction from the counter anion, to give [[(L2Pt)6(4,4′-
bipy)2(tpt)2F](PF6)2]3+ (1114 m/z), which subsequently loses another 4,4′-bipy by a 
fluoride promoted/stabilised route to produce [[(L2Pt)6(4,4′-bipy)(tpt)2F2](PF6)2]3+ 
(1020 m/z). Again, the selective loss of 4,4′-bipy ligands from the weaker trans-to-
phenylato coordination sites supports the formation of trans-[(L2Pt)6(4,4′-
bipy)3(tpt)2](PF6)6 (Figure 2.5b, inset). 
 





Figure 2.5. Partial nESI mass spectra with increasing collisional energy of the +3 intact 
prism (1208 m/z) to illuminate the fluoride (purple) induced CID pathways (see insets) 
for a) cis and b) trans-[(L2Pt)6(4,4′-bipy)3(tpt)2](PF6)6. 
 
The four metallosupramolecular stereochemical isomers do not undergo isomerisation, 
or reassemble to generate other assemblies (e.g. Pt4 squares or Pt6(tpt)4 cages) at room 
temperature in solution.[9] We attribute this stability to the non-labile Pt-N bonds trans 
to the nitrogen donors of HL1/L2; although these bonds form readily at room 
temperature (or just above in the case of L2) from the corresponding solvato/halide 
complexes, the activation barrier for de-coordination is such that this step is essentially 
irreversible under ambient conditions. Therefore the sequence in which the N-donor 
bridging ligands are added to the starting platinum complexes determines the 
stereochemical outcome of the reaction. In this regard, the synthesis of these 
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metallosupramolecular isomers combines elements of covalent (irreversible) synthesis 
and noncovalent (reversible) thermodynamically controlled assembly. It could also be 
expected that the isomers would show some thermodynamic bias towards either the cis 
or the trans form, however, heating samples of either cis or trans-[(HL1/L2Pt)6(4,4′-
bipy)3(tpt)2](PF6)6 at 80 °C for 24 h results in a complex mixture with no obvious 
preference for a single species. This is perhaps unsurprising as to gain greater than 
95% selectivity for a single species, an energy difference greater than 1.74 kcal mol−1 
would be required at 298 K.[10] This is in marked contrast to the sequential, kinetically 
controlled syntheses described herein; these syntheses give greater than 95% 
selectivity for single stereochemical isomers, thus highlighting the potential benefits of 
exploiting differences in rates of assembly, rather than simply considering ground-state 
energies, for the preparation of multicomponent systems. 
Since the completion of this work these metallosupramolecular cages were further 
characterised using innovative ion mobility mass spectrometry techniques.[11] 
 
2.4 Conclusion 
The vast difference in labilities of cis exchangeable platinum coordination sites have 
been exploited to selectively synthesise multicomponent stereoisomeric assemblies 
using a template-free, sequential, kinetically controlled approach. This approach has 
the potential to generate other more complex and less symmetric coordinationally 
driven supramolecular assemblies. The highly shape-specific cavities could then play 
host to selective guest binding and catalyse regio- and stereo-specific reactions. 
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2.5 Experimental Section 
2.5.1 General Experimental Procedure 
Unless stated otherwise, all reagents and solvents were purchased from commercial 
sources and used without further purification. cis-[(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6 was 
synthesised as previously described.[7] [L1Pt(DMSO)],[12] [(L2Pt)2Cl2],[8a] 2,4,6-tris(4-
pyridyl)-1,3,5-triazine[13] (tpt) and AgX (where X = (+)-camphor-10-sulfonate)[14] were 
prepared according to the literature procedures. 4,4′-bipy·2CSA was prepared by 
mixing 4,4′-bipy (1 eq) with CSA (2 eq) in CH2Cl2, followed by removal of the solvent 
under reduced pressure.  
2.5.2 Synthesis 




The synthesis of cis-[(HL1Pt)6(4,4′-bipy)3(tpt)2](PF6)6 as reported in the literature.[7] 1H 
NMR (500 MHz, C2D2Cl4): 8.97 (12H, d, J = 6.5 Hz, HB), 8.13 (12H, d, J = 6.0, HC), 8.02 
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(18H, m, HD+J), 7.90 (6H, d, J = 8.0 Hz, HI), 7.74 (12H, d, J = 6.5 Hz, HA), 7.70 (6H, d, J = 8.3 
Hz, HH), 7.44 (30H, m, HL+M+N), 7.29 (12H, m, HG+K), 7.08 (6H, m, HF), 6.26 (6H, d, J = 7.2 






[L1Pt(DMSO)] (0.50 g, 1.0 mmol) was dissolved in CH2Cl2, to which tpt (0.10 g, 0.33 
mmol) was charged. The resulting mixture was stirred for 18 h at RT, before being 
filtered and washed with CH2Cl2 (30 mL) to give the title compound as a dark purple 
solid (0.432 g, 85%). 1H NMR (500 MHz, C2D2Cl4): 9.33 (6H, d, J = 6.1 Hz, HC), 8.62 (6H, 
d, J = 6.1 Hz, HD), 7.55 (3H, t, J = 7.9 Hz, HJ), 7.46 (6H, d, J = 7.8 Hz, HH), 7.30 (6H, m, HF), 
7.24 (6H, d, J = 7.9 Hz, HI), 7.13 (6H, m, HG), 7.03 (6H, d, J = 7.0 Hz, HE); 13C NMR (126 
MHz, C2Cl4D2): 171.0 170.0, 167.6, 154.3, 149.1, 141.2, 139.7, 132.8, 130.5, 124.9, 124.1, 
124.0, 114.5; LR-FAB: m/z = 1586.2 [(LPt)3(tpt)H]+. 
 






To a suspension of [(L1Pt)3(tpt)] (57.4 mg, 0.036 mmol) in CH2Cl2 (7 mL) was added 
4,4′-bipy·2CSA (33.7 mg, 0.054 mmol). Over 3 h, the red suspension gradually dissolved 
to give a clear yellow solution. The volume of solvent was reduced to ca. 3 mL under 
reduced pressure. NH4PF6 (59.0 mg, 0.36 mmol) in acetone (3 mL) was added to the 
reaction mixture and stirred at RT for 30 min. The resultant suspension was filtered off 
and washed with acetone, CH2Cl2 and Et2O to yield a pale orange solid (80.5 mg, 99%). 
1H NMR (500 MHz, C2D2Cl4): 9.02 (12H, d, J = 6.5 Hz, HC), 8.57 (12H, d, J = 6.5 Hz, HD), 
8.13 (12H, d, J = 6.2 Hz, HB), 8.07 (6H, m, HJ), 7.92 (6H, d, J = 8.2 Hz, HI), 7.68 (6H, d, J = 
8.1 Hz, HH), 7.55 (12H, d, J = 7.4 Hz, HL), 7.43 (6H, m, HN), 7.34 (18H, m, HK+M), 7.24 (6H, 
m, HG), 7.19 (12H, d, J = 6.2 Hz, HA), 6.99 (6H, m, HF), 6.06 (6H, d, J = 7.6 Hz, HE). nESI 
(TCE): m/z = 2112.1 [(HL1Pt)6(4,4′-bipy)3(tpt)2(PF6)4]2+, 1360.1 [(HL1Pt)6(4,4′-
bipy)3(tpt)2(PF6)3]3+. 
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To a yellow suspension of [(L2Pt)2Cl2] (99.9 mg, 0.130 mmol) in TCE (15 mL) was 
charged 4,4′-bipyridine (20.3 mg, 0.130 mmol). The colour of the solution and 
suspension changed to a brighter yellow with gentle heating at 45 °C for 24 h. AgX 
(where X = (+)-camphor-10-sulfonate) (97.0 mg, 0.286 mmol) was charged to the 
mixture, which was then stirred for a further 3 h at RT. The colour changed to a dark 
orange/red. The resulting AgCl was removed by filtration through celite and 
thoroughly washed with CH2Cl2. The filtrate was concentrated by the removal of CH2Cl2 
under reduced pressure and tpt (27.0 mg, 0.0867 mmol) charged to the orange 
solution. Over the course of 24 h the colour of the solution changed to yellow and a fine 
precipitate formed. NH4PF6 (141.0 mg, 0.867 mmol) was added in acetone (15 mL) and 
the mixture changed colour to a pale yellow after 1 h. The suspension was filtered using 
a Buchner funnel, washed with acetone, DCM and Et2O to yield a pale orange solid (172 
mg, 98%). 1H NMR (500 MHz, C2D2Cl4): 9.19 (12H, d, J = 5.9 Hz, HB), 9.15 (12H, d, J = 6.0 
Hz, HC), 8.90 (12H, d, J = 6.0 Hz, HD), 8.03 – 7.93 (18H, m, HA+K), 7.84 (6H, d, J = 8.6 Hz, 
HJ), 7.62 (6H, d, J = 8.0 Hz, HI), 7.46 (6H, d, J = 6.4 Hz, HF), 7.25 (6H, m, HH), 7.18 (6H, m, 
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HL), 7.10 (6H, m, HG), 6.27 (6H, d, J = 7.6 Hz, HE); nESI (TCE): m/z = 1884.6 [(L2Pt)6(4,4′-




To a yellow suspension of [(L2Pt)2Cl2] (81.5 mg, 0.106 mmol) in TCE (15 mL) was 
charged tpt (22.0 mg, 0.071 mmol). The colour of the solution and suspension changed 
to slightly orange with gentle heating at 45 °C for 24 h. AgX (where X = (+)-camphor-
10-sulfonate, 79.0 mg, 0.233 mmol) was charged to the mixture, which was then stirred 
at RT for 3 h. The colour changed to a yellow/green. The resulting AgCl was removed 
by filtration through celite and thoroughly washed with CH2Cl2. The filtrate was 
concentrated by the removal of CH2Cl2 under reduced pressure and 4,4′-bipyridine 
(16.5 mg, 0.106 mmol) charged to the yellow solution. Over the course of 24 h the 
colour of the solution remained yellow. NH4PF6 (115.0 mg, 0.706 mmol) was added in 
acetone (15 mL) and the mixture paled slightly over 1 h. The resulting suspension was 
filtered using a Buchner funnel, washed with acetone, CH2Cl2 and Et2O to yield a pale 
yellow solid. Further materiel was obtained following concentration of the filtrate 
under reduced pressure at 60 °C, which was again isolated following filtration and 
washings with acetone, CH2Cl2 and Et2O (total yield from 1st and 2nd crop; 110 mg, 
77%). 1H NMR (500 MHz, C2D2Cl4): 9.19 (12H, br, HC), 9.05 (12H, br, HB), 8.77 (12H, d, J 
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= 5.3 Hz, HD), 8.06 (12H, d, J = 6.3 Hz, HA), 7.96 (6H, br, HK), 7.83 (6H, br, HJ), 7.67 (6H, 
br, HF), 7.56 (6H, m, HI), 7.20 (12H, m, HH+L), 7.03 (6H, m, HG), 6.06 (6H, d, J = 6.9 Hz, HE); 
nESI (TCE): m/z = 1884.6 [(L2Pt)6(4,4′-bipy)3(tpt)2(PF6)4]2+, 1208.9 [(L2Pt)6(4,4′-
bipy)3(tpt)2(PF6)3]3+. 
 
2.5.3 Mass spectra and isotopic distribution patterns for selected 
peaks 
 
Figure 2.6. nESI (100 µM in TCE) mass spectra of a) cis- and b) trans-[(HL1Pt)6(4,4′-











b) 3+ 3+ 




Figure 2.7. nESI (100 µM in TCE) mass spectra of a) cis- and b) trans-[(L2Pt)6(4,4′-



















Figure 2.8. nESI-MS measured (black) versus modelled (red) isotopic distribution 




Figure 2.9. nESI-MS measured (black) versus modelled (red) isotopic distribution 
pattern for cis-[[(L2Pt)6(4,4′-bipy)3(tpt)2](PF6)3]3+. 
3+ 
3+ 





Figure 2.10. nESI-MS measured (black) versus modelled (red) isotopic distribution 




Figure 2.11. nESI-MS measured (black) versus modelled (red) isotopic distribution 
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Herein, the first molecular capsule based on an [Ir(ppy)2]+ unit (ppy = 2-
phenylatopyridine) has been prepared. Initial studies revealed that the Ir-pyridine bond is 
reversible at low temperatures and self-sorting pathways for the [Ir(ppy)2]+ unit with 
pyridine-based ligands are accessible in the self-assembly of discrete Ir structures. 
However, due to dihedral angle constraints at the exchangeable site on the Ir centres, 
assemblies using the tritopic tpt ligand (tpt = 2,4,6-tris(4-pyridyl)-1,3,5-triazine) were 
unobtainable. Following the development of a method to resolve rac-[(Ir(ppy)2Cl)2] into 
its enantiopure forms and replacing the tritopic pyridine ligand with the nitrile analogue, 
tcb (tcb = 1,3,5-tricyanobenzene), homochiral M6L4 octahedra were synthesised. Solution 
studies and X-ray diffraction show that these capsules encapsulate four of the six 
associated OTf- counteranions, which can be exchanged for other anionic guests. 
Photophysical studies have demonstrated how an ensemble of weakly coordinating 
ligands can lead to luminescence not present in comparable mononuclear systems. 




The combination of transition metal ions and geometrically complementary, multitopic 
bridging organic ligands has led to the preparation of numerous molecular capsules 
and cages.[1] These assemblies possess well-defined internal cavities that promote the 
ingress of guest molecules so that interesting functions, such as catalysis or the 
stabilisation of reactive species may be observed.[1, 2] By and large, the transition metal 
ions within these systems have played solely a structural role, offering advantages such 
as predictable, well-defined coordination preferences and bond strength. However, 
transition metals and their complexes often possess many other notable features, such 
as interesting photophysical properties; arguably the most well-known class are the 
poly(pyridyl) complexes of ruthenium(II),[3] while more recently, analogous 
cyclometalated C^N iridium(III) complexes have found widespread use as luminescent 
biological probes[4] and as dopants in organic light-emitting devices.[5] Although several 
examples of metallocycles and dendrimers which feature [Ru(terpy)2]2+ and helicates 
which feature [Ru(bipy)3]2+ connections exist in the literature,[6] the use of Ru 
poly(pyridyl) or cyclometalated Ir complexes as structural components in 
metallosupramolecular assemblies, in particular polyhedral architectures, remains 
rare.[7] Herein, reported is the first molecular capsule based on an [Ir(ppy)2]+ (ppy = 2-
phenylatopyridine) motif. We have shown that incorporation of this unit into a 
multimetallic array leads to a significant luminescence enhancement with respect to a 
comparable mononuclear complex, thus paving the way to capsules with light-
harvesting functionality and the development of devices with emergent luminescent 
properties. 
 
3.3 Results and Discussion  
It was initially envisaged that [Ir(ppy)2]+ could be used in an analogous fashion to cis-
protected square planar complexes, such as [Pd(en)]2+ or [Pt(dppp)]2+,[8] and that the 
ppy ligands, arranged in a C,C-cis-N,N-trans orientation, would sufficiently labilise the 
exchangeable sites to facilitate self-assembly.[9]  
Prior to attempting the synthesis of an M6L4 capsule, the reversibility and self-sorting of 
pyridine ligands at the exchangeable sites on the [Ir(ppy)2]+ unit was investigated via 
the construction of a simpler M2L2 assembly. 
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3.3.1 [(Ir(ppy)2)2(bpe)2](OTf)2 metallamacrocycle 
Ditopic 1,2-bis(4-pyridyl)ethane (bpe) ligand was used in the attempted synthesis of an 
M2L2 assembly, analogous to a Pd metallamacrocycle previously assembled by Fujita 
and co-workers.[10] On heating [Ir(ppy)2(CH3CN)2]OTf and bpe in C2H4Cl2 for 18 h an 
orange precipitate was isolated (see Scheme 3.1a). 
 
 
Scheme 3.1. Synthesis of heterochiral iridium metallamacrocycles 
[(Ir(ppy)2)2(bpe)2](OTf)2 and [(Ir(ppz)2)2(bpe)2](OTf)2 under thermodynamic control. 




1H NMR revealed the formation of a symmetric assembly (see Figure 3.1a) containing 
twelve proton environments. All twelve 1H signals belong to a single species with a 
measured diffusion coefficient log (D / m2s-1) = -9.39 and a corresponding 
hydrodynamic radius = 8.5 Å in CD3NO2 (see section 3.5.3, Figure 3.13a). Signals at 
1519 and 685 m/z were observed under nESI-MS analysis, which matched the 
calculated isotopic distribution patterns for [(Ir(ppy)2)2(bpe)2](OTf)+ and 
[(Ir(ppy)2)2(bpe)2]2+, respectively (see section 3.5.4).  





Figure 3.1. 1H NMR spectra (500 MHz, C2D2Cl4, 298 K) of a) [(Ir(ppy)2)2(bpe)2](OTf)2 
and b) [(Ir(ppz)2)2(bpe)2](OTf)2. 
 
Yellow crystals were grown by slow ether diffusion into a CH3NO2 solution of 
[(Ir(ppy)2)2(bpe)2](OTf)2 and from the refined X-ray diffraction (XRD) data it was 
observed that [(Ir(ppy)2)2(bpe)2](OTf)2 had crystallised in the cubic achiral space 
group Ia ̅ as a racemic mixture of homochiral helicates (see Figure 3.2a).  
 
 
Figure 3.2. X-ray crystal structures of a) [(Ir(ppy)2)2(bpe)2]2+ and b) cross sectional 
space-fill view of [(Ir(ppy)2)2(bpe)2]2+, looking down the C2 axis through the two Ir 
centres. The carbon atoms of ppy are shown in dark blue and bpe in red, iridium ions in 
magenta and nitrogen atoms in pale blue. Counterions and solvent molecules have been 
omitted for clarity. See section 3.5.19 for crystal data and refinement, bond lengths and 
angles. 
 
Under a closer inspection, the 1H NMR spectrum for [(Ir(ppy)2)2(bpe)2](OTf)2 (see 
Figure 3.1a) revealed a minor secondary splitting in the proton signals for HE and HH.[11] 
a) b) 
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This splitting revealed that the three possible isomers, ΛΛ- and ΔΔ- helicate and ΛΔ-
mesocate, were all present in solution and, due to the dynamic flexibility of the bpe 
ligands, chiral information transfer between the two Ir centres was thus deemed not 
viable for this system. 
The sole formation of the M2L2 metallamacrocycle without the formation of any higher 
ordered assemblies or oligomers strongly suggests that the Ir-bpe bond is kinetically 
reversible at low temperatures and the self-assembly process is under thermodynamic 
control. 
3.3.2 [(Ir(ppz)2)2(bpe)2](OTf)2 metallamacrocycle 
The synthesis of an M2L2 assembly using an [Ir(ppz)2]+ (ppz = 1-phenylatopyrazole) 
motif was also attempted to determine what effect, if any, the substitution of ppy for 
the ppz ligand would have on the kinetic stability. Under a similar experimental 
procedure as for [Ir(ppy)2]+, 1H NMR (see Figure 3.1b) confirmed 
[(Ir(ppz)2)2(bpe)2](OTf)2 to form at 79% non-isolated yield but only after prolonged 
reaction times at elevated temperature. 1H DOSY NMR confirmed the presence of a 
single major species with a diffusion coefficient log (D / m2s-1) = -9.39 and a 
hydrodynamic radius = 8.5 Å in CD3NO2 (see section 3.5.3, Figure 3.13b), virtually 
identical to the diffusion coefficient for [(Ir(ppy)2)2(bpe)2](OTf)2 (see section 3.5.3, 
Figure 3.13a). The protons HI-L for the coordinated bpe ligand are almost all 
superimposable with those for [(Ir(ppy)2)2(bpe)2](OTf)2, as are the phenylato protons 
HF-H, however HE is significantly shifted up field implying that the pyrazole ring is 
donating more electron density to the phenylato group than the pyridyl group in the 
ppy system. The phenylato-Ir bond is consequently weakened and, via trans-influence, 
the Ir-bpe interaction is strengthened. The greater energy input needed to form 
[(Ir(ppz)2)2(bpe)2](OTf)2, along with 1H NMR evidence suggests that exchanging the 
ppy ligands for ppz increases the activation barrier to self-sorting. Further evidence 
that the [(Ir(ppz)2]+ unit increases the kinetic stability of a supramolecular assembly 
was obtained using EXSY NMR experiments in Chapter 4 (see section 4.5.7). 
Given that the thermodynamically controlled synthesis of a macrocycle using the 
[Ir(ppy)2]+ unit and the bpe pyridine ligand was accessible at lower temperatures, a 
larger M6L4 octahedron, analogues to Fujita’s Pd cage,[12] was subsequently targeted.  
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3.3.3 Attempted synthesis of [(Ir(ppy)2)6(tpt)4](X)6 octahedra 
The synthesis of an M6L4 capsule was attempted using the commonly used 2,4,6-tris(4-
pyridyl)-1,3,5-triazine (tpt) ligand[13] with the same bis(acetonitrile) iridium starting 
material, [Ir(ppy)2(CH3CN)2](X). Numerous attempts were made to synthesise 
[(Ir(ppy)2)6(tpt)4](X)6 using different counterions, solvents and a variety of different 
reaction conditions (see section 3.5.2.3), however, no discrete or M6L4 assembly was 
detected using either NMR or nESI-MS analysis. 
Having a closer look at the ligand geometry around the iridium centres of 
[(Ir(ppy)2)2(bpe)2](OTf)2, the pyridines on the bpe ligands are positioned at a dihedral 
angle of ~45°, with respect to the trans-ppy-Ir plane (see Figure 3.2b). The ~45° 
dihedral twist appears to be the consequence of a steric clash between the bpe 
pyridines with the ppy ligands, which sit partially “overhanging” the exchangeable 
sites. This constrained dihedral twist would be greatly disfavoured with the 
conformationally “locked” planar tpt ligand within an M6L4 assembly. In order for the 
M6L4 assembly to form, the pyridines on the tpt ligand would need to twist out of plane; 
this would be energetically disfavoured due to the broken conjugation of the π system. 
The steric clash between the ppy and tpt ligands is believed to be the reason why the 
self-assembly of [(Ir(ppy)2)6(tpt)4](X)6 was not observed. 
3.3.4 [(Ir(ppy)2)6(tcb)4](X)6 octahedra 
In order to avoid the steric clash between the tritopic bridging ligands and the ppy on 
the iridium metal centres, 1,3,5-tricyanobenzene (tcb) was investigated as a less-bulky 
substitute for tpt. The symmetry around the cyano-groups of the tcb ligand is isotropic, 
which abolishes any preference the ligand may have in the dihedral angle 
conformation. While it was anticipated that acetonitrile displacement from 
[Ir(ppy)2(CH3CN)2]OTf by tcb to generate the M6L4 assembly should be entropically, if 
not enthalpically, favoured, initial experiments suggested only partial displacement. 
Instead, what is presumed to be [(Ir(ppy)2OTf)2],[14] prepared by treating 
[(Ir(ppy)2Cl)2] with silver triflate in C2H4Cl2, was reacted with tcb in the same solvent 
(Scheme 3.2, route 1). While the product gave a relatively complex 1H NMR spectrum 
(see Figure 3.3a), nESI-MS showed an intense 2+ peak at 2106 m/z (see section 3.5.5), 
which matched the predicted isotope pattern for [1·4OTf]2+. A 1H DOSY NMR spectrum 
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of the product also showed that the multiple aromatic signals possessed similar 
diffusion coefficients (see section 3.5.6). This led to the postulation that 1·6OTf is 
formed as a complex mixture of diastereoisomers[15] when the synthesis commences 
from racemic [(Ir(ppy)2Cl)2] (Scheme 3.2, route 1), and thus tcb, similarly to bpe, does 
not efficiently transmit stereochemical information between adjacent metal centres.  
 
Scheme 3.2. Synthesis of heterochiral and homochiral hexanuclear iridium assemblies. 
Conditions: a) (i) AgOTf, C2H4Cl2, RT, 2 h; (ii) tcb, C2H4Cl2, RT, 4 h, 48% (starting from 
rac-[(Ir(ppy)2Cl)2]). b) (i) D-serine, NaOMe, MeOH, 313 K, 16 h; (ii) 1M HCl, MeOH, RT, 
10 min, 50% (from rac-[(Ir(ppy)2Cl)2]). c) (i) L-serine, NaOMe, MeOH, 313 K, 16 h; (ii) 
1M HCl, MeOH, RT, 10 min, 37% (from rac-[(Ir(ppy)2Cl)2]). d) (i) AgOTf, C2H4Cl2, RT, 2 
h; (ii) tcb, C2H4Cl2, RT, 5 h, 57% (starting from Λ-[(Ir(ppy)2Cl)2]). e) (i) AgOTf, C2H4Cl2, 
RT, 2 h; (ii) tcb, C2H4Cl2, RT, 4 h, 68% (starting from Δ-[(Ir(ppy)2Cl)2]). 
 
 





Figure 3.3. 1H NMR spectra (500 MHz, C2D2Cl4, 298 K) of a) 1·6OTf obtained from rac-
[(Ir(ppy)2Cl)2]; b) Λ-1·6OTf; c) Δ-1·6OTf. The assignments correspond to the lettering 
shown in Scheme 3.2. 
 
To eliminate the problem of mixed stereoisomer formation, a preparative method to 
resolve rac-[(Ir(ppy)2Cl)2] into its enantiopure forms was developed. Although 
techniques to access enantiopure Ir compounds using either chiral ligands,[16] chiral 
anions[17] or resolution on a chiral phase,[18] are available thus far a method for 
obtaining homochiral [(Ir(ppy)2Cl)2] has yet to be reported. Thus, it was reasoned that 
complexation of the racemic iridium fragment [Ir(ppy)2]+ to an enantiopure amino acid 
would yield a diastereomeric mixture of Ir complexes that should possess different 
physiochemical properties. It was also postulated that the overall charge neutrality of 
these diastereomeric complexes would facilitate purification by chromatography on 
standard silica gel. We were thus delighted to find that serine complexed to Ir and 
produced diastereoisomers that were not only different by 1H NMR spectroscopy, but 
also showed distinct spots via TLC.[19] Although these spots were close running, it was 
found that under conventional silica flash column chromatography conditions, 
significant pure quantities of the faster running species could be obtained although the 
slower running species was always contaminated with the less polar component. In 
order to overcome this, it was found that the most efficient method to obtain an iridium 
complex with the opposite stereochemistry was to complex the Ir to the opposite 
enantiomer of serine. X-ray crystallography revealed that Δ-[(Ir(ppy)2(L-serine)] (see 
Figure 3.4) is the faster running diastereoisomer when L-serine was used and thus Λ-
[(Ir(ppy)2(D-serine)] is presumed, and later confirmed, to be the isolated 
diastereoisomer with D-serine. 





Figure 3.4. X-ray crystal structures of Δ-[(Ir(ppy)2(L-serine)]. The carbon atoms of ppy 
are shown in dark blue and L-serine in green, iridium ions in magenta, nitrogen atoms 
in pale blue and oxygen atoms in green. See section 3.5.20 for crystal data and 
refinement, bond lengths and angles. 
 
Λ- and Δ-[(Ir(ppy)2Cl)2] were readily obtained with addition of HCl (aq.) to a CH3OH 
solution of the corresponding enantiopure Ir serine complexes (Scheme 3.2, steps b and 
c). Both [(Ir(ppy)2Cl)2] enantiomers (which, as expected, exhibit mirror image circular 
dichroism (CD) spectra; see section 3.5.7) crystallised in the chiral space group P212121 
upon diethyl ether diffusion into saturated dichloromethane solutions. The solid-state 
structures (see section 3.5.8) confirmed that no racamisation occurs when converting 
back to the bridged-chloride complex and the compound isolated, following resolution 
with D-serine, was Λ-[(Ir(ppy)2Cl)2], and L-serine was Δ-[(Ir(ppy)2Cl)2] (Scheme 3.2, 
steps b and c). 
When the self-assembly was commenced from either Λ- or Δ-[(Ir(ppy)2Cl)2] (Scheme 
3.2, routes 2 and 3), a precipitate was observed shortly after the addition of tcb to what 
are presumed to be Δ- and Λ-[(Ir(ppy)2OTf)2], which was then isolated after a few hours 
of stirring at RT. The 1H NMR spectra of the two products not only were 
indistinguishable (see Figure 3.3b and 3.3c) but also clearly showed single species with 
the number and ratio of tcb-to-ppy signals consistent with the sole formation of Λ- and 
Δ-1·6OTf. CD confirmed that the two compounds were enantiomers (see section 3.5.7). 
The mass spectra also showed essentially a single species at 2106 m/z, which 
corresponds to the doubly charged [1·4OTf]2+ (see section 3.5.5, Figure b and c). The 
surprising lack of other charge states in the mass spectra of Λ- and Δ-1·6OTf prompted 
us to look at the 19F NMR spectra (see Figure 3.5a), which showed two distinct signals 
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at −77.45 and −79.04 ppm in a ratio of 1:2, respectively. Addition of excess Bu4NOTf 
resulted in an increase in the intensity of the peak at −77.45 ppm (see Figure 3.5b), 
strongly suggesting that the peak at −79.04 ppm is due to encapsulated OTf- anions. 
Other NMR techniques (HOESY and DOSY; see section 3.5.9) confirm this assignment 
and thus support the solution structure [4OTf⊂Δ-1]2OTf. Further EXSY NMR 
experiments have shown that the exo and endo triflates are in slow exchange and that 
the activation barrier for this process is 18 kcal mol–1 (see section 3.5.10). 
 
Figure 3.5. 19F NMR spectra (376 MHz, C2D2Cl4, 298 K) for a) Λ-1·6OTf (200 μM) and b) 
Λ-1·6OTf (200 μM) with excess Bu4NOTf (5 mM). Green singlet (B) corresponds to 
encapsulated OTf- and red singlet (A) to free OTf-. 
 
Corroboration of the capsule’s structure was obtained from XRD using single crystals 
grown from benzene diffusion into a saturated dichloroethane solution of Λ- and Δ-
1·6OTf (see Figure 3.6 for structure and section 3.5.22 for crystal data and refinement, 
bond lengths and angles). The solid-state structure supports the solution structure, 
[4OTf⊂Δ-1]2+, showing OTf- anions located in each of the octahedron “windows”. For 
two encapsulated triflates (with S labels 3 and 4), the S–C axis points toward the centre 
of these vacant windows (or, if viewed as a truncated tetrahedron, toward the vertex), 
forming a series of close contacts between the triflate oxygens and the hydrogen atoms 
attached to tcb and the ortho-pyridyl positions. The other encapsulated anions (with S 
labels 1 and 6) are positioned in a slightly more “side-on” fashion, with the cage 
forming short contacts between two of the oxygen atoms and one of the fluorines. It 
seems probable that, in solution, these two distinct triflate co-conformations 
participate in a low-energy exchange process, thus explaining the presence of a single 
“encapsulated” signal in the 19F NMR spectrum at RT. The encapsulation of multiple 
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ions within a metallosupramolecular assembly is rare in the literature, due to repulsive 
anion-anion interactions, and has only been observed on a small number of 
occasions.[20] 
 
Figure 3.6. X-ray crystal structures of [4OTf⊂Δ-1]2+. Colour code: Ir, magenta; C(ppy), 
blue; C(tcb), dark green; C(OTf-), grey; N, light blue; O, red; S, yellow; F, light green. 
 
To explore whether the structure and, in particular, the encapsulated anions are 
preserved under MS conditions, ion-mobility mass spectrometry (IMMS) 
measurements have been undertaken.[21] For the ions at 2106 m/z, both samples gave 
superimposable arrival time distributions, consistent with a single 
species/conformation (see section 3.5.11). The observed rotationally averaged collision 
cross sections for [4OTf⊂Δ/Λ-1]2+ were found to be 551 and 543 Å2, respectively, 
virtually within error of each other. To validate these, IMMS simulations have been 
carried out using structures derived from the XRD data. The values calculated using 
either the exact hard-spheres scattering or trajectory method, 555 and 551 Å2, 
respectively, agree remarkably well with the experimental data, suggesting that the 
counteranions remain within the capsule upon ionisation into the gas phase.  
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Examples of metallocapsules which encapsulate multiple species of the same charge 
are very rare.[22] Clearly, the strong Coulombic attraction between the positively 
charged Ir vertices and negative counteranions, alongside the series of CH···X (X = O, F) 
hydrogen bonds (vide supra), is enough to overcome the repulsion between same-
charge ions. It could also be that the CF3 groups, which are “meshed” together within 
the centre of the cavity (C–C distances between encapsulated OTf- counteranions range 
from 4.93 to 6.05 Å, with an average distance of 5.55 Å), act to insulate this charge. To 
probe further, we have calculated the capsule’s occupancy. Based on an irregular 
hexadecahedron model (see section 3.5.12 for details), the volume of the empty cavity 
has been calculated to be 506 Å3, of which the triflate counteranions occupy 280 Å3, 
which equates to 55% filled cavity space, in line with previous observations made by 
Rebek.[23] 
3.3.5 Photochemistry 
Held under a standard long-wavelength UV lamp, 1,1,2,2-tetrachloroethane (TCE) 
solutions of Λ- and Δ-1·6OTf luminesce orange (Figure 3.7, inset b) (i) and (ii)).  
 
Figure 3.7. Absorption and emission (excitation at 413 nm) spectra of Λ and Δ-1·6OTf. 
Λ = black line; Δ = redline; TCE, 2 μM. For comparison, the spectra of the mononuclear 
[Ir(ppy)2(PhCN)2]OTf are also shown (Ir only = green line; Ir + 3000 eq. PhCN = blue 
line; TCE, 12 μM). Inset: A photograph of i) Λ-1·6OTf, ii) Δ-1·6OTf and iii) 
[Ir(ppy)2(PhCN)2]OTf in NMR tubes held a) in ambient lighting and b) under a UV lamp 
(254 nm). 




As most literature Ir complexes are luminescent, the significance of the capsules’ 
photophysical properties only becomes apparent when compared against the 
representative mononuclear bis(benzonitrile) complex, [Ir(ppy)2(PhCN)2]OTf (see 
section 3.5.13 for 1H NMR and UV-Vis absorption spectra).[24] Placed next to the 
samples of Λ- and Δ-1·6OTf under UV light, there is no visible luminescence from 
[Ir(ppy)2(PhCN)2]OTf (Figure 3.7, inset b) (iii)) in the same solvent (at equivalent [Ir]). 
The absorption and emission spectra of these samples confirm these visual 
observations (Figure 3.7). Even with a vast excess of benzonitrile, [Ir(ppy)2(PhCN)2]OTf 
is only weakly luminescent (Figure 3.7, blue line). The emission of Λ- and Δ-1·6OTf is 
also broadened and red-shifted with respect to [Ir(ppy)2(PhCN)2]OTf (in the presence 
of excess benzonitrile), signifying increased charge-transfer character of the emitting 
state. While the quantum yields (Ф) for Λ- and Δ-1·6OTf, found to be 4% in air-
equilibrated TCE, are comparable to those for many cyclometalated Ir(III) complexes 
under similar ambient conditions,[25] these often utilise either bidentate or strongly 
coordinating (and high ligand strength) monodentate ligands.[26] As far as we are 
aware, this is the first time a collection of weakly coordinating ligands has been used to 
inhibit nonradiative ligand dissociation pathways.[27] Interestingly, the emission 
intensity of Λ- and Δ-1·6OTf increases only marginally (by a factor of 1.1) when the 
samples are thoroughly degassed, in contrast to many other such Ir complexes,[25] 
suggesting that the metallosupramolecular architecture may also in some way inhibit 
collisional O2 quenching.[25b] Alternatively, the presence of four desolvated anions 
located within the cavity of the capsule may provide such an efficient, alternative 
nonradiative decay pathway (e.g. via electron transfer) that the capsule is insensitive to 
the presence of O2. 
3.3.6 Anion exchange experiments 
Preliminary investigations into the host-guest chemistry of [4OTf⊂Δ/Λ-1]2+ indicate 
that the encapsulated OTf- anions can be exchanged for other anionic species. When 
Bu4NPF6 was titrated into a sample of [4OTf⊂Δ-1]2OTf in C2D2Cl4, 19F NMR 
spectroscopy (see Figure 3.8) shows multiple OTf- and PF6- signals at low [PF6-], 
indicative of mixed PF6--OTf- host-guest complexes. At equimolar anionic 
concentrations, encapsulated OTf- has mostly been displaced.  




Figure 3.8. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of Bu4NPF6 titration into Δ-
1·6OTf: a) Δ-1·6OTf; b) Δ-1·6OTf with excess Bu4NOTf; c) 0.8 eq Bu4NPF6; d) 1.6 eq; e) 
3.1 eq; f) 6.8 eq; g) 9.9 eq; h) 13.0 eq; i) 17.0 eq; j) 33.4 eq; k) 94.3 eq.  peak for free 
OTf-; ∎ encapsulated OTf-; ● encapsulated PF6-; ▲ free PF6-. 
 
This process has also been monitored by 1H NMR spectroscopy (see Figure 3.9), which 
shows that while the overall symmetry is preserved, the proton signals closest to the 
anion binding sites (the tcb hydrogen atom HI and the orto- and meta- pyridyl sites, HA 
and HB) are noticeably shifted.  




Figure 3.9. 1H NMR (400 MHz, C2D2Cl4, 298 K) spectra of Bu4NPF6 titration into Δ-
1·6OTf: a) Δ-1·6OTf; b) Δ-1·6OTf with 0.8 eq Bu4NPF6; c) 1.6 eq; d) 3.1 eq; e) 6.8 eq; f) 
9.9 eq; g) 13.0 eq; h) 17.0 eq; i) 33.4 eq. The assignments correspond to the lettering 
shown in Scheme 3.2. 
 
Similar experiments with Bu4NBF4 and Bu4NCF3BF3, and additional titrations into Λ-
1·6BF4 (see section 3.5.14), have ascertained that the overall affinity of perfluorinated 
anions for the cavity of [Δ/Λ-1]6+ follows the sequence PF6- > OTf- ≈ CF3BF3- > BF4-.[23c] 
Rationalisation of this affinity will be discussed in Chapter 4, however, additional DOSY 
and MS measurements show that the cage remains intact following guest exchange (see 
section 3.5.17 and 3.5.18). Counterion exchange for various other anions was also 
attempted but the assembly either decomposed or rearranged or the results were 
inconclusive (see section 3.5.15). An attempt to expand host–guest chemistry to neutral 
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organic species has thus far been hampered by the low solubility/stability of Δ/Λ-16+ in 
more polar solvents (see Chapter 4 for further discussion). 
We have ascertained that there is communication between the luminescent properties 
of [Δ/Λ-1]6+ and the cavity-bound guests, as evidenced by changes to the emission 
spectra during anion titration experiments (see Figure 3.10). When Bu4NPF6 was 
slowly added to a C2H2Cl4 solution of Λ-1·6OTf the emission intensity dropped 
significantly (see Figure 3.10i). However, titrating Bu4NOTf into Λ-1·6BF4 had the 




Figure 3.10. i) emission (excitation = 403 nm) spectra of Bu4NPF6 titration into Λ-
1·6OTf: a) Λ-1·6OTf; b) Λ-1·6OTf with 1 eq Bu4NPF6; c) 2 eq; d) 4 eq; e) 6 eq; f) 10 eq; g) 
20 eq; h) 50 eq; ii)emission (excitation = 392 nm) spectra of Bu4NOTf titration into Λ-
1·6BF4: a) Λ-1·6BF4; b) Λ-1·6BF4 with 0.5 eq Bu4NOTf; c) 1 eq; d) 2 eq; e) 4 eq; f) 6 eq; 
g) 10 eq; h) 20 eq; i) 50 eq. For experimental detail see section 3.5.16. 
 
As well as showing that [Δ/Λ-1]6+ acts as a luminescent anion sensor, this also suggests 
that it may be possible to tune luminescent properties of multimetallic Ir assemblies 
through supramolecular means rather than via conventional covalent modification.  
























 a) 0 eq
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 d) 4 eq
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 g) 20 eq
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In summary, the first molecular capsule based on an [Ir(ppy)2]+ unit has been 
assembled using a tritopic nitrile ligand and enantiopure Ir starting materials. The first 
reported method of resolving the readily used Ir bridged-chloride species into its 
enantiopure counterparts was demonstrated. Using the enantiomeric precursors, 
homochiral octahedra were assembled that displayed luminescence not present in a 
comparable mononuclear complex. In addition, the same capsule has demonstrated the 
capability of binding multiple same-charge species and that these can be exchanged for 
other anionic guests. Characteristic emission spectra were observed when different 
guests were used showing that [Δ/Λ-1]6+ can act as a luminescent anion sensor. 
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3.5 Experimental Section 
3.5.1 Experimental Procedures 
3.5.1.1 General Experimental Procedure 
Unless stated otherwise, all reagents and solvents were purchased from commercial 
sources and used without further purification. [Ir(ppy)2(CH3CN)2]OTf,[27] 2,4,6-tris-(4-
pyridyl)-1,3,5-triazine (tpt),[28] [Ir(ppz)2(CH3CN)2]OTf, rac-[(Ir(ppy)2Cl)2][29] and 1,3,5-
tricyanobenzene[30] were prepared according to the literature procedures. 
3.5.1.2 Ion-Mobility Mass Spectrometry (IMMS) 
Ion-mobility (IM) mass spectrometry measurements were performed on a MoQ-ToF, an 
in-house modified[31] Q-ToF 1 (Micromass UK Ltd) fitted with nESI source. Capillary 
voltages were adjusted between 1 and 1.2 kV to optimise spray quality, while the cone 
voltage was set to 43 V. Source temperature was set at 80 °C. The energy of injection 
into the drift cell was set at 42 V. 
Modification of instrument involved the insertion of a 5.1 cm long copper drift cell and 
supplementary ion optics situated post source optics and before the quadrupole 
analyser.[31] A potential difference can be applied across the drift cell, thus when ions 
are pulsed into the drift cell (which is filled with helium at pressure of ~3.5 Torr, room 
temperature) and drift through under the influence of this field, they are hindered by 
collisions with the intervening buffer gas molecules. Thus the time taken for ions to 
traverse the cell, in conjunction with the strength of the electric field applied across the 
drift cell, is due to the charge they carry and their mobility (K). K is inversely related to 
the rotationally averaged collision cross sections (CCS) of the ion. The ions then pass 
through the quadrupole and time of flight analysers and are detected by microchannel 
plates. The time from when ions are pulsed into the drift cell to when they are detected 
is therefore a combination of the time the ions spend in the drift cell (drift time) and 
that outside it (dead time). This is obtained from the measured mass selected arrival 
time distribution (ATD), and can be deconvoluted into ATDs of each individual ion.  
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For a given mass/charge the drift time will vary depending on its CCS but the dead time 
will be invariant. The ions ATD distributions are measured at 6 different values of the 
electric field applied to the drift cell (15-60 V). If the arrival times are plotted against 
P/V the intercept will be the dead time and the gradient 1/K. After normalising for the 
experimental temperature and pressure inside the drift cell K can be converted into 






















where z is ion charge, e is electron charge, N0 is the buffer gas number density, µ is the 
reduced mass of the buffer gas and ion, kB is the Boltzmann constant, T is the effective 
temperature and Ω is the momentum transfer collision integral. 
3.5.1.3 Ion-Mobility Simulations 
Collision cross sections were simulated using MOBCAL software developed by Jarrold 
et al.[33] Two different methods of were used to calculate collision cross section of 
analyte ion with helium: 
1. The exact hard sphere scattering (EHSS) method. The Ion is treated as a 
collection of overlapping spheres with radii equal to hard sphere collision 
distances. Orientationally-averaged momentum transfer cross section is 
calculated by determining the scattering angles between the incoming buffer 
gas atom trajectory and the departing buffer gas atom trajectory.[33] This 
approach ignores long range interactions between ion and gas molecule but 
accounts for multiple scattering.[34] 
2. The trajectory method (TJM). Treats the ion as a collection of atoms, each one 
represented by a 12-6-4 potential. The effective potential is obtained by 
summing over the individual atomic contributions and then trajectories are run 
in this potential to obtain the scattering angle (the angle between the incoming 
and departing buffer gas atom trajectory). The orientationally-averaged 
collision integral is determined by averaging over all possible collision 
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geometries.[33] This method is the most rigorous and should give the most 
reliable estimate. TJM method accounts for long range interactions and multiple 
scattering.[33, 35] 
3.5.1.4 Circular Dichroism (CD) 
CD was performed on a JASCO J-810 spectropolarimeter. Data was collected over a 
wavelength range of 273-600 nm, at a scan speed of 100 nm min-1, bandwidth of 1 nm 
and data pitch of 0.1 nm. Samples were measured at RT and at given concentrations 
using a 1 mm path length cuvette (Starna Ltd.). Use of the CTCB Facilities was 
supported by The Wellcome Trust, the Scottish University Life Sciences Alliance and 
the BBSRC. 
3.5.1.5 Emission Spectroscopy 
Steady-state luminescence spectra were measured using the Fluoromax (Horiba Jobin 
Yvon) photon-counting spectrofluorometer. Spectra were recorded with a bandpass of 
3 nm for both excitation and emission monochromators and were corrected for 
variation in the excitation lamp intensity and the wavelength-dependence of the 
detector response. The data was further corrected with background subtraction and 
baseline correction. Spectral intensities were determined by integration over entire 
emission peaks bandwidth. Samples were measured in 1,1,2,2-tetrachloroethane (TCE) 
at RT using a fused silica cuvette (Starna Ltd.) with a 10 mm path length. The 
luminescence intensities for each sample were measured at 5 distinct absorbance 
values (between 0.01 and 0.1) with an excitation wavelength of 413 nm. De-aerated 
samples were prepared by bubbling high purity argon into the sealed cuvette for 30 
min. Emission quantum yields (Ф) were determined using [Ru(bipy)3](PF6)2 (Фair = 
0.018 in acetonitrile)[36] as reference with coumarin 153 (Фair = 0.58 in ethanol)[37] as a 
second reference to verify the yields. The quantum yields were calculated using the 
expression ФX = ФR(mX/mR)(ηX2/ηR2), where X and R denote sample being measured 
and reference respectively, m is the gradient from the plot of integrated luminescence 
intensity vs. absorbance and η is the refractive index of the solvent (ηTCE = 1.494, 
ηacetonitrile = 1.344 and ηEtOH = 1.361)[38]. 




3.5.2.1 Synthesis of [(Ir(ppy)2)2(bpe)2](OTf)2  
 
 
To a solution of [Ir(ppy)2(CH3CN)2]OTf (104.7 mg, 0.143 mmol) in C2H4Cl2 (15 mL) was 
charged bpe (26.3 mg, 0.143 mmol) and the solution heated at 50 °C. After 18 h, the 
solution was reduced on the rotary evaporator to ca. 0.5 mL and the product crashed 
out with Et2O diffusion, filtered and washed with Et2O to yield an orange precipitate 
(81.6 mg, 68% yield). Orange crystals, suitable for X-ray crystallography, were grown 
with slow ether diffusion into CH3NO2. 1H NMR (400 MHz, C2Cl4D2): 8.75 (4H, d, J = 5.5 
Hz, HA), 8.34 (8H, d, J = 5.8 Hz, HI), 7.82 (4H, m, HC), 7.74 (4H, d, J = 7.7 Hz, HD), 7.52 (4H, 
m, HB), 7.45 (4H, m, HE), 6.92 (16H, m, HF,G,J), 6.32 (4H, m, HH), 3.02 (4H, d, J2 = 10.4 Hz, 
HK), 2.59 (4H, d, J2 = 10.4 Hz, HL); 13C NMR (126 MHz, C2D2Cl4): 167.2, 151.1, 150.5, 
149.3, 148.1, 144.1, 137.9, 131.9, 130.2, 127.3, 124.4, 123.8, 122.2, 118.9, 35.3; 19F NMR 
(376 MHz, C2Cl4D2): -77.30 (6F, s, OTf-); nESI (DCE): m/z = 685.2 [(Ir(ppy)2)2(bpe)2]2+ 
and 1519.3 [(Ir(ppy)2)2(bpe)2](OTf)+; Anal. Calculated for C70H56F6Ir2N8O6S2: C, 50.41; 
H, 3.38; N, 6.72%. Found: C, 50.31; H, 3.35; N, 6.77%.  
3.5.2.2 Synthesis of [(Ir(ppz)2)2(bpe)2](OTf)2  
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To an NMR tube was charged [Ir(ppz)2(CH3CN)2]OTf (5.1 mg, 0.0072 mmol) in C2D2Cl4 
(0.5 mL) and bpe (1.3 mg, 0.0072 mmol). After stirring for 16 h at RT the solution was 
heated for 7 h at 60 °C, a further 16 h at 75 °C and 20 h at 80 °C. Equilibrium was 
reached at 79% qualitative yield (by 1H NMR). 1H NMR (500 MHz, C2Cl4D2): 8.32 (8H, d, 
J = 6.2 Hz, HI), 8.10 (4H, d, J = 2.2 Hz, HA), 8.04 (4H, d, J = 2.9 Hz, HC), 7.09 (4H, m, HE), 
6.99 (8H, d, J = 6.2 Hz, HI), 6.94 (4H, m, HF), 6.86 (4H, m, HG), 6.78 (4H, m, HB), 6.37 (4H, 
m, HH), 3.07 (4H, d, J2 = 11.0 Hz, HK), 2.67 (4H, d, J2 = 11.0 Hz, HL); 19F NMR (376 MHz, 
C2Cl4D2): -77.44 (6F, s, OTf-); nESI (DCE): m/z = 663.2 [(Ir(ppz)2)2(bpe)2]2+ and 1475.3 
[(Ir(ppz)2)2(bpe)2](OTf)+. 
3.5.2.3 Synthesis of [(Ir(ppy)2)6(tpt)4](X)6 
To [Ir(ppy)2(CH3CN)2]OTf (25.3 mg, 0.034 mmol) in C2H4Cl2 (10 mL) as solvent was 
charged tpt (7.2 mg, 0.023 mmol) and the solution heated at 50 °C for 24 h. The 
reaction was repeated using [Ir(ppy)2(CH3CN)2]X (where X = (+)-camphor-10-
sulfonate, PF6- or NO3-), [(Ir(ppy)2Cl)2], [(Ir(ppy)2OTf)2], [Ir(2,5-dppy)2(CH3CN)2]OTf or 
[Ir(ppz)2(CH3CN)2]OTf in CH3NO2, CH2Cl2, C2D2Cl4, CD3OD or D2O at temperatures 
ranging from RT to reflux and reaction times from hours to days. The reaction was also 
attempted using solid phase grinding and a microwave reactor. 
3.5.2.4 Synthesis of [(Ir(ppy)2)6(tcb)4](OTf)6 (1·6OTf) 
 
A mixture of rac-[(Ir(ppy)2Cl)2] (48.3 mg, 0.0451 mmol) and AgOTf (23.2 mg, 0.0902 
mmol) in C2H4Cl2 (25 mL) were stirred at rt in a darkened flask for 2 h. The orange 
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solution was filtered through celite and concentrated on the rotary evaporator. The 
crude product was re-dissolved in C2H4Cl2 (2 mL) and tcb (9.2 mg, 0.0601 mmol) 
charged. The solution was stirred for 4 h at RT. The resulting precipitate was filtered off 
and washed with a minimal amount of C2H4Cl2 and Et2O to give 1 as a yellow solid (32.4 
mg, 48%). Anal. Calculated for C174H108F18Ir6N24O18S6: C, 46.33; H, 2.41; N, 7.45%. 
Found: C, 46.23; H, 2.44; N, 7.51%; 1H NMR (500 MHz, C2D2Cl4): see Figure 3.3. nESI 
(DCE): m/z = 2106.2 [1·4OTf]2+. 
3.5.2.5 Synthesis of Δ/Λ-[(Ir(ppy)2)6(tcb)4](OTf)6 (Δ/Λ-1·6OTf) 
Synthesis of intermediate [(Δ/Λ-Ir(ppy)2)(L/D-serine)] follows a similar procedure to 
that of R. Urban et. Al.[19] 
 
A mixture of rac-[(Ir(ppy)2Cl)2] (0.277 g, 0.26 mmol), L-serine (54.6 mg, 0.52 mmol) 
and NaOMe (27.9 mg, 0.52 mmol) in CH3OH (20 mL) were stirred at 40 oC for 16 h. The 
solvent was removed in vacuo and the crude product purified using silica-gel flash 
column chromatography (CH2Cl2/CH3OH/NEt3 (96:3:1) as eluent). While pure fractions 
of the faster running diastereoisomer, Δ-[Ir(ppy)2(L-serine)], could be obtained, the 
slower eluting compound, Λ-[Ir(ppy)2(L-serine)], was always contaminated with the 
other isomer. The pure Δ-[Ir(ppy)2(L-serine)] isolated from the column was dissolved 
in CH3OH (5 mL) and to this was added 1M HCl solution (1 mL). A precipitate formed 
after 10 min at RT. This was filtered off, washed with CH3OH and Et2O and air dried to 
give a yellow solid (50.7 mg, 37% (starting from rac-[(Ir(ppy)2Cl)2]). Single crystals 
suitable for XRD were grown by slow vapour diffusion of Et2O into a saturated CH2Cl2 
solution. 1H NMR (500 MHz, C2D2Cl4): 9.17 (4H, d, J = 6.9 Hz, HA), 7.90 (4H, d, J = 7.7 Hz, 
HD), 7.79 (4H, m, HC), 7.55 (4H, d, J = 6.9 Hz, HE), 6.86 (4H, m, HF), 6.81 (4H, m, HB), 6.65 
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(4H, m, HG), 5.95 (4H, d, J = 7.7 Hz, HH); 13C NMR (126 MHz, C2D2Cl4): 168.0, 151.3, 
144.5, 144.0, 136.5, 130.5, 129.1, 123.7, 122.3, 121.5, 118.4; nESI (DCE): m/z = 1314.4 




Λ-[(Ir(ppy)2Cl)2] was synthesised following the same procedure as above starting with 
rac-[(Ir(ppy)2Cl)2] (0.178 g, 0.16 mmol), D-serine (33.6 mg, 0.32 mmol) and NaOMe 
(17.3 mg, 0.32 mmol). Yellow solid obtained (44.2 mg, 50%). Single crystals suitable for 
XRD were grown by slow vapour diffusion of Et2O into a saturated CH2Cl2 solution. 
Characterisation as for Δ-[(Ir(ppy)2Cl)2]. 
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Λ-[(Ir(ppy)2)6(tcb)4](OTf)6 (Λ-1·6OTf) was synthesised following the same procedure 
as for 1·6OTf starting with Λ-[(Ir(ppy)2Cl)2] (21.0 mg, 0.020 mmol). Yellow solid 
obtained (16.7 mg, 57%). 1H NMR (500 MHz, C2D2Cl4): 9.32 (12H, d, J = 7.1 Hz, HA), 8.36 
(12H, s, HI), 8.19 (12H, m, HC), 7.97 (12H, d, J = 7.1 Hz, HD), 7.80 (12H, m, HB), 7.55 (12H, 
d, J = 7.8 Hz, HE), 6.95 (12H, m, HF), 6.81 (12H, m, HG), 6.16 (12H, d, J = 7.8 Hz, HH); 13C 
NMR (126 MHz, C2D2Cl4): 165.8, 152.5, 144.3, 142.6, 141.9, 139.0, 131.3, 129.5, 125.1, 
124.0, 123.3, 119.5, 114.2, 112.8; 19F NMR (376 MHz, C2Cl4D2): -77.45 (6F, bs, OTf-free), -
79.04 (12F, s, OTf-encapsulated); nESI (DCE): m/z = 2106.2, Λ-[1·4OTf]2+. Anal. Calculated 




Δ-[(Ir(ppy)2)6(tcb)4](OTf)6 (Δ-1·6OTf) was synthesised from Δ-[(Ir(ppy)2Cl)2] (26.4 mg, 
0.025 mmol) in an analogues fashion to Δ-1·6OTf. Yellow solid obtained (25.3 mg, 
68%). Single crystals suitable for XRD were grown by slow vapour diffusion of benzene 
into a saturated C2H2Cl4 solution. Anal. Calculated for C174H108F18Ir6N24O18S6: C, 46.33; H, 
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3.5.2.6 Synthesis of [Ir(ppy)2(PhCN)2]OTf 
 
 
A mixture of rac-[(Ir(ppy)2Cl)2] (30.0 mg, 0.0280 mmol) and AgOTf (14.4 mg, 0.0560 
mmol) in C2H4Cl2 (20 mL) were stirred at RT in a darkened flask for 2 h. The yellow 
solution was filtered through celite and concentrated on the rotary evaporator. The 
resultant residue was re-dissolved in C2H4Cl2 (2 mL) and benzonitrile (9.2 mg, 0.0601 
mmol) charged. The solution was stirred for 1 h at RT, concentrated on the rotary 
evaporator. A yellow precipitate was obtained following Et2O diffusion into the 
solution, which was isolated via filtration (10.2 mg, 21%). 1H NMR (500 MHz, C2D2Cl4 + 
10 eq. PhCN): 9.03 (2H, d, J = 5.7 Hz, HA), 8.07 – 8.00 (4H, m, HC+D), 7.80 – 7.40 (m, 
HB,E,I,J,K + HPhCN), 7.04 (2H, m, HF), 6.89 (2H, m, HG), 6.20 (2H, d, J = 7.4 Hz, HH). 13C NMR 
(126 MHz, C2D2Cl4 + 10 eq. PhCN): 167.1, 149.9, 143.7, 142.8, 138.9, 134.9, 133.0, 132.9 
(CPhCN), 132.0 (CPhCN), 131.2, 130.2, 129.5, 129.1 (CPhCN), 124.3, 123.6, 123.1, 119.8, 
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3.5.2.7 Synthesis of Λ-[(Ir(ppy)2)6(tcb)4](BF4)6 (Λ-1·6BF4) 
 
 
To Λ-[(Ir(ppy)2Cl)2] (16.2 mg, 0.015 mmol) was added AgBF4 (5.9 mg, 0.030 mmol) in 
THF (5 mL) and the mixture was stirred at RT in a darkened flask for 2 h. The orange 
solution was filtered through celite and concentrated on the rotary evaporator. The 
crude product was dissolved in C2H4Cl2 (1 mL) and tcb (3.1 mg, 0.020 mmol) charged. 
The solution was stirred for 4 h at RT. The resulting precipitate was filtered off and 
washed with a minimal amount of C2H4Cl2 and Et2O to give Λ-1·6BF4 as a yellow solid 
(11.6 mg, 56%).1H NMR (400 MHz, C2D2Cl4): 9.27 (12H, d, J = 5.2 Hz, HA), 8.20 (12H, m, 
HC), 8.11 (12H, s, HI), 7.98 (12H, d, J = 8.4 Hz, HD), 7.86 (12H, m, HB), 7.56 (12H, d, J = 8.3 
Hz, HE), 6.96 (12H, m, HF), 6.83 (12H, m, HG), 6.20 (12H, d, J = 7.4 Hz, HH); 19F NMR (376 
MHz, C2Cl4D2): -150.77 (24F, bs, BF4-); nESI (DCE): m/z = 1981.9 [Λ-1·4BF4]2+. 
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3.5.3 1H DOSY NMR for [(Ir(ppy)2)2(bpe)2](OTf)2 and 
[(Ir(ppz)2)2(bpe)2](OTf)2 
The hydrodynamic radius of [(Ir(ppy)2)2(bpe)2](OTf)2 and [(Ir(ppz)2)2(bpe)2](OTf)2 in 
CD3NO2 was determined using 1H DOSY NMR spectroscopy. From the 1H DOSY NMR 
spectra (Figure 3.13), the measured diffusion coefficient D was used in the Stokes-





     (1) 
where kB is the Boltzmann constant, T absolute temperature and η the viscosity of the 
solvent. The viscosity of CD3NO2 not being available, that of CH3NO2 (0.63 mPa.s)[38] at 
298 K was used instead. The diffusion coefficient and computed Stokes-Einstein radius 
are listed in Table 3.1. 
 log D D / m2 s-1 Stokes-Einstein radius / Å 
[(Ir(ppy)2)2(bpe)2](OTf)2 -9.39 4.07×10-10 8.5 
[(Ir(ppz)2)2(bpe)2](OTf)2 -9.39 4.07×10-10 8.5 
 
Table 3.1. Diffusion coefficient and computed Stokes-Einstein radius of 
[(Ir(ppy)2)2(bpe)2](OTf)2 and [(Ir(ppz)2)2(bpe)2](OTf)2 in CD3NO2 at 298 K. 







Figure 3.13. 1H DOSY NMR (400 MHz, CD3NO2, 298 K) spectra for a) 
[(Ir(ppy)2)2(bpe)2](OTf)2 and b) [(Ir(ppy)2)2(bpe)2](OTf)2, with corresponding log (D / 
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3.5.4 Mass spectra and isotopic distribution patterns for 
[(Ir(ppy)2)2(bpe)2](OTf)2 and [(Ir(ppz)2)2(bpe)2](OTf)2. 
 
Figure 3.11. nESI mass spectra for [(Ir(ppy)2)2(bpe)2]2+ with measured (black) versus 




Figure 3.12. nESI mass spectra for [(Ir(ppz)2)2(bpe)2]2+ with measured (black) versus 
modelled (red) isotopic distribution pattern for each ion, 50 µM in C2H4Cl2 
 
 
0629 Ir2bpe2.OTf in MeNO2 100uM MS
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0702ppzIr2bpe2.OTf in DCE 100uM
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3.5.5 Mass spectra and isotopic distribution patterns for 1·6OTf 
 
 
Figure 3.14. nESI mass spectra of a) 1·6OTf, b) Λ-1·6OTf, c) Δ-1·6OTf with measured 
(black) versus modelled (red) isotopic distribution pattern for each [1·4OTf]2+ ion, 50 
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Figure 3.15. 1H DOSY NMR (400 MHz, C2D2Cl4, 298 K) spectra for a) 1·6OTf, b) Λ-
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3.5.7 Circular Dichroism (CD) for selected compounds 
 
Figure 3.16. CD spectra of Δ-1·6OTf (red, 5 µM), Λ-1·6OTf (black, 5 µM), 1·6OTf (green, 
5 µM), Δ-[(Ir(ppy)2Cl)2] (light blue, 20 µM) and Λ-[(Ir(ppy)2Cl)2] (dark blue, 20 µM), 
(298 K, TCE). 
 
3.5.8 X-ray crystal structures of Λ and Δ-[(Ir(ppy)2Cl)2] 
 
Figure 3.17. X-ray crystal structures of (a) Λ-[(Ir(ppy)2Cl)2] and (b) Δ-[(Ir(ppy)2Cl)2]. 
The carbon atoms of ppy are shown in dark blue, iridium ions in magenta, nitrogen 
atoms in pale blue and chloride ions in green. See section 3.5.21 for crystal data and 
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3.5.9 1H-19F HOESY and 19F DOSY NMR for Λ-1·6OTf 
 
 
Figure 3.18. 19F-1H HOESY NMR spectra (376 MHz, C2D2Cl4, 298 K) of Λ-1·6OTf (200 
µM). Cross peak between the tcb ligand and the encapsulated OTf- counterions, 
intercepts at 8.36 ppm and -79.04 ppm on the 1H and 19F NMR spectra, respectively. 
 
 




Figure 3.19. 19F DOSY NMR spectra (376 MHz, C2D2Cl4, 298 K) of Λ-1·6OTf (200 µM). 
Cross peak intercepts at log (D / m2s-1) = -10.02 (-79.04 ppm) and -9.85 (-77.45 ppm) 
for the encapsulated (green) and free OTf- (red), respectively. 
 
3.5.10 Exchange Spectroscopy (2D-EXSY) Investigation of guest 
binding within 16+ 
19F 2D-EXSY was used to investigate the kinetics of exchange for [4OTf⊂-1]2OTf; all 
spectra were recorded on a Bruker 400 MHz NMR spectrometer at 298 K with the 
mixing time, τm, set to 1.0 s. Using equation 2 shown below, where IAA and IBB are the 
diagonal peak intensities and IAB and IBA are the cross-peak intensities, r was calculated. 
k which is the sum of the forward, k1, and backward, k-1, pseudo-first order rate 
constants for the guest exchange process was obtained using equations 3-4. As both 
processes are equal opposites (k1 = k-1) the observed pseudo-first order rate constant, 
kobs, can be determined from equation 5. kobs was used in the Eyring equation (equation 
6) to determine the value of ΔG‡. 

































    (4) 
 






obsln‡      (6) 
 (R = 1.9872 cal K-1 mol-1, kB = 3.30 x 10-24 cal K-1, h = 1.58 x 10-34 cal s) 
 




Figure 3.20. Partial 19F 2D-EXSY spectrum of (376 MHz, C2D2Cl4, 298 K) of Δ-1·6OTf. 
 
 IAA IAB IBB IBA kobs (s-1) ΔG‡ (kcal mol-1) 
FOTf 0.4716 0.2793 1.0000 0.2432 0.37 18.0 
 
Table 3.2. Kinetic parameters of Δ-1·6OTf in C2D2Cl4. 
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3.5.11 Ion-Mobility MS ATD and CCS calculations 
 
Figure 3.21. Arrival time distribution (ATD) at electric field of 4 V cm-1, for Λ-












Table 3.3. Collision cross sections (CCS) for Λ and Δ-[1·4OTf]2+ at 2106 m/z.  
acalculated using the XRD data for Δ-1·6OTf with solvent molecules and outer OTf- 
counterions omitted. EHSS = Exact Hard Spheres Scattering, TJM = Trajectory Method. 
  
3.5.12 Capsule occupancy calculations 
A python program based on the molecular simulation library Sire was written to 
estimate the capsule occupancy using a numerical approach.[39] A 3-dimensional 
rectangular grid of cubes of 0.5 Å edge length was overlapped on the crystallographic 
structure of Δ-1·6OTf. An irregular hexadecahedron was then defined to cover the 
capsule cavity. The coordinates of the polyhedron edges were defined by the 6 iridium 
atoms, and four virtual sites. As shown in Figure 3.22A, the coordinate of each virtual 
site was taken as the geometric centre of the meta-pyridyl proton from three nearby 
three ppy groups. Any cubes on the rectangular grid whose centre did not fit inside the 
 Λ-[1·4OTf]2+ Δ-[1·4OTf]2+ 
Ωexpt (Å2) 551±3 543±3 
ΩcalcEHSS (Å2) - 555a 
ΩcalcTJM (Å2) - 551a 
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hexadecahedron were then discarded. Any remaining cube whose centre was 
overlapped by any atom present in the crystallographic structure was then discarded. 
Bondi van der Waals radii were used to compute atomic overlaps (Hydrogen 1.20 Å; 
Carbon 1.70 Å; Nitrogen 1.55 Å; Oxygen 1.52 Å; Fluoride 1.47 Å; Sulphur 1.8 Å; Iridium 
2.00 Å).[40] The free volume was then estimated by summing the volume of every 
remaining cube. To estimate the volume of the cavity without ligands, the calculation 
was repeated after removing the 4 encapsulated triflate ions present in the 
crystallographic structure. Similar volumes were obtained using a grid of cubes of 1.0 Å 
or 0.25 Å edge lengths. The volumes computed using this protocol were 506 Å3 for the 
capsule without OTf- guests (Figure 3.22B), and 226 Å3 with the four OTf- anions bound 
(Figure 3.22C). The cavity occupancy by the four OTf- anions is therefore 55%.  
 
Figure 3.22. A) Cavity definition using an irregular hexadecahedron. The green spheres 
depict the position of iridium atoms, and the pink spheres the position of virtual sites 
(see main text). B) Free volume of the cavity without ligands. C) Free volume of the 
cavity with four OTf- bound. Each purple sphere represents the centre of a cube of edge 
length 0.5 Å. Cyan spheres represent carbon atoms, white spheres hydrogen atoms, 
blue spheres nitrogen atoms, green spheres iridium atoms, red spheres oxygen atoms, 
yellow spheres sulfur atoms, gray spheres fluorine atoms. Figure created with the 
software VMD.[41] 
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3.5.13 1H NMR and UV-Vis of [Ir(ppy)2(PhCN)2]OTf 
 
Figure 3.23. 1H NMR spectra (500 MHz, C2D2Cl4, 298 K) of a) [Ir(ppy)2(PhCN)2]OTf and 
b) [Ir(ppy)2(PhCN)2]OTf with excess PhCN (10 eq). See section 3.5.2.6 for assignment. 
 
 
Figure 3.24. UV-Vis spectra of [Ir(ppy)2(PhCN)2]OTf with 0 eq PhCN (green) and 3000 
eq PhCN (blue), (12 μM, 298 K, TCE). 
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3.5.14 Guest exchange experiments 
Anion exchange experiments were performed by titrating a mixed C2D2Cl4 solution of 
Bu4NX / Δ/Λ-1·6X ([Bu4NX] = 4-5 mM, [Δ/Λ-1·6X] = 100-200 μM ) into a C2D2Cl4 
solution of Δ/Λ-1·6X ([Δ/Λ-1·6X] = 100-200 μM ). The anion exchange experiments 
were monitored by 1H and 19F NMR. 
 
 
Figure 3.25. 1H NMR (400 MHz, C2D2Cl4, 298 K) spectra of: a) Λ-1·6OTf; b) Λ-1·6OTf 




Figure 3.26. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of: a) Λ-1·6OTf; b) Λ-1·6OTf 
with 35 eq Bu4NBF4. peak for free OTf-; ∎ ecapsulated OTf-; ● encapsulated/free BF4- 
in fast exchange on the NMR timescale. 
 




Figure 3.27. 1H NMR (400 MHz, C2D2Cl4, 298 K) spectra of Bu4NCF3BF3 titration into Δ-
1·6OTf: a) Δ-1·6OTf; b) Δ-1·6OTf with 0.7 eq Bu4NPF6; c) 1.9 eq; d) 3.5 eq; e) 6.2 eq; f) 
8.4 eq; g) 8.8 eq; h) 12.8 eq; i) 18.5 eq; j) 25.5 eq; k) 38.1 eq; l) 76.8 eq. See section 
3.5.2.5 for assignment. 
  





Figure 3.28. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of Bu4NCF3BF3 titration into Δ-
1·6OTf: a) Δ-1·6OTf; b) Δ-1·6OTf with 0.7 eq Bu4NPF6; c) 1.9 eq; d) 3.5 eq; e) 6.2 eq; f) 
8.4 eq; g) 8.8 eq; h) 12.8 eq; i) 18.5 eq; j) 25.5 eq; k) 38.1 eq; l) 76.8 eq.  peak for free 
OTf-; ∎ ecapsulated OTf-; ● encapsulated CF3BF3-; ▲ free CF3BF3-. 
 




Figure 3.29. 1H NMR (400 MHz, C2D2Cl4, 298 K) spectra of Bu4NOTf titration into Λ-
1·6BF4: a) Λ-1·6BF4; b) Λ-1·6BF4 with 0.8 eq Bu4NOTf; c) 1.6 eq; d) 3.1 eq; e) 6.2 eq; f) 
9.1 eq. See section 3.5.2.7 for assignment. 
 




Figure 3.30. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of Bu4NOTf titration into Λ-
1·6BF4: a) Λ-1·6BF4; b) Λ-1·6BF4 with 0.8 eq Bu4NOTf; c) 1.6 eq; d) 3.1 eq; e) 6.2 eq; f) 
9.1 eq.  peak for free OTf-; ∎ ecapsulated OTf-; ● encapsulated/free BF4- in fast 
exchange on the NMR timescale. 
 




Figure 3.31. 1H NMR (400 MHz, C2D2Cl4, 298 K) spectra of Bu4NPF6 titration into Λ-
1·6BF4: a) Λ-1·6BF4; b) Λ-1·6BF4 with 0.5 eq Bu4NPF6; c) 0.9 eq; d) 2.0 eq; e) 3.9 eq; f) 
6.2 eq; g) 7.9 eq; h) 9.5 eq. See section 3.5.2.7 for assignment. 
  






Figure 3.32. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of Bu4NPF6 titration into Λ-
1·6BF4: a) Λ-1·6BF4; b) Λ-1·6BF4 with 0.5 eq Bu4NPF6; c) 0.9 eq; d) 2.0 eq; e) 3.9 eq; f) 
6.2 eq; g) 7.9 eq; h) 9.5 eq.  peak for free PF6-; ∎ ecapsulated PF6-; ● 
encapsulated/free BF4- in fast exchange on the NMR timescale. 
 




Figure 3.33. 1H NMR (400 MHz, C2D2Cl4, 298 K) spectra of Bu4NCF3BF3 titration into Λ-
1·6BF4: a) Λ-1·6BF4; b) Λ-1·6BF4 with 0.4 eq Bu4NPF6; c) 2.0 eq; d) 3.0 eq; e) 5.4 eq; f) 
9.0 eq. See section 3.5.2.7 for assignment. 
 




Figure 3.34. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of Bu4NCF3BF3 titration into Λ-
1·6BF4: a) Λ-1·6BF4; b) Λ-1·6BF4 with 0.4 eq Bu4NPF6; c) 2.0 eq; d) 3.0 eq; e) 5.4 eq; f) 
9.0 eq.  peak for free CF3BF3-; ∎ ecapsulated CF3BF3-; ● encapsulated/free BF4- in fast 
exchange on the NMR timescale. 
 
3.5.15 Other attempted guests 
The following anions and neutral guests (see Table 3.4) were screened for 
encapsulation within [Δ/Λ-1]6+. All neutral and anionic guests (anions as their Bu4N+ 
salts) were added to a C2D2Cl4 (unless stated otherwise) solution of either Δ/Λ-1·6BF4 
or Δ/Λ-1·6OTf. 
guest observation starting from 
OTf- encapsulation Δ/Λ-1·6BF4 
PF6- encapsulation Δ/Λ-1·6BF4 
BF4- encapsulation Δ/Λ-1·6BF4 
ClO4- encapsulation Δ/Λ-1·6BF4 
CF3BF3- encapsulation Δ/Λ-1·6BF4 
CH3BF3- partial encapsulation Δ/Λ-1·6BF4 
CH3SO3- decomposition Δ/Λ-1·6BF4 
OTs- decomposition Δ/Λ-1·6OTf 
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NTf2- re-assembled (see Chapter 4) Δ/Λ-1·6BF4 
Mo6O192- inconclusive, broadened NMR Δ/Λ-1·6BF4 
B12F122- caborate decomposition Δ/Λ-1·6BF4 
NO3- decomposition Δ/Λ-1·6BF4 
Fc(SO3)22- decomposition Δ/Λ-1·6OTf 
SbF6- decomposition Δ/Λ-1·6BF4 
Δ-TRISPHAT- no change Δ/Λ-1·6BF4 
CF3CH2OH no change Δ/Λ-1·6OTf 
CF3(OH)3 no change Δ/Λ-1·6OTf 
CD3NO2 partial decomposition Δ/Λ-1·6OTf 
NO2Ph in CD3NO2 no change Δ/Λ-1·6OTf 
MeOH decomposition Δ/Λ-1·6OTf 
naphthalene no change Δ/Λ-1·6OTf 
 
Table 3.4. Guests screened for encapsulation within [Δ/Λ-1]6+. 
 
3.5.16 Emission titration experiments 
Anion exchange experiments were performed by titrating a mixed C2H2Cl4 solution of 
Bu4NX / Λ-1·6X ([Bu4NX] = 0.5 mM, [Λ-1·6X] = 5 µM) into a C2H2Cl4 solution of Λ-1·6X 
([Λ-1·6X] = 5 µM). A Wavelength in the 420-370 nm region at which the absorption of 
mixed solution Λ-1·6X / Bu4NX ([Bu4NX] = 0.5 mM, [Λ-1·6X] = 5 μM) and pure Λ-1·6X 
([Λ-1·6X] = 5 μM) were equal was selected for excitation. 
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3.5.17 1H DOSY NMR spectra of Λ-1·6BF4 and Λ-1·6PF6 
 
Figure 3.35. 1H DOSY NMR (400 MHz, C2D2Cl4, 298 K) spectra of Λ-1·6BF4. 
Corresponding log (D / m2s-1) = -10.00. 
 




Figure 3.36. 1H DOSY NMR (400 MHz, C2D2Cl4, 298 K) spectra of Λ-1·6OTfwith 30 eq 
Bu4NPF6 added. Corresponding log (D / m2s-1) = -9.99. 
 




Figure 3.37. nESI mass spectra of a) Λ-1·6BF4 with measured (black) versus modelled 
(red) isotopic distribution pattern for [1·4BF4]2+ ion, 50 μM in C2H4Cl2. 
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Figure 3.38. X-ray crystal structure of [(Ir(ppy) 2)2(bpe)2]2+. The carbon atoms of ppy 
are shown in dark blue and bpe in red, iridium ions in magenta and nitrogen atoms in 
pale blue. Selected bond lengths [Å] and angles [°]: Ir-Ir 9.287(2), Ir1-N21 2.05(2), Ir1-
N41 2.13(2), Ir1-C48 1.97(3), Ir1-C28 2.01(3), Ir1-N12 2.17(2), Ir1-N1 2.17(3), 1 N12-
Ir1-N21 88.0(8), N12-Ir1-N41 97.4(8), N12-Ir1-N1 92.3(9), N1-Ir1-N21 100.3(9), N1-
Ir1-N41 85.0(9), N21-Ir1-C48 90(1), N21-Ir1-C28 82(1), C48-Ir1-N41 84(1), C28-Ir1-
N41 93(1), N1-Ir1-C48 91(1), N12-Ir1-C28 87(1), N1-Ir1-C28 177(1), N12-Ir1-C48 
176(1). 
 
Identification code [(Ir(ppy)2)2(bpe)2](OTf)2 
Empirical formula C70H56F6Ir2N8O6S2 
Formula weight 1667.81 
Temperature 93(1) K 
Wavelength 0.71075 Å 
Crystal system Cubic 
Space group Ia ̅ 
Unit cell dimensions a = 36.636(4) Å  α = 90° 
 b = 36.636(4) Å  β = 90° 
 c = 36.636(4) Å  γ = 90° 
Volume 49172(9) Å3 
Z 24 
Density (calculated) 1.352 g cm-3 
Absorption coefficient 3.365 mm-1 
F(000) 19680.00 
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Crystal size 0.1 × 0.1 × 0.1 mm 
Theta range for data collection 3.04 to 25.33° 
Index ranges -43<=h<=44, -44<=k<=43, -44<=l<=44 
Reflections collected 237542 
Independent reflections 7513 [R(int) = 0.0878] 
Completeness to theta = 25.33° 95.6% 
Absorption correction Multiscan 
Max. and min. transmission 0.714 and 0.597 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7513 / 0 / 199 
Goodness-of-fit on F2 1.158 
Final R indices [I>2sigma(I)] R1 = 0.2125 
R indices (all data) wR2 = 0.4285 
Absolute structure parameter - 
Largest diff. peak and hole 5.94 and -4.52 e- Å-3 
 
Table 3.5. Crystal data and structural refinement for [(Ir(ppy) 2)2(bpe)2](OTf)2. 
 
Special details: The unit cell comprises regions of diffused disordered solvent 
(benzene) which could not be modelled as discrete sites. In the crystal structure the 
anions are disordered and no restraints were made on the isotropic behaviour of any of 
the atoms. These two qualities contribute to the large values in the R indices. 
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Figure 3.39. X-ray crystal structure of Δ-[(Ir(ppy)2(L-serine)]. The carbon atoms of ppy 
are shown in dark blue and L-serine in green, iridium ions in magenta, nitrogen atoms 
in pale blue and oxygen atoms in green. Selected bond lengths [Å] and angles [°]: Ir1-
O14 2.15(1), Ir1-N13 2.20(2), Ir1-N1 2.05(1), Ir1-N21 2.03(1), Ir1-N13 1.97(2), Ir1-
N13 2.01 (2), N15-C26 3.21(3), O14-Ir1-N1 81.79(6), N21-Ir1-N13 96.2(6), N21-Ir1-
O14 86.1(5), N21-Ir1-C28 81.1(7), C28-Ir1-N1 95.9(7), O14-Ir1-N1 94.9(5), N13-Ir1-N1 
86.9(6), N21-Ir1-C8 99.1(7), C8-Ir1-N1 80.0(7), N13-Ir1-O14 77.5(5), N13-Ir1-C8 
102.1(7), C8-Ir1-O14 174.8(6), C28-Ir1-N13 169.9(7), O14-Ir1-C28 92.5(6). 
 
Identification code Δ-[(Ir(ppy)2(L-serine)] 
Empirical formula C34H33IrN3O4 
Formula weight 739.87 
Temperature 93(1) K 
Wavelength 0.71075 Å 
Crystal system Primitive Monoclinic 
Space group P21 (#4) 
Unit cell dimensions a = 10.366(3) Å  α = 90° 
 b = 20.154(5) Å  β = 104.730(6)° 
 c = 14.904(4) Å  γ = 90° 
Volume 3011.1(13) Å3 
Z 4 
Density (calculated) 1.632 g cm-3 
Absorption coefficient 4.489 mm-1 
F(000) 1468.0 
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Crystal size 0.1 × 0.1 × 0.02 mm 
Theta range for data collection 2.03 to 25.36° 
Index ranges -10<=h<=12, -24<=k<=17, -17<=l<=17 
Reflections collected 18384 
Independent reflections 9406 [R(int) = 0.0570] 
Completeness to theta = 25.36° 99.0% 
Absorption correction Multiscan 
Max. and min. transmission 0.914 and 0.532 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9406 / 25 / 723 
Goodness-of-fit on F2 1.128 
Final R indices [I>2sigma(I)] R1 = 0.0597 
R indices (all data) R1 = 0.0639, wR2 = 0.1575 
Absolute structure parameter 0.00000 
Largest diff. peak and hole 5.40 and -1.81 e- Å-3 
 
Table 3.6. Crystal data and structural refinement for Δ-[(Ir(ppy)2(L-serine)]. 
 
3.5.21 Crystal data and structure refinement for Λ-[(Ir(ppy)2Cl)2] 
and Δ-[(Ir(ppy)2Cl)2] 
Structural data were collected at 93 K using a Rigaku Saturn diffractometer (MM007 
high-flux RA/MoKa radiation, confocal optic). All data collection employed narrow 
frames (0.3-1.0) to obtain at least a full hemisphere of data. Intensities were corrected 
for Lorentz polarisation and absorption effects (multiple equivalent reflections). The 
structures were solved by direct methods, non-hydrogen atoms were refined 
anisotropically with CH protons being refined in riding geometries (SHELXTL) against 
F2. 
CCDC 888470 and 888469 contains the supplementary crystallographic data for Λ-
[(Ir(ppy)2Cl)2] and Δ-[(Ir(ppy)2Cl)2], respectively. This data can be obtained free of 
charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 




Figure 3.40. X-ray crystal structure of Λ-[(Ir(ppy)2Cl)2]. The carbon atoms of ppy are 
shown in blue, iridium in magenta, nitrogen in pale blue and chlorine in green. Selected 
bond lengths [Å] and angles [°]: Ir1-Cl1 2.5131(17), Ir1-Cl2 2.5235(16), Ir1-N1 
2.050(7), Ir1-N21 2.069(7), Ir1-C8 2.003(9), Ir1-C28 1.983(8), Ir2-Cl1 2.5291(1), Ir2-
Cl2 2.5249(18), Ir2-N41 2.061(6), Ir2-N61 2.044(6), Ir2-C48 1.985(8), Ir2-C68 
2.004(8), Cl1-Ir1-Cl2 81.79(6), Cl1-Ir1-N1 93.01(18), Cl1-Ir1-N21 91.91(17), Cl1-Ir1 -
C8 173.5(3), Cl1-Ir1-C28 92.1(2), Cl2-Ir1-N1 91.09(17), Cl2-Ir1-N21 93.4(2), Cl2-Ir1-C8 
97.5(2), Cl2-Ir1-C28 171.4(2), Cl1-Ir2-Cl2 81.44(5), Cl1-Ir2-N41 92.86(18), Cl1-Ir2-N61 
94.49(19), Cl1-Ir2-C48 91.6(2), Cl1-Ir2-C68 175.0(2), Cl2-Ir2-N41 94.39(17), Cl2-Ir2-
N61 90.72(19), Cl2-Ir2-C48 171.6(2), Cl2-Ir2-C68 97.0(2), N21-Ir1-C8 94.6(3), N1-Ir1-
C28 95.3(3), N61-Ir2-C48 94.6(3), N41-Ir2-C68 92.0(3). 
 
Identification code Λ-[(Ir(ppy)2Cl)2] 
Empirical formula C44H32Cl2Ir2N4 
Formula weight 1072.11 
Temperature 93(1) K 
Bond precision C-C = 0.0130 Å 
Wavelength 0.71075 Å 
Crystal system Orthorhombic 
Space group P212121 
Unit cell dimensions a = 9.9782(17) Å  α = 90° 
 b = 12.560(2) Å  β = 90° 
 c = 29.008(5) Å  γ = 90° 
Volume 3635.4(11) Å3 
Z 4 
















Table 3.7. Crystal data and structural refinement for Λ-[(Ir(ppy)2Cl)2]. 
 
Figure 3.41. X-ray crystal structure of Δ-[(Ir(ppy)2Cl)2]. The carbon atoms of ppy are 
shown in blue, iridium in magenta, nitrogen in pale blue and chlorine in green. Selected 
bond lengths [Å] and angles [°]:Ir1-Cl1 2.5261(14), Ir1-Cl2 2.5298(13),Ir1-N1 2.056(6), 
Ir1-N21 2.059(5), Ir1-C8 2.007(8), Ir1-C28 1.988(6), Ir2-Cl1 2.5359(13), Ir2-Cl2 
2.5328(15), Ir2-N41 2.062(5), Ir2-N61 2.044(5), Ir2-C48 1.986(6), Ir2-C68 2.002(6), 
Cl1-Ir1-Cl2 81.95(5), Cl1-Ir1-N1 92.84(15), Cl1-Ir1-N21 92.02(15), Cl1-Ir1-C8 
Absorption coefficient 7.520 mm-1 
F(000) 2048.0 
Crystal size 0.1 × 0.03 × 0.03 mm 
Theta range for data collection 1.77 to 25.38° 
Index ranges -12<=h<=12, -14<=k<=15, -32<=l<=34 
Reflections collected 36752 
Independent reflections 6664 [R(int) = 0.0398] 
Completeness to theta = 25.38° 99.8% 
Absorption correction Multiscan 
Max. and min. transmission 0.798 and 0.595 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6664 / 0 / 469 
Goodness-of-fit on F2 0.996 
Final R indices [I>2sigma(I)] R1 = 0.0314 
R indices (all data) wR2 = 0.0752 
Absolute structure parameter 0.001(10) 
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173.79(19), Cl1-Ir1-C28 92.07(17), Cl2-Ir1-N1 91.38(14), Cl2-Ir1-N21 93.61(18), Cl2-
Ir1-C8 97.30(17), Cl2-Ir1-C28 171.24(17), Cl1-Ir2-Cl2 81.70(4), Cl1-Ir2-N41 92.58(15), 
Cl1-Ir2-N61 94.64(15), Cl1-Ir2-C48 91.04(19), Cl1-Ir2-C68 175.04(17), Cl2-Ir2-N41 
94.50(14), Cl2-Ir2-N61 91.20(15), Cl2-Ir2-C48 171.45(19), Cl2-Ir2-C68 97.06(17), N1-
Ir1-C28 95.3(2), N21 Ir1 C8 94.2(3), N41-Ir2-C68 92.3(3), N61-Ir2-C48 93.9(3). 
 
 
Table 3.8. Crystal data and structural refinement for Δ-[(Ir(ppy)2Cl)2]. 
Identification code Δ-[(Ir(ppy)2Cl)2] 
Empirical formula C44H32Cl2Ir2N4 
Formula weight 1072.11 
Temperature 93(1) K 
Bond precision C-C = 0.0109 Å 
Wavelength 0.71075 Å 
Crystal system Orthorhombic 
Space group P212121 
Unit cell dimensions a = 10.0039(19) Å  α = 90° 
 b = 12.557(3) Å  β = 90° 
 c = 29.038(6) Å  γ = 90° 
Volume 3647.7(12) Å3 
Z 4 
Density (calculated) 1.952 g cm-3 
Absorption coefficient 7.494 mm-1 
F(000) 2048.0 
Crystal size 0.06 × 0.06 × 0.02 mm 
Theta range for data collection 2.15 to 25.35° 
Index ranges -10<=h<=12, -15<=k<=15, -31<=l<=34 
Reflections collected 36825 
Independent reflections 6664 [R(int) = 0.0457] 
Completeness to theta = 25.35° 99.8% 
Absorption correction Multiscan 
Max. and min. transmission 0.8649 and 0.6626 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6664 / 0 / 469 
Goodness-of-fit on F2 0.939 
Final R indices [I>2sigma(I)] R1 = 0.0255 
R indices (all data) wR2 = 0.0537 
Absolute structure parameter 0.023(8) 
Largest diff. peak and hole 0.646 and -0.540 e- Å-3 
Luminescent Iridium-based coordination capsules                                                     Chapter 3 
146 
 
3.5.22 Crystal data and structure refinement for Δ- and Λ-1·6OTf 
3.5.22.1 Δ-[(Ir(ppy)2)6(tcb)4](OTf)6, Δ-1·6OTf 
Structural data was collected using Rigaku AFC12 goniometer equipped with an 
enhanced sensitivity (HG) Saturn724+ detector mounted at the window of an FR-E+ 
SuperBright molybdenum rotating anode generator with VHF Varimax optics (70µm 
focus). Cell determination and data collection employed CrystalClear-SM Expert 2.0 r11 
(Rigaku, 2011). The structures were solved using SHELXL97.[42] 
CCDC 898757 contains the supplementary crystallographic data for Δ-1·6OTf. This data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 3.42. X-ray crystal structure of Δ-1·6OTf. For clarity, non-encapsulated OTf- 
counteranions, solvent molecules and hydrogens have been removed. The carbon 
atoms of ppy are shown in blue, tcb in dark green and OTf- carbon in orange, iridium in 
pink, nitrogen in pale blue, sulfur in yellow, oxygen in red and fluorine in pale green. 
 




Table 3.9. Crystal data and structural refinement for Δ-1·6OTf. 
 
Special details: The unit cell comprises regions of diffused disordered solvent 
(benzene) which could not be modelled as discrete sites. SQUEEZE[43] routine of 
PLATON[44] was applied to remove the contributions to the structure factors from the 
Identification code Δ-1·6OTf 
Empirical formula C242H176Cl4F18Ir6N24O19S6 
Formula weight 5553.43 
Temperature 100(2) K 
Bond precision C-C = 0.0109 Å 
Wavelength 0.71075 Å 
Crystal system Triclinic 
Space group P1 
Unit cell dimensions a = 18.2508(4) Å  α = 84.800(6)° 
 b = 19.2160(5) Å  β = 63.270(5)° 
 c = 20.1901(14) Å  γ = 72.872(5)° 
Volume 6036.4(5) Å3 
Z 1 
Density (calculated) 1.528 g cm-3 
Absorption coefficient 3.469 mm-1 
F(000) 2736.0 
Crystal Colour, Description yellow, prism 
Crystal size 0.07 × 0.07 × 0.05 mm 
Theta range for data collection 3.05 to 25.03° 
Index ranges -21<=h<=17, -22<=k<=22, -24<=l<=24 
Reflections collected 87282 
Independent reflections 36199 [R(int) = 0.0593] 
Completeness to theta = 25.03° 99.8% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8457 and 0.7933 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 36199 / 494 / 2648 
Goodness-of-fit on F2 1.039 
Final R indices [I>2sigma(I)] R1 = 0.0523, wR2 = 0.1296 
R indices (all data) R1 = 0.0588, wR2 = 0.1339 
Absolute structure parameter 0.043(5) 
Largest diff. peak and hole 2.336 and -1.265 e- Å-3 
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solvent molecules. This improved the model quality and led to structure refinement 
with satisfactory convergence. 
In the crystal structure several atoms are disordered. One ppy ligand has been 
modelled over two positions with 70:30 percent ratio. Furthermore, for disordered 
components (ppy ligand as well as solvent molecules) vibrational restraints 
(SIMU/DELU), similar displacement restraints (EADP) and distance/angle restraints 
DFIX/DANG and AFIX 66 were used to maintain sensible geometries and atomic 
displacement ellipsoids. Some atoms required ISOR restraint to approximate isotropic 
behaviour. 
3.5.22.2 Λ-[(Ir(ppy)2)6(tcb)4](OTf)6, Λ-1·6OTf 
Structural data were collected at 93 K using a Rigaku Saturn diffractometer (MM007 
high-flux RA/MoKa radiation, confocal optic). All data collection employed narrow 
frames (0.3-1.0) to obtain at least a full hemisphere of data. Intensities were corrected 
for Lorentz polarisation and absorption effects (multiple equivalent reflections). The 
structures were solved by direct methods, non-hydrogen atoms were refined 
anisotropically with CH protons being refined in riding geometries (SHELXTL) against 
F2. 




Figure 3.43. X-ray crystal structure of Λ-1·6OTf. For clarity, non-encapsulated OTf-
counteranions, solvent molecules and hydrogens have been removed. The carbon 
atoms of ppy are shown in blue, tcb in dark green and OTf- carbon in orange, iridium in 
pink, nitrogen in pale blue, sulfur in yellow, oxygen in red and fluorine in pale green. 
 
 
Identification code Λ-1·6OTf 
Empirical formula C174H108Cl2F18Ir6N24O18S6 
Formula weight 4581.47 
Temperature 93(1) K 
Wavelength 0.71075 Å 
Crystal system Triclinic 
Space group P1 
Unit cell dimensions a = 18.1600(18) Å  α =  80.319(9)° 
 b = 19.280(3) Å  β =  63.690(6)° 
 c = 20.067(3) Å  γ =  73.531(8)° 
Volume 6032.5(14) Å3 
Z 1 
Density (calculated) 1.261 g cm-3 
Absorption coefficient 3.444 mm-1 
F(000) 2218.0 
Crystal Colour, Description yellow, prism 








Crystal size 0.1 × 0.1 × 0.1 mm 
Theta range for data collection 1.54 to 25.40° 
Index ranges -21<=h<=21, -23<=k<=23, -24<=l<=23 
Reflections collected 61379 
Independent reflections 35576 [R(int) = 0.0703] 
Completeness to theta = 25.40° 98.9% 
Absorption correction Multiscan 
Max. and min. transmission 0.444 and 0.709 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 35576 / 0 / 2845 
Goodness-of-fit on F2 1.509 
Final R indices [I>2sigma(I)] R1 = 0.1108 
R indices (all data) wR2 = 0.3277 
Absolute structure parameter 0.078(13) 
Largest diff. peak and hole 7.830 and -7.430 e- Å-3 
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In Chapter 3, the synthesis of the first molecular capsule based on an [Ir(ppy)2]+ 
metallosupramolecular 90° acceptor unit and a tritopic tricyanobenzene ligand (tcb) was 
described. Preliminary investigations showed that, amongst other things, four of the six 
associated triflate counteranions reside within the cavity of the octahedral Ir6L4 capsule, 
16+, as evidenced by both solution and the solid state studies. In this chapter, we further 
explore the host-guest relationship of 16+ by preparing capsules with a wider range of 
counteranions (OTf-, PF6-, BF4- and ClO4-). Different spectroscopic techniques indicate that 
a similar supramolecular structure is formed (i.e. with at least four of the six associated 
counteranions residing in the cavity) irrespective of the counterion used. This 
encapsulation allows the counteranions to not only impart different optical properties, 
but also markedly alter the kinetic stability of 16+. By monitoring the rate of exchange of 
the Δ- and Λ-[Ir(ppy)2]+ subcomponents between preformed enantiopure enantiomers of 
16+, scrambling half-lives ranging from 4.7 mins with BF4- to as long as 4.5 days with OTf- 
were observed. In the case of OTf-, this represents a 1.4×104 enhancement in kinetic 
stability with respect to the rate of nitrile ligand exchange in a comparative mononuclear 
complex (as determined by NMR EXSY experiments). In further contrast to the cage 
scrambling experiments, the rate of ligand exchange in comparative mononuclear 
complexes was shown to be roughly independent of the associated counteranions. The 
capsule scrambling experiments have also revealed a trend in kinetic stabilities which 
mirrors the relative affinities of the anions for the cavity of 16+. This can be explained by 
differences in the inter-anion repulsive forces between the different encapsulated 
counteranions, as evidenced by 1H NMR chemical shifts of the protons in environments 
closest to the anion binding pockets, and further supported by electrostatic potential 
energy models of each of the anions. The one exception appears to be PF6-, which exhibits 
a greater affinity for the cavity of 16+ and yet the half-life of scrambling of 1·6PF6 is 
significantly less than that of 1·6OTf. This anomaly can be explained using solvophobic 
arguments.  
In an attempt to make an “empty” cage species, assembly experiments using an Ir starting 
material with bulky triflimide counteranions (NTf2-) were also carried out. Surprisingly, 
rather than form a discrete assembly, the formation of a complex, dynamic combinatorial 
library (DCL) of aggregates was observed. However, on addition of OTf- to the DCL, the 
formation of [4OTf⊂1]2+ occurred, indicating that these smaller anions clearly play a 
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templating-role. A similar explanation has also been used to explain why a capsule based 
on an extended tritopic ligand doesn’t form. Further structural variations have also been 
explored, by investigating the self-assembly with [Ir(ppz)2]+ (ppz = 1-phenylatopyrazol) 
units. While this produces the as expected Ir6L4 octahedron with tcb, the larger pore sizes 
result in faster exchange of guest anions and also an overall decrease in the kinetic 
stability with respect to 16+, despite further studies suggesting that the individual Ir-
nitrile interaction is stronger for [Ir(ppz)2]+ in comparison to [Ir(ppy)2]+. 
  




Over billions of years nature has developed highly complex dynamic chemical 
processes that function in tandem, often triggered by external stimuli that induce a 
cascade of events. In the cellular world, for example, dynamic template effects mark the 
start of new life in the transcription of genetic code from DNA to RNA, while apoptosis, 
often triggered by small molecules,[1] is a cascade of intra-cellular processes that result 
in cell shrinkage and eventual death. In these and many other examples, nature utilises 
intermolecular interactions to construct and process highly complex systems. In the 
abiotic world we are still far behind nature in constructing sophisticated chemical 
assemblies and processes, however, the recent interest in metallosupramolecular self-
assembly has led to the development of highly dynamic, three-dimensional 
architectures that have been utilised as molecular containers.[2] Often inspired by 
nature, these artificial scaffolds will potentially help us unravel the mysteries within 
the biotic world and are already paving the way for the next generation of catalysts and 
sensors. 
Three-dimensional metallosupramolecular assemblies are often referred to in the 
literature as cages and are treated as rigid, kinetically robust entities. Contrary to this 
description their self-assembly relies on reversible metal-ligand interactions which 
allow for self-sorting to take place, to ensure, occasionally with the aid of a template,[3] 
that the most thermodynamically favoured assembly will form. Recent studies by 
Nitschke and co-workers have revealed that their cages are in fact far more dynamic 
than initially anticipated with different polyhedra easily accessible through counterion 
and/or metal exchange.[4] Although the capsules often exhibit remarkable kinetic 
stability in solution due to cooperative effects,[5] a subtle change to the identity of the 
metal centre,[2d, 4, 6] ligand geometry,[7] counterions[4, 6a, 8] or even a change in solvent[9] 
can lead to significant structural changes to the product or, like apoptosis in cells, a 
weakening and complete disassembly of the three-dimensional structure altogether. 
Herein, we demonstrate the vital role played by the counterions and ligands in tuning 
the physical properties of the previously developed metallosupramolecular iridium 
capsule 16+.[10] 
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4.3 Results and Discussion 
4.3.1 Synthesis and characterisation 
In Chapter 3, the synthesis and characterisation of Λ/Δ-16+ utilising triflate (OTf-) and 
tetrafluoroborate (BF4-) as the counterions was discussed. Here, two further salts of 
cage 16+, hexafluorophosphate (PF6-) and perchlorate (ClO4-), were isolated, via an 
analogous method to the formation of 1·6BF4 (Scheme 4.1) and the physical properties 
of all 4 salts were compared.  
 
 
Scheme 4.1. Synthesis of Λ/Δ-1·6X (where X = BF4-, PF6- or ClO4-). Conditions: (i) AgX 
(where X = BF4-, PF6- or ClO4-), THF, RT, 2 h; (ii) tcb, C2H4Cl2, RT, 4 h; Λ-1·6BF4, 56%; Δ-
1·6BF4, 29%; Λ-1·6PF6, 32%; Δ-1·6PF6, 81%; Λ-1·6ClO4, 62%; Δ-1·6ClO4, 86%. Yields 
calculated starting from Λ/Δ-[(Ir(ppy)2Cl)2]. 
 
The 1H NMR spectra of the two newly isolated salts confirmed the presence of highly 
symmetrical assemblies with 9 different aromatic proton environments, analogous to 
1·6OTf and 1·6BF4 (Figure 4.1). Changing the counterions associated with 16+ appears 
to have little influence on the environments of protons HC-HH, which sit on the 
periphery of the scaffold, evident by their superimposable 1H NMR chemical shifts. 
However, it came as no great surprise that changing the anions associated with the 
system significantly affected the chemical shifts of protons HA, HB and HI, which are 
positioned next to the anion binding pockets. 






Figure 4.1. 1H NMR spectra (500 MHz, C2D2Cl4, 298 K) of a) Λ-1·6OTf, b) Λ-1·6PF6, c) Λ-
1·6ClO4 and d) Λ-1·6BF4. See Scheme 4.1 for peak assignment. 
 
In addition, the different counteranions have little influence on the size of 16+, as near 
identical diffusion coefficients were measured for 1·6X (where X = OTf-, BF4-, PF6- or 
ClO4-) using 1H DOSY NMR (see section 4.5.3). As had previously been observed for 
1·6OTf and 1·6BF4, capsules with ClO4- and PF6- counteranions only exhibit intact 
assemblies with 2+ charge under nESI-MS conditions (visible at 2098.3 and 2007.2 
m/z, respectively), strongly suggesting that in all cases four of the six anions reside in 
the cavity (see section 4.5.4). However, further analysis of 1·6PF6 using 19F NMR 
spectroscopy showed three sets of doublets centred at -69.37, -70.05 and -72.39 ppm 
(see Figure 4.2a), in contrast to 1·6OTf, where only two signals, assignable to 
counteranions inside and outside the cage, were observed. 





Figure 4.2. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of a) -1·6PF6, using 1,2-
difluorobenzene as internal standard the number of encapsulated (●, green) and free 
(▲, red) PF6- anions per capsule (-1·6PF6) was calculated to be 0.3, 4.4 and 1.2, 
respectively or qualitatively as 0.3, 4.5 and 1.2; b) -1·6PF6 with excess Bu4NPF6. 
 
The ratio of PF6- anions in the three different environments was measured as 
0.3:4.5:1.2. The broad doublet centred at -72.39 ppm (▲) increases in intensity with 
the addition of Bu4NPF6 (see Figure 4.2b), suggesting that, on average, 1.2 PF6- anions 
are associated with the outside of the capsule and 4.8 PF6- anions reside within the 
cavity in two different environments (●). In addition, the encapsulated 
hexafluorophophate guests are deshielded with respect to the unencapsulated anions, 
the reverse of that observed with triflate. Presumably this deshielding is caused by the 
formation of CH···F(P) hydrogen bonds, whereas in the case of 1·6OTf, the cage prefers 
to form hydrogen bonds with the oxygen atoms of the triflate anions leaving the tcb 
aromatic panels to shield the CF3 portion of this anion (see Chapter 3). Further support 
for this assignment comes from 19F DOSY measurements and 19F-1H HOESY NMR 
analysis (see section 4.5.5), the former technique shows that both encapsulated PF6- 
signals have the same diffusion coefficients of log (D / m2 s-1) = -10.00 in C2D2Cl4 as the 
1H DOSY diffusion coefficient for the scaffold (see section 4.5.3). From these results, the 
time-averaged 4.8 anions that are within the cavity are believed to be encapsulated by 
16+ in two different environments that differ based on the total number of PF6- anions 
present within the cavity. Integration of these 19F signals indicates that 1·6PF6 is 
composed of [4PF6⊂1](PF6)2 and [5PF6⊂1]PF6 in a ratio of 1:9 at 298 K. This integral 
ratio of the two 19F signals was observed to change as a function of temperature (see 
Figure 4.3). Reducing the temperature to 243 K saw a decrease in the presence of 
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[5PF6⊂1]PF6 and an increase in [4PF6⊂1](PF6)2. This result suggests that while 
[5PF6⊂1]PF6 is enthalpically favoured, through minimising unfavourable solvent-anion 
interactions (vide infra), [4PF6⊂1](PF6)2 is preferred on entropic grounds, presumably 
as the loss in the number of degrees of freedom for four bound counteranions is less in 
comparison to binding five (i.e. two “free” anions are favoured over one, and because 
five encapsulated anions will experience restricted, tighter binding, than four). 
 
 
Figure 4.3. 19F NMR (376 MHz, C2D2Cl4) spectra of Λ-1·6PF6 at a) 298 K (10:90 ratio in 
the integrals for the encapsulated signals), b) 273 K (20:80), c) 263 K (31:69), d) 253 K 
(43:57), e) 243 K (57:43) and f) spectrum of Bu4NPF6 at 298 K. Encapsulated (●, green) 
and free (▲, red) PF6- anions annotated accordingly in the spectra. 
 
For 1·6BF4, a marginally shifted and broadened 19F peak relative to Bu4NBF4 in C2D2Cl4, 
was observed, suggesting that the BF4- counterions are also binding within the cavity of 
16+ and are in fast exchange on the NMR timescale (see Figure 4.4). The time-averaged 
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signal is also deshielded with respect to free BF4-, suggesting that these anions form 
CH···F(B) hydrogen bonds with HB, HC and HI, in a similar fashion to PF6-. The number of 
encapsulated BF4- counterions within 16+ however remained inconclusive as only 
partial broadening of the 19F resonance was observed at the lower temperature limit of 
253 K. Similarly for 1·6ClO4, it is not possible to directly measure the number of 
counteranions which reside within the cavity of 16+, and the only evidence, in the 
absence of XRD data, for the dominance of [4X⊂Δ-1]2+, where X = ClO4- or BF4-, is the 
observation of solely the dicationic species under nESI-MS conditions. 
 
 
Figure 4.4. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of a) Λ-1·6BF4 and b) Bu4NBF4. 
 
4.3.2 Stability of 16+ and a comparison to similar mononuclear 
complexes 
In the biotic world, large assemblies, such as double-stranded DNA, rely on multiple 
weak supramolecular interactions that cooperatively drive the formation of very stable, 
robust, structures. Abiotic metallosupramolecular assemblies also often heavily rely on 
cooperative effects to kinetically stabilise structures through multiple metal-ligand 
interactions. However, detailed investigations of these effects remain scarce.[5, 11] By 
measuring the ligand exchange rate between two similarly endohedrally functionalised 
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M12L24 assemblies, Fujita and co-workers found their nano-spheres to be remarkably 
stable with a half-life, t1/2, value of 20 days, a value which is ~105 times more stable 
than the comparable monodentate Pt(II)-pyridine complex.[5] The same study also 
showed that part of the reason ligand scrambling between intact assemblies occurs 
very slowly is due to the negligible steady state concentration of free ligand; when 
small amounts of free ligand are added to the intact cage, the rate of scrambling 
increases dramatically, with a half-life, t1/2 = 23 min. Stang and co-workers similarly 
showed scrambling of ligand components between a set of Pt-based polygons using 
4,4′-bipy and the analogous deuterium labelled ligand.[11b] They too observed that these 
assemblies were remarkably stable with a ligand exchange t1/2 of 17 days (based upon 
the first-order kinetic exchange rate constant k = 0.0024 h-1), however, no comparison 
was made with a mononuclear complex making the assessment of cooperativity within 
their system difficult. In both of these examples, the assemblies between which the 
ligand exchange rates were measured were not isoenergetic, therefore the ligand 
exchange rate constant and the calculated overall stability are an average of the 
forward and reverse exchange processes. Measuring the true stability value for an 
ensemble of aggregates based on their exchange rates is possible when the ensembles, 
and the exchanging aggregates, are enantiomers of one another and the different 
structural isomers, which result due to scrambling, are distinguishable by analysis, 
such as NMR. Capsule 16+ represents an ideal candidate for such a study as both the 
homo-Λ and homo-Δ enantiomers are isoenergetic and the hetero-chiral assemblies, 
which form as a result of scrambling, have significantly different 1H NMR chemical 
shifts to the enantiopure starting isomers.  
The kinetic stabilities of 1·6X (where X = OTf-, PF6-, ClO4- or BF4-) were measured by 
mixing both Λ- and Δ-1·6X in a 1:1 ratio; as the Λ and Δ-[Ir(ppy)2]+ subcomponents 
scrambled the diminishing concentration of the homochiral assemblies was monitored 
using 1H NMR spectroscopy (see Figure 4.5 for the Λ/Δ-1·6OTf scrambling experiment 
compared to 1·6OTf obtained from rac-[(Ir(ppy)2Cl)2]; see section 4.5.6 for further 
experimental details). 





Figure 4.5. 1H NMR (500 MHz, C2D2Cl4, 298 K) spectra for the scrambling of Λ/Δ-
1·6OTf, a) combined Λ- and Δ-1·6OTf after 0.5 h; b) 24 h; c) 48 h and d) 7 days; e) 
1·6OTf obtained from rac-[(Ir(ppy)2Cl)2]. See Scheme 4.1 for peak assignment. 
 
Straight-line plots of (1/[Λ/Δ-1·6X]-1/[Λ/Δ-1·6X]0) versus t with all 4 counterions (see 
section 4.5.6) indicated that the scrambling kinetics were second order with respect to 
16+. The observed exchange rate constant, kobs, and half-life, t1/2, values for 1·6X (where 
X = OTf-, PF6-, ClO4- or BF4-), which were derived from their corresponding plots, were 
observed to be highly dependent on the associated counterions (see Table 4.1). A 
rational of the relative stabilities of 16+ is discussed in detail in section 4.3.5. 
 
 




kobs / M-1 s-1 t1/2 / day(s) 
Λ/Δ-1·6OTf 1.52×10-2 4.5 
Λ/Δ-1·6PF6 3.90×10-2 2.2 
Λ/Δ-1·6ClO4 11.0 0.0073 
Λ/Δ-1·6BF4 22.7 0.0033 
 
Table 4.1. The observed exchange rate constant, kobs, and half-life, t1/2, values for 1·6X 
(where X = OTf-, PF6-, ClO4- or BF4-) derived from plots of (1/[Λ/Δ-1·6X]-1/[Λ/Δ-1·6X]0) 
versus t (see section 4.5.7). 
 
 kobs / s-1 ΔG‡ / kcal mol-1 t1/2 / s 
[Ir(ppy)2(NCC6H4F)2]OTf 0.0256 19.6 27 
[Ir(ppy)2(NCC6H4F)2]PF6 0.0197 19.8 35 
[Ir(ppy)2(NCC6H4F)2]ClO4 0.0188 19.8 35 
[Ir(ppy)2(NCC6H4F)2]BF4 0.0255 19.6 27 
 
Table 4.2. Kinetic parameters for NCC6H4F ligand exchange for [Ir(ppy)2(NCC6H4F)2]X 
(where X = OTf-, PF6-, BF4- and ClO4-) in C2D2Cl4. 
 
In order to ascertain how effective cooperativity is in stabilising the structure of 16+, the 
ligand exchange rates for 1·6X were compared against representative mononuclear 
complexes, [Ir(ppy)2(NCC6H4F)2]X (where X = OTf-, PF6-, ClO4- or BF4-). While the 
exchange of nitrile ligands for the mononuclear complexes is slow on the NMR 
timescale, it is too quick to accurately measure via the same spectroscopic technique 
using a similar “pairs-scrambling” experiment. Instead, as the 19F NMR spectrum of 
[Ir(ppy)2(NCC6H4F)2]+ gave a signal for coordinated NCC6H4F that was distinct from free 
ligand, 19F EXSY spectroscopy was used to ascertain the activation barrier to the 
exchange process for the different anionic salts of this mononuclear complex. The 
activation barrier, ΔG, observed first order rate constant, kobs, and calculated half-life, 
t1/2, are shown in Table 4.2. In the case of the simple mononuclear complex, the identity 
of the associated counterions has no significant effect on the rate of the ligand exchange 
process, despite the anticipated difference in coordinating abilities of the four anions. 
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This is in stark contrast to 16+, where the associated counteranions lead to remarkably 
differing kinetic stabilities (see Table 4.1). In addition, when comparing 1·6OTf to 
[Ir(ppy)2(NCC6H4F)2]OTf, a 1.4×104 fold increase in the stability of ligand exchange is 
observed. While the enhanced stability in previous metallosupramolecular systems has 
been postulated to be primarily due to cooperativity between the multiple metal-ligand 
interactions,[5, 11b] in this system there appears to be additional parameters which 
stabilise the assembly. In particular the use of different counteranions appears to 
stabilise the structure to significantly different extents seemingly through additional 
non-covalent interactions between the embedded anions and the capsule’s scaffold. 
4.3.3 Encapsulation of OTf- versus PF6- 
In Chapter 3, the anion binding properties of capsule 16+ were explored using anion 
titration experiments; it was shown that this capsule preferentially binds anions in the 
order PF6- > OTf- > BF4-. The activation barrier for OTf- exchange within [4OTf⊂1](OTf)2 
was previously measured to be 18.0 kcal mol-1 using 19F EXSY NMR (see section 3.5.10). 
A similar analysis of the mixture of [4PF6⊂1](PF6)2 and [5PF6⊂1]PF6 using 19F EXSY 
NMR revealed that the energy barrier for PF6- exchange, 17.6 kcal mol-1 (see Section 
4.5.7),[12] is lower than that for 1·6OTf, suggesting that there is poor correlation 
between guest binding strength and the activation barrier to guest exchange. Through 
extensive experimental work on ion exchange, Raymond and co-workers have also 
revealed that the trends in ion binding affinities and exchange rates for their system do 
not run in parallel.[13] In this current system, there also appears to be poor correlation 
between guest binding strength and the kinetic stability of the overall ensemble, with 
t1/2 of 4.5 and 2.2 days for 1·6OTf and 1·6PF6, respectively. 
The primary determinant of binding strength of guests within the cavities of hosts has 
often been postulated to be due to Rebek’s 55% optimum cavity occupancy,[14] whereby 
guests which volumetrically fill closest to 55% of the space available within the host will 
bind strongest.[6a, 15] However, for this system, Rebek’s model for ideal guest binding 
proves to be an over simplification. In Chapter 3, the 4 OTf- counterions of [4OTf⊂1]2+ 
were shown to occupy an ideal 55%. However, PF6- anions have been shown to 
preferentially displace the triflate guests of [4OTf⊂1]2+ giving a mixture of [4PF6⊂1]2+ 
and [5PF6⊂1]+. Recently Nitchke’s group have demonstrated that anion binding 
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predictions for their system using volume occupancy ratios failed when hydrogen 
bonding and electrostatic interactions were present.[8a] Simple calculations,[16] would 
appear to suggest that the volume occupancies for [4PF6⊂1]2+ and [5PF6⊂1]+ are 48% 
and 60%, respectively, and as PF6- binds more strongly than OTf- this appears to 
contradict Rebek’s theory. 55% occupancy could however be achieved with an average 
of 4.6 PF6- ions, which is close to the 4.8 encapsulated PF6- ions observed to exist for 
pure 1·6PF6 (see section 4.3.1). Although [5PF6⊂1]·PF6 appears as the dominant 
species by 19F NMR analysis, the co-existence of [4PF6⊂1]·2PF6 as a minor species (see 
Scheme 4.2) is potentially crucial and its existence could be explained by and would 
support Rebek’s optimum occupancy theory. This however still leaves the question 
why PF6- is preferentially encapsulated over OTf-, yet both are estimated to occupy 
close to ~55%? 
 
 
Scheme 4.2. 1·6PF6 exists as an equilibrium between the [4PF6⊂1](PF6)2 and 
[5PF6⊂1]PF6 species, qualitatively measured at 10% and 90% in C2D2Cl4 at 298K, 
respectively. Annotated Ir (blue) ≡ [Ir(ppy)2]+. 
 
For other metallosupramolecular capsules, anion binding affinities for cationic cavities 
have often been observed to follow the trend PF6- > OTf- > ClO4- > BF4-, when the 
encapsulation process is not sterically hindered by the size or shape of the cavity.[15, 17] 
We now believe it is no coincidence that the anions frequently follow this trend and 
believe the reason behind it may be connected to solvophobic effects. 
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In considering the binding affinities of PF6-, OTf-, ClO4- and BF4-, it appeared that the 
interaction of the counterions with the bulk phase had been largely ignored. The free 
energy of binding neutral guests within a metallosupramolecular host has been 
previously demonstrated to be linearly proportional to the solubility of the guests in the 
binding medium i.e. the less soluble the guest the greater the binding affinity to the 
host.[18] Nitschke’s group have also demonstrated that in an aqueous solution CBr4 was 
preferentially bound over the more water soluble CCl4 within the hydrophobic cavity of 
their cage.[19] These results are consistent with the proposed hypothesis that the 
affinity for guest binding has a relationship to the solubility of the guests in the bulk 
phase, when the size and shape differences of the guest molecules are negligible in 
respect to the size and shape of the cavity.  
In order to ascertain whether there is a difference in solubility between OTf- and PF6- 
anions we decided to measure the relative solubility of the pyridinium salts (PyH·X) of 
the different anions in C2D2Cl4.[20] Fully saturating the solution with the corresponding 
salt and using 1H NMR for analysis, PyH·OTf appeared only partially soluble (see Figure 
4.6a). In contrast, PyH·PF6 appeared completely insoluble in C2D2Cl4 (see Figure 4.6b), 
whereas the solubility of PyH·ClO4 and PyH·BF4 in the same solvent were significantly 
less than PyH·OTf but greater than PyH·PF6 (see Figure 4.6c and 4.6d). 
 





Figure 4.6. Partial 1H NMR (400 MHz, C2D2Cl4, 298 K) spectra for a) PyH·OTf, b) 
PyH·PF6, c) PyH·ClO4 and d) PyH·BF4. All NMR samples were fully saturated with the 
corresponding salts and the spectra normalised. 
 
As predicted, PF6- appears to be less soluble than OTf- in C2D2Cl4, presumably due to 
less favourable anion-solvent interactions. This supports the hypothesis that when the 
anions are in competition, PF6- is preferentially bound over OTf- in the solvent free 
environment of the cavity of 16+ due to its greater solvophobicity in C2D2Cl4. The 
solvophobicity of the different anions, however, fails to explain the observed trend in 
the stability of 1·6X (where X = OTf-, PF6-, ClO4- or BF4-). In order to explain this trend 
electrostatic potential energy surfaces were modelled for the different anions in 
question. 
4.3.4 Modelled electrostatic potential surfaces 
Computer generated molecular electrostatic potential surfaces have been used in a 
variety of important chemical and biological systems[21] including the prediction of non-
covalent interactions such as hydrogen bond donor/acceptor ability,[22] cation-π 
binding strengths,[23] arene π-π stacking affinities[24] and host-guest recognition.[25] At 
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any given point on the surface of a molecule, the electrostatic potential is a measure of 
the electrostatic energy a positive unit test charge would experience at that point, red 
indicative of a more negative and blue a less negative charge.  
We decided to model the electrostatic potential surfaces for the different counterions to 
see if electrostatic interactions could potentially explain the large differences in 
stability of 1·6X (where X = OTf-, PF6-, ClO4- or BF4-). The electrostatic potential surfaces 
for OTf-, PF6-, BF4- and ClO4- were calculated using density function theory (DFT) with 
B3LYP/6-31G** as the basis set.[26] Observations revealed that OTf- has a distinct 
dipole, which is not present for PF6- (see Figure 4.7a and 4.7b). PF6- on the other-hand 
has a less electronegative surface with the more negative region centred towards its 
core. The electrostatic potential surfaces for ClO4- and BF4- are also spherical in 
symmetry (see Figure 4.7c and 4.7d), however the surface for ClO4- is more negatively 
charged than PF6-, and BF4- more negatively charged than ClO4-. 
 
 
Figure 4.7. B3LYP/6-31G** calculated electrostatic potential surfaces for a) OTf-, b) 
PF6-, c) ClO4- and d) BF4-. The rendered colour legend (kJ mol-1) is generic for all 4 
electrostatic potential surfaces.  
 
4.3.5 Stability of 16+ rationalised 
Following on from the kinetic stability studies in section 4.3.2, the reasoning behind the 
differences in stability of capsules 1·6X (where X = OTf-, PF6-, ClO4- or BF4-) was 
explored by looking at the electrostatic potential energy surfaces of the anions (see 
section 4.3.4) and re-examining the X-ray crystal structure of 1·6OTf (see section 
3.5.22). From the X-ray crystal structure of 1·6OTf, the OTf- anions bound within 16+, 
are aligned with the CF3 end pointing into the centre of the cavity and the SO3 group out 
towards the capsule’s “windows”. The oxygens associated with the OTf- anions appear 
a) b) c) d) 
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to hydrogen bond to both the protons on the tcb ligands and the ortho-proton on the 
pyridine of the ppy ligands, satisfying the electronegative node of the OTf- anion (see 
section 3.3.4). The CH hydrogen bound OTf- anions are also confined within a favoured 
tetrahedral close-packed conformation within the cavity of 16+, pre-orientated in the 
optimum position for hydrogen bonding. Comparing the computational models (see 
Figure 4.7a and 4.7b), PF6- on the other-hand has a spherical geometry with no net 
dipole and the electrostatic potential surface for PF6- is more electronegative than the 
inward pointing CF3 group yet less electronegative than the SO3 group on the OTf-. The 
less electronegative fluorine atoms of PF6- mean that this anion will be a poorer 
hydrogen bond acceptor and, based on the modelled electrostatic potential surfaces, 
one would predict that PF6- would experience greater inter-anion repulsive forces and 
therefore overall weaker binding within the framework of 16+ relative to OTf-. The 
attractive Coulombic forces, which are enhanced by hydrogen bonding, between the 
cationic framework of 16+ and the anionic core of 4 OTf- anions for which the repulsive 
forces are buffered by the CF3 groups, is believed to be the reason for the enhanced 
robustness of 1·6OTf with respect to 1·6PF6, whereas the higher affinity of PF6- over 
OTf- for the cavity of 16+ in C2D2Cl4 is caused by solvophobic effects. 
Both ClO4- and BF4-, like PF6-, have spherical symmetry with no net dipole and the 
electrostatic potential surfaces exhibit non-directional inter-anion repulsive forces (see 
Figure 4.7c and 4.7d). The modelled electrostatic potential surface for BF4-, however, 
overall appears more electronegative than ClO4-, which in turn is more electronegative 
than PF6-, thus BF4- would experience greater inter-anion repulsion within the cavity 
than ClO4-, which in turn would experience greater repulsion than PF6-. This trend in 
the inter-anion repulsive forces runs in parallel to the trend observed for the stability 
of capsules 1·6X, 1·6OTf >> 1·6PF6 >> 1·6ClO4 > 1·6BF4. By this analogy, the 
discrepancy in the stability of capsule 16+ appears to be at least partially governed by 
the inter-anion repulsive forces. 
Interestingly, when the calculated electrostatic potential energy on the repulsive node 
of the anions is compared to the chemical shift of the tcb proton HI (see Figure 4.1) an 
excellent linear correlation (R2 = 0.9998) is observed (see Figure 4.8). The more 
repulsive the node of the anion, the more shielded the electron environment around 
proton HI. This implies that the stability of capsule 16+ is closely related to the 
Exploration into the properties of the Ir capsules                                                        Chapter 4                                                           
172 
 
electrostatic potential of the repulsive node of the associated counterions, which in 




Figure 4.8. Chemical shift of HI from the 1H NMR spectra of Λ-1·6OTf, Λ-1·6PF6, Λ-
1·6ClO4 and Δ-1·6BF4 verses the calculated electrostatic potential on the repulsive node 
of the corresponding anion. R2 = 0.9998. 
 
4.3.6 Template effects 
Iridium capsule 16+ has thus far displayed interesting host-guest chemistry with various 
anions. However, in order to bind neutral guests the capsule must either contain an 
empty cavity or a cavity where the ions and/or solvent molecules could be readily 
displaced. We therefore attempted to synthesise the empty capsule using 
trifluoromethanesulfonimide (NTf2-), a bulky anion that is potentially too large to fit 
inside the cationic pocket of 16+ (see Scheme 4.3). 




Scheme 4.3. Synthesis of Λ/Δ- 1·6NTf2 and Λ/Δ-[(Ir(ppy)2)3(tcb)3](NTf2)3. Conditions: 
a) 3:2 stoichiometric ratio of Λ- or Δ-[(Ir(ppy)2THF2]NTf and tcb, C2H4Cl2, RT and b) Λ- 
or Δ- [(Ir(ppy)2THF2]NTf with excess tcb, C2H4Cl2, RT. 
 
Starting from the readily synthesised Λ-[Ir(ppy)2THF2]NTf2 precursor (see Figure 4.9a) 
in C2D2Cl4 two thirds of an equivalents of tcb was added. A complex library of 
aggregates appears to form, as seen by 1H NMR spectroscopy (see Figure 4.9b), and 
more importantly, no M6L4 assemblies were detected by nESI-MS analysis. However, 
titrating Bu4NOTf into the mixture led to the broad and “messy” 1H NMR spectrum 
converging into sharp signals (see Figure 4.9b-4.9g), superimposable with authentic 
1·6OTf. Addition of only 4 equivalents of OTf- (see Figure 4.9f), the quantity required to 
fill the cavity of 16+, led to instantaneous formation of Λ-[1·4OTf]2+, demonstrating the 
high preference in the self-assembly of the octahedral architecture over any other. 
What is also interesting is if a small excess of tcb is charged to the NMR sample 
containing the dynamic library of aggregates (Figure 4.9b) what is believed to be an 
open-ended form of the capsule, Λ-[(Ir(ppy)2)3(tcb)3](NTf2)3, is observed to form (see 
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Figure 4.9h and Section 4.3.7). These results strongly suggest that the self-assembly of 





Figure 4.9. 1H NMR (400 MHz, C2D2Cl4, 298 K) spectra of a) Λ-[Ir(ppy)2THF2](NTf2); b) 
a dynamic library of aggregates formed on addition of 3 eq of Λ-[Ir(ppy)2](NTf2) to 2 eq 
of tcb; dynamic library of aggregates with c) 1 eq of Bu4NOTf; d) 2 eq; e) 3 eq; f) 4 eq; g) 
6 eq and h) Λ-[(Ir(ppy)2)3(tcb)3](NTf2)3 formed on addition of 1.3 eq of tcb to Λ-
[Ir(ppy)2THF2](NTf2). See Scheme 4.3 for peak assignment. 
 
Further empirical evidence that the self-assembly of 16+ is driven by counterion 
templation effects was obtained by replacing tcb for a larger tritopic cyano ligand, 
1,3,5-tris(4-cyanophenylethynyl)benzene (tceb), which has previously been used by 
Stang to create diverse Pd(II) and Pt(II)-based octahedra.[27] The larger tritopic ligand 
was used in an attempt to construct a capsule with wider “windows” allowing for easier 
anion migration in and out of the cavity. Self-assembly was attempted starting from 
both the [(Ir(ppy)2OTf)2] and [Ir(ppy)2(THF)2]NTf2 precursors (see Scheme 4.4) but, as 
with NTf2-, no single species or M6L4 assemblies were detected by NMR or nESI-MS 
analysis. The larger assembly is believed to possess a cavity that is non-complimentary 
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in size and/or shape to either OTf- or NTf2- counterions and, without the templation 
effect, the entropic costs of the larger assembly outweigh the enthalpic gains of the 
multiple metal-ligand interactions. 
 
 
Scheme 4.4. Synthesis of Λ/Δ-[(Ir(ppy)2)6(tceb)4](X)6 (where X = a) OTf- or b) NTf2-). 
Conditions starting from Λ/Δ-[(Ir(ppy)2Cl)2]: a) (i) AgOTf, C2H4Cl2, RT, 2 h; (ii) tceb, 
C2H4Cl2, RT, 24 h; b) (i) AgNTf2, THF, RT, 2 h; (ii) tceb, C2H4Cl2, RT, 24 h. Annotated Ir 
(blue) ≡ [Ir(ppy)2]+. 
 
In the literature there are several instances where templates have been used to 
thermodynamically drive the exclusive formation of metallosupramolecular 
architectures by means of reducing the ground state energy of the desired assembly.[3, 
28] Ions acting as templates are common in the area of coordination chemistry, 
specifically in the assembly of macrocycles,[29] rotaxanes, catenanes and knots[30] and 
other higher order assemblies.[8b, 31] The use of ions as templates in the self-assembly of 
metallosupramolecular capsules is also common and has been reported by the likes of 
Hay,[8d] Nitschke,[4, 6a] Raymond[8c] and Ward.[32] With anion templated self-assembly, 
there are several potential non-covalent interactions that can take place between the 
anions and the molecular scaffold including; hydrogen bonding, weak metal-anion and 
anion-π interactions[33] and/or simply Coulombic negative-positive charge attraction. 
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Ionic templates are often single ions of a constrained geometry. Multiple ions acting as 
ionic templates are far less common due to inter-ion repulsive forces, with only a small 
number of examples reported in the literature.[4, 6a, 34] One such example was 
demonstrated recently by Nitschke’s group who, using NTf2- with Co(II) and a bis-
bidentate ligand, observed the formation of a dynamic library of aggregates.[4, 6a] 
However, analogous to our observations with 16+, on addition of OTf-, PF6-, BF4- or ClO4- 
a discrete Co4L6, Co8L12 or Co10L15 assembly formed. In coordination chemistry, 
molecular templates have generally been used to energetically favour the self-assembly 
of one discrete structure from a dynamic library, however, templation effects could also 
be used for other useful applications, such as sensing of heavy metal cations in 
industry[35] and mono-disperse silica nanoparticle synthesis.[36] 
Thus far, the analysis of 1·6X has been conducted using C2H4Cl2 or C2D2Cl4 as solvent 
due to good solubility and stability. Protic solvents such as CH3OH and aprotic 
coordinating solvents such as DMSO are not compatible with this system as they 
compete with the nitrile ligands of 16+ and facilitate decomposition of the assembly. 
CD3NO2 has also been observed to partially decompose/disassemble 1·6OTf. However, 
as CD3NO2 is non-coordinating, the disassembly process is believed to result due to the 
increased solubility of OTf- ions (presuming nitromethane will form CH···O H-bonds to 
OTf-) in the solvent system, weakening the structure and destabilising the highly 
charged assembly. Saturating the CD3NO2 solution with OTf- in the form of Bu4NOTf, 
reverses this process and pushes the equilibrium to the left-hand-side leading to the 
reassembly of 1·6OTf. In a mixed CD3NO2/C2D2Cl4 (1:2) solvent system 1·6OTf remains 
intact, however the presence of CD3NO2, increases OTf- solubility and as a consequence 
significantly decreases the energy barrier to OTf- exchange in and out of the cavity and 
potentially the number of encapsulated OTf- anions, as evidenced by the broad 19F NMR 
signals re-equilibrated into a 1:1 ratio (see section 4.5.8). 
Re-examining the XRD data of 1·6OTf, 4 OTf- anions clearly form a closely packed 
anionic “cluster” within the cationic cavity of 16+, reducing the effective charge of the 
assembly from +6 to +2. [1·4OTf]2+ was also the only intact assembly cation visible by 
nESI-MS, implying that removal of even just one OTf- anion from the cavity greatly 
destabilises the capsule. The kinetic stability of 16+ has also been demonstrated to be 
particularly sensitive to different anions and solvents with half-lives ranging from days 
to minutes. This wealth of evidence is indicative that the anions, which have been 
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observed to reside in the cationic pocket, not only balance the charge but are 
fundamentally key in stabilising and controlling the self-assembly process of 16+. It has 
also been demonstrated that due to their different shapes and sizes, the different 
anions, in situ, form geometrically unique anionic templates that, based on their shape, 
size and electrostatic potential energy surfaces, determine the stability of 16+ and 
whether or not 16+ forms in the first instance.  
4.3.7 Metallocavitand [(Ir(ppy)2)3(tcb)3](NTf2)3 
In the previous section we demonstrated that the self-assembly of 16+ was counterion 
mediated with the NTf2- anion appearing either too large or of a mismatched geometry 
to template the formation. Adding an excess of tcb to the dynamic library of aggregates 
however led to the formation of what is believed to be an open-ended form of the 
capsule, what could be referred to as a metallocavitand.[28]  
The 1H NMR spectrum of Λ/Δ-[(Ir(ppy)2)3(tcb)3](NTf2)3 (see Figure 4.9h) revealed 10 
aromatic proton environments; 8 for the hydrogen atoms on the ppy and 2 on the tcb 
ligand. All signals appear sharp apart from HB, which is split. The cavitand was 
modelled in Spartan ’10 in order to try and explain the observed splitting phenomena. 
From the modelled structure of [(Ir(ppy)2)3(tcb)3]3+ (see Figure 4.10), the two ppy 
ligands are evidently inequivalent due to the reduced symmetry in this assembly 
relative to 16+. Proton HB (see Figure 4.10) sits in two distinct environments, either at 
the base or the lip of the metallocavitand, which differ to a much greater extent than 
any of the other ppy proton environments. This explains why only HB is split in the 1H 
NMR spectrum for Λ/Δ-[(Ir(ppy)2)3(tcb) 3](NTf2)3. 1H DOSY NMR confirmed that the 
aromatic protons all belonged to the same assembly (see section 4.5.9), with a log (D / 
m2 s-1) of -9.86 in C2D2Cl4 equivalent to a hydrodynamic radius of 10.9 Å, smaller than 
the radius of capsule 16+ and comparable to the diameter of the modelled structure (see 
Figure 4.10). The intact cavitand was also visible by nESI-MS (see section 4.5.10), 
where both the 1+ and 2+ cations for the M3L3 species were present. No higher order 
MnLn assemblies were observed. 





Figure 4.10. Model of Δ-[(Ir(ppy)2)3(tcb) 3]3+, energy minimised in Spartan ’10. 
Diameter measured at 21.0 Å. The two different environments for proton HB depicted. 
 
Further evidence for the formation of [(Ir(ppy)2)3(tcb)3](NTf2)3 was acquired by 
replacing one of the non-participating cyano groups on the tcb ligand with a methyl 
group, to give 1,3-dicyano(5-methyl)benzene (dcmb). Being di-topic, dcmb was 
predicted to only form macrocyclic assemblies of MnLn conformation. Following a 
similar experimental procedure (see Scheme 4.5) to Δ-[(Ir(ppy)2)3(tcb)3](NTf2)3 in 
C2D2Cl4, 1H NMR analysis confirmed the appearance of a major species, Δ-
[(Ir(ppy)2)3(dcmb)3](NTf2)3, for which the ppy proton signals were near 
superimposable with those of Δ-[(Ir(ppy)2)3(tcb)3](NTf2)3 (see section 4.5.11). 
 
 
Scheme 4.5. Synthesis of Δ-[(Ir(ppy)2)3(dcmb)3](NTf2)3, starting from Δ- 
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Isolation of the metallocavitand Λ-[(Ir(ppy)2)3(tcb)3](NTf2)3 was attempted by scaling 
up the reaction of Λ-[Ir(ppy)2THF2]NTf2 with 1 eq of tcb in C2H4Cl2. After 2 h at RT a 
precipitate was isolated from the reaction mixture which, when dissolved in C2D2Cl4 
appeared, by 1H NMR analysis, to be a dynamic combinatory library of aggregates, 
identical in appearance to the dynamic library formed previously in situ. In the 
presence of excess tcb in C2D2Cl4 the metallocavitand reformed as the sole product. 
The instability of the metallocavitand is postulated to be due to the highly reversible 
nature of Ir-nitrile bond and a lack of bonding cooperativity within the system. With 
fewer metal-nitrile interactions than capsule 16+, the entropic costs far outweigh the 
enthalpic gains and, without an excess of tcb to push the equilibrium to the right-hand-




Scheme 4.6. Synthetic pathway to the self-assembly of Λ/Δ-[(Ir(ppy)2)3(tcb)3](NTf2)3. 
Annotated Ir (blue) ≡ [Ir(ppy)2]+. 
 
4.3.8 Exchanging ppy for ppz (2·6OTf) 
The kinetic stability of the Ir scaffold 16+ is primarily governed by the cooperativity of 
the multiple metal-ligand bonds with secondary interactions between the scaffold and 
the different counterions giving rise to the varying stability. Attempts to move the 
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counterions to the periphery, leaving an empty chamber, have thus far been 
unsuccessful.  
From earlier experiments with the bpe ligand in Chapter 3, we observed that the bond 
between the Ir and the exchangeable ligand is more kinetically inert when 1-
phenylatopyrazole (ppz) is used instead of ppy as the cyclometalating ligand. We thus 
compared the Ir-nitrile exchange rates between the ppz and the ppy mononuclear Ir 
complex using 19F EXSY NMR analysis (vide supra). The activation barrier for Ir-nitrile 
exchange rate based on the ppz mononuclear analogue, [Ir(ppz)2(NCC6H4F)2](OTf), was 
measured at 20.3 kcal mol-1 (see section 4.5.7), strongly supporting our previous 
empirical observations. We therefore reasoned, taking these experimental results into 
consideration, that substitution of the ppy for the ppz ligand may kinetically stabilise 
the metallosupramolecular scaffold to a sufficient extent to allow the anionic templates 
to be removed without disruption of the octahedron. Enantiopure Λ- and Δ-Ir capsules 
with ppz concomitant ligands, [(Ir(ppz)2)6(tcb)4](OTf)6 (2·6OTf), were subsequently 
synthesised and their physical properties compared to those of 1·6OTf. 
Starting from the known rac-[(Ir(ppz)2Cl)2] bridged-chloride dimer and converting it 
into the subsequent L-serine diastereoisomers chiral resolution was this time achieved 
through solubility differences between the Λ-L and Δ-L diastereoisomers in CH2Cl2. Λ-
[Ir(ppz)2(L-serine)] appeared to be significantly more soluble in CH2Cl2 and was 
separated from the crude mixture by conventional Buchner filtration before being 
converted into enantiopure Λ-[(Ir(ppz)2Cl)2] with 1M HCl in CH3OH. Δ-[(Ir(ppz)2Cl)2] 
was obtained in the same manner using D-serine. Λ- and Δ-2·6OTf were synthesised 
from Λ- and Δ-[(Ir(ppz)2Cl)2] following an analogues experimental procedure to that for 
1·6OTf (see Scheme 4.7).  





Scheme 4.7. Synthesis of Λ/Δ-2·6OTf. Conditions: (i) AgOTf, C2H4Cl2, RT, 2 h; (ii) tcb, 
C2H4Cl2, RT, 4 h; Λ-2·6OTf, 16% (starting from Λ-[(Ir(ppz)2Cl)2]); Δ-2·6OTf, 22% 
(starting from Δ-[(Ir(ppz)2Cl)2]). 
 
The 1H NMR spectrum for the two enantiomers Λ- and Δ-2·6OTf were identical and 
similar to the spectrum for Λ/Δ-1·6OTf (see section 4.5.12). In the aromatic region 8 
different proton environments, 7 for the ppz and 1 singlet for the tcb ligand, were 
observed for the two enantiopure assemblies. From the 1H DOSY NMR experiments, a 
diffusion coefficient of log (D / m2 s-1) = -9.98 was calculated (see section 4.5.12) for Δ-
2·6OTf in C2D2Cl4, a value near identical to the diffusion coefficient measured 
previously for 1·6OTf (see section 3.5.6). In the gas phase under nESI-MS analysis, 
capsule 26+, as with 16+, was observed intact only as the 2+ cation, [2·4OTf]2+ at 2040.2 
m/z (see section 4.5.13). The appearance of only the 2+ species once again strongly 
suggests that 4 OTf- counterions are enclatherated in the cationic cavity of the capsule.  
An X-ray crystal structure for Δ-2·6OTf (see Figure 4.11a) was obtained by slow 
diffusion of benzene into a saturated C2H4Cl2 solution of 2·6+ (see section 4.5.14). The 
geometry of capsule 26+ was observed to be very similar in size and shape to 16+, with 
the largest difference being an increase in the size of the “windows” to the cavity (see 
Figure 4.11). Exchanging the ppy ligands on the Ir centre for the smaller ppz 
concomitant groups effectively increases the portal size and allows for more rapid 
counterion migration, as was subsequently demonstrated using 19F NMR.  






Figure 4.11. Space-fill representations of the X-ray crystal structures of a) Δ-2·6OTf 
and b) Δ-1·6OTf. The areas for the triangular shaped portals, highlighted in yellow, 
were calculated using trigonometry between the 3 meta-carbons on the pyrazole and 
pyridine rings of the ppz and ppy ligands, respectively. Portal areas were calculated as 
a) 14.4 Å2 and b) 11.7 Å2. The carbon atoms of ppy are shown in blue, tcb in dark green 
and OTf- carbons in orange, iridium in pink, nitrogen in pale blue, sulfur in yellow, 
oxygen in red and fluorine in pale green. Hydrogens have been omitted for clarity. 
 
The 19F NMR spectrum for Δ-2·6OTf revealed a broad, partially split, fluorine signal at 
RT, indicative of fast anion exchange on the NMR timescale and a lower energy barrier 
to anion encapsulation, relative to Δ-1·6OTf (see Figure 4.12). The fast anion exchange 
was monitored and a coalescence temperature of 30 °C was determined using VT NMR 
(see section 4.5.15). The rate constant for OTf- exchange was determined using 19F 
EXSY NMR and a change in Gibbs free energy of 15.8 kcal mol-1 calculated (see section 
4.5.7). The energy barrier to OTf- exchange for 2·6OTf was 2.1 kcal mol-1 lower than for 
1·6OTf, most likely due to less hindered anion migration in and out of the cavity 











Figure 4.12. 19F NMR spectra (376 MHz, C2D2Cl4, 298 K) for a) Δ-2·6OTf and b) Δ-
1·6OTf. Green singlet (B) corresponds to encapsulated OTf- and red singlet (A) is for 
free OTf-. 
 
The effect the larger portals have on the stability of the Ir capsule, given that the Ir-
nitrile interaction has been demonstrated to be stronger with the ppz ligands but the 
anion encapsulation weaker, was investigated next.  
The stability of 2·6OTf was measured, as for 16+, by mixing Λ- and Δ-2·6OTf in equal 
proportions and, using 1H NMR, recording the decreasing concentration of the intact 
homochiral assemblies with time. From a straight-line plot of t versus (1/[Λ/Δ-2·6OTf]-
1/[Λ/Δ-2·6OTf]0) the t1/2 for 2·6OTf was calculated as 1.9 days, less than half the value 
of 1·6OTf (see section 4.5.16). The diminished stability of 2·6OTf, relative to 1·6OTf, is 
believed to be due to the larger portal size in the scaffold, leading to weaker anion 
binding affinities, a reduced barrier to anion exchange and a more rapid flux of anions 
in and out of the cavity. Hydrogen bonding and potentially other weak intermolecular 
interactions between the encapsulated OTf- anions and the tcb and ppy ligands have 
been postulated key in stabilising the assembly of 16+. In the case of 26+, these 
interactions are still present but with a conformational and chemical change in the 
scaffold – exchange of the pyridyl groups for pyrazole – the interactions are potentially 
weaker. The combination of weaker interactions between the OTf- anions and the 
scaffold and the less sterically hindered barrier to anion exchange, both of which 
destabilise the assembly, appear to outweigh the enthalpic gains of the enhanced Ir-
Exploration into the properties of the Ir capsules                                                        Chapter 4                                                           
184 
 
nitrile bond strength for the [Ir(ppz)2]+ motif. As a result capsule 2·6OTf has been 
demonstrated to be less stable than capsule 1·6OTf. 
4.3.9 Photophysical Properties 
The [Ir(ppy)2]+ moiety has been extensively used to construct luminescent complexes 
which exhibit high quantum yields. In Chapter 3, the luminescent properties of capsule 
1·6OTf were first investigated and titration with different anions was demonstrated to 
alter the emission intensity of the capsule. Although, both PF6- and BF4- anions were 
observed to qualitatively quench the emission of 1·6OTf, no absolute values in the 
quantum yields of 1·6PF6 and 1·6BF4 were calculated.  
Preliminary measurements have revealed that the maximum emission wavelength 
(λmax) for 1·6BF4 is slightly blue shifted and 1·6PF6 and 1·6ClO4 slightly red shifted 
relative to 1·6OTf (see Figure 4.13). Air equilibrated quantum yields for the 3 new salts 
were measured to be lower than the yields observed for 1·6OTf, ranging between 0.6-
1.2% (see section 4.5.17). These experimental results were in agreement with the 
titration experiments conducted in Chapter 3. The luminescent data for 16+ with 
various counter ions appears to have little correlation to the kinetic stabilitie of the 
capsule or the vibrational stretching frequencies of the 4 anions,[37] except for 1·6OTf 
that is most stable and has the highest quantum yield. With a 100 fold excess of tcb in 
C2H2Cl4, the Ir cavitand, Δ-[(Ir(ppy)2)3(tcb) 3](NTf2)3, was demonstrated to maintain the 
luminescent properties of 1·6OTf, but once again with a reduced quantum yield (Ф = 
0.6%) (see section 4.5.17). 





Figure 4.13. Absorption and emission (excitation 413 nm) spectra of Λ-1·6OTf (2 µM), 
Λ-1·6PF6 (2 µM), Δ-1·6ClO4 (2 µM), Λ-1·6BF4 (2 µM), Δ-[(Ir(ppy)2)3(tcb)3](NTf2)3 (6 µM 
with 100 eq of tcb) and Λ-2·6OTf (1.2 µM) in C2H2Cl4. 
 
The inherent luminescent properties of analogous cationic Ir complexes have been 
demonstrated to arise primarily due to MLCT transitions. The λmax and quantum yields 
are subsequently tuned by altering the HOMO-LUMO gap of the complexes using an 
array of different ligands. Substituting for a more electron withdrawing ligand often 
leads to a blue shift in emission. Emission spectroscopy for 2·6OTf was consistent with 
the literature, with an observed λmax blue shifted to 551 nm, relative to 1·6OTf (λmax = 
560 nm). The blue shift is believed to be due to the greater electron withdrawing 
nature of the ppz ligand, with respect to the ppy. The quantum yield for 2·6OTf was 
measured at 5.7%, an increase of 1.6% on the quantum yield of 1·6OTf (see section 
4.5.17). This result was surprising given that 1·6OTf is more stable than 2·6OTf, and as 
a result ligand dissociation as a means to luminescence quenching would be expected 
to be more profound for 2·6OTf. 
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These preliminary results suggest that the quantum yields for the Ir assemblies are 
primarily governed by the anions and the auxiliary ligands on the Ir metal-centres and 
not the kinetic stabilities of the assemblies. 
 
4.4 Conclusion 
In conclusion, the vital roles played by the counterions in facilitating self-assembly and 
stabilising the assembled structures of 16+ have been explored. The stability of 16+ was 
demonstrated to be particularly sensitive to different counterions with measured 
stability half-lives ranging from 4.5 days (for 1·6OTf) to 5 mins (for 1·6BF4). 
Irrespective of the counterions, a large reduction in the ligand exchange rate (up to 
1.4×104 fold) was still observed when comparing capsule 16+ to similar mononuclear 
complexes. Modelled electrostatic potential energy surfaces were used to explain the 
observed differences in the stability of 16+ when OTf-, PF6-, ClO4- or BF4- were used as 
counterions. These small non-coordinating anions were shown to form complimentary 
templates that mediate the self-assembly of 16+, however, using a bulkier NTf2- anion 
led to the formation of a unique Ir metallocavitand. The metallocavitand maintained the 
photoluminescent properties associated with the corresponding capsules but was 
observed to be far less stable, most likely due to the reduced number of metal-ligand 
interactions and counteranion binding in the structure. Exchanging the ppy 
concomitant ligands on the Ir metal centres for ppz increased the rate of anion 
migration in and out of the capsule’s cavity, destabilising the assembly as a 
consequence. The luminescence quantum yields were however enhanced indicating 
that the irradiative quenching associated with these Ir capsules is not directly 
proportional to their kinetic stabilities. 
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4.5 Experimental Section 
4.5.1 General Experimental Procedure 
Unless stated otherwise, all reagents and solvents were purchased from commercial 
sources and used without further purification. rac-[(Ir(ppy)2Cl)2],[38] rac-




4.5.2.1 Synthesis of Λ/Δ-[(Ir(ppy)2)6(tcb)4](OTf)6 (Λ/Δ-1·6OTf) 
Experimental procedure for the synthesis of Λ- and Δ-[(Ir(ppy)2)6(tcb)4](OTf)6 (Λ/Δ-
1·6OTf) is discribed in section 3.5.2.5. 
4.5.2.2 Synthesis of Λ/Δ-[(Ir(ppy)2)6(tcb)4](BF4)6 (Λ/Δ-1·6BF4) 
Experimental procedure for the synthesis of Λ-[(Ir(ppy)2)6(tcb)4](BF4)6 (Λ-1·6BF4) is 
discribed in section 3.5.2.7. 
Starting from Δ-[Ir(ppy)2Cl)2] (8.9 mg, 0.008 mmol), the Δ-enantiomer was synthesised 
following the same procedure as for Λ-1·6BF4. Yellow solid obtained (3.3 mg, 29%). 
Characterisation was identical to Λ-1·6BF4. 
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4.5.2.3 Synthesis of Λ/Δ-[(Ir(ppy)2)6(tcb)4](PF6)6 (Λ/Δ-1·6PF6) 
 
 
To Λ-[(Ir(ppy)2Cl)2] (21.0 mg, 0.020 mmol) was added AgPF6 (9.9 mg, 0.040 mmol) in 
THF (5 mL) and the mixture stirred at RT in a darkened flask for 2 h. The orange 
solution was filtered through celite and concentrated under pressure. The crude 
product was dissolved in C2H4Cl2 (1 mL), tcb (4.0 mg, 0.026 mmol) charged and the 
solution stirred for 4 h at RT. The resulting precipitate was filtered off and washed with 
a minimal amount of C2H4Cl2 and Et2O to give Λ-1·6PF6 as a yellow solid (9.4 mg, 32%). 
1H NMR (400 MHz, C2D2Cl4): 9.22 (12H, d, J = 5.7 Hz, HA), 8.19 (12H, m, HC), 8.17 (12H, s, 
HI), 7.97 (12H, d, J = 7.9 Hz, HD), 7.74 (12H, m, HB), 7.55 (12H, d, J = 8.3 Hz, HE), 6.95 
(12H, m, HF), 6.81 (12H, m, HG), 6.16 (12H, d, J = 7.1 Hz, HH); 19F NMR (376 MHz, 
C2Cl4D2): -69.37 (1.8F, d, JFP = 715 Hz, 0.3PF6-), -70.05 (27.0F, d, JFP = 714 Hz, 4.5PF6-), -
72.39 (7.2F, d, JFP = 707 Hz, 1.2PF6-); nESI m/z: 2098.3 [Λ-1·4PF6]2+.  
Starting from Δ-[Ir(ppy)2Cl)2] (8.5 mg, 0.008 mmol), the Δ-enantiomer was synthesised 
following the same procedure as for Λ-1·6PF6 above. Yellow solid obtained (9.6 mg, 
81%). Characterisation was identical to Λ-1·6PF6. 
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4.5.2.4 Synthesis of Λ/Δ-[(Ir(ppy)2)6(tcb)4](ClO4)6 (Λ/Δ-1·6ClO4) 
 
 
The synthesis of Λ-1·6ClO4 followed a similar experimental procedure to Λ-1·6PF6, 
starting with Λ-[Ir(ppy)2Cl)2] (16.7 mg, 0.016 mmol) and using AgClO4 (6.4 mg, 0.032 
mmol) instead of AgPF6. Yellow solid obtained (13.6 mg, 62%). 1H NMR (500 MHz, 
C2D2Cl4): 9.35 (12H, d, J = 5.5 Hz, HA), 8.19 (12H, m, HC), 8.09 (12H, s, HI), 7.94 (24H, m, 
HB+D), 7.56 (12H, d, J = 8.0 Hz, HE), 6.96 (12H, m, HF), 6.84 (12H, m, HG), 6.17 (12H, d, J = 
7.4 Hz, HH); nESI m/z: 2007.2 [Λ-1·4ClO4]2+. Anal. Calculated for C168H108Cl6Ir6N24O24: C, 
47.90; H, 2.58; N, 7.98%. Found: C, 47.75; H, 2.47; N, 7.93%.  
Starting from Δ-[Ir(ppy)2Cl)2] (16.5 mg, 0.015 mmol), the Δ-enantiomer was 
synthesised following the same procedure as for Λ-1·6ClO4. Yellow solid obtained 
(18.6mg, 86%). Characterisation was identical to Λ-1·6ClO4. 
 
4.5.2.5 Synthesis of [Ir(ppy)2(NCC6H4F)2](X) where X = OTf-, PF6-, ClO4- and BF4- 
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[(Ir(ppy)2Cl)2] (63.6 mg, 0.059 mmol) and AgOTf (30.5 mg, 0.118 mmol) were dissolved 
in C2H4Cl2 (30 mL). The solution was stirred at room temperature in a darkened flask 
for 2 h. The mixture was filtered through celite and washed with C2H4Cl2. The filtrate 
was concentrated (~4 mL) and 4-fluorobenzonitrile (NCC6H4F) (28.6 mg, 0.236 mmol) 
was charged. After 1 h at RT, the solution was concentrated to 0.5 mL and the product 
was precipitated out of solution with Et2O. The resultant yellow solid was filtered and 
washed with Et2O to yield [Ir(ppy)2(NCC6H4F)2]OTf (39.6 mg, 37%). 1H NMR (400 MHz, 
C2D2Cl4 + 10 eq NCC6H4F): 9.06(2H, d, J = 5.4 Hz, HA), 8.03 (4H, m, HC+D), 7.75-7.58 (m, 
HE+I + HNCC6H4F), 7.50 (2H, m, HB), 7.26-7.14 (m, HJ + HNCC6H4F), 7.03 (2H, m, HF), 6.89 (2H, 
m, HG), 6.19 (2H, d, J = 7.6Hz, HH); 19F NMR (376 MHz, C2D2Cl4 + 10 eq NCC6H4F): -77.41 
(18F, s, OTf-), -96.98 (2F, s, NCC6H4Fbound), -101.60 (s, NCC6H4Ffree). 
 
 
[(Ir(ppy)2Cl)2] (23.2 mg, 0.022 mmol) and AgBF4 (8.6 mg, 0.044 mmol) were dissolved 
in THF (10 mL). The solution was stirred at RT in a darkened flask for 2 h. The mixture 
was filtered through celite and washed with THF. The filtrate was concentrated and 
redissolved in C2H4Cl2 (3 mL). NCC6H4F (10.6 mg, 0.088 mmol) was charged and the 
solution was stirred at room temperature for 1 h. The solution was concentrated to 
~0.5 mL and the product was precipitated out of solution with Et2O. The resultant 
yellow solid was filtered and washed with Et2O to yield [Ir(ppy)2(NCC6H4F)2]BF4 (22.0 
mg, 61%). 1H NMR (400 MHz, C2D2Cl4 + 10 eq FC6H4CN): 9.09 (2H, d, J = 5.7 Hz, HA), 8.05 
(4H, m, HC+D), 7.76-7.63 (m, HE+I + HNCC6H4F), 7.52 (2H, m, HB), 7.26-7.15 (m, HJ + HNCC6H4F), 
7.06 (2H, m, HF), 6.93 (2H, m, HG), 6.22 (2H, d, J = 7.5Hz, HH); 19F NMR (376 MHz, C2D2Cl4 
+ 10 eq NCC6H4F): -97.12 (2F, s, NCC6H4Fbound), -101.15 (s, NCC6H4Ffree), -151.60 (24F, s, 
BF4-). 





[Ir(ppy)2(NCC6H4F)2]PF6 and [Ir(ppy)2(NCC6H4F)2]ClO4 were synthesised starting from 
[(Ir(ppy)2Cl)2] and AgX (where X = PF6- and ClO4-, respectively) following an analogous 
procedure to [Ir(ppy)2(NCC6H4F)2]BF4 above.  
 Starting from rac-[Ir(ppy)2Cl)2] (60.1 mg, 0.056 mmol), [Ir(ppy)2(NCC6H4F)2]PF6 was 
synthesised as a yellow solid (29.6 mg, 30% yield). 1H NMR (400 MHz, C2D2Cl4 + 10 eq 
NCC6H4F): 9.07 (2H, d, J = 5.7 Hz, HA), 8.02 (4H, m, HC+D), 7.76-7.61 (m, HE+I + HNCC6H4F), 
7.49 (2H, m, HB), 7.25-7.12 (m, HJ + HNCC6H4F), 7.03 (2H, m, HF), 6.88 (2H, m, HG), 6.20 (2H, 
d, J = 7.6Hz, HH); 19F NMR (376 MHz, C2D2Cl4 + 10 eq NCC6H4F): -71.94 (6F, d, JFP = 713.8 
Hz, PF6-), -97.28 (2F, s, NCC6H4Fbound), -101.60 (s, NCC6H4Ffree). 
Starting from rac-[Ir(ppy)2Cl)2] (60.5 mg, 0.056 mmol), [Ir(ppy)2(NCC6H4F)2]ClO4 was 
synthesised as a yellow solid (4.9 mg, 5% yield). 1H NMR (400 MHz, C2D2Cl4 + 10 eq 
NCC6H4F): 9.06 (2H, d, J = 5.6 Hz, HA), 8.06 (4H, m, HC+D), 7.73-7.62 (m, HE+I + HNCC6H4F), 
7.48 (2H, m, HB), 7.25-7.14 (m, HJ + HNCC6H4F), 7.03 (2H, m, HF), 6.88 (2H, m, HG), 6.19 (2H, 
d, J = 7.6Hz, HH); 19F NMR (376 MHz, C2D2Cl4 + 10 eq NCC6H4F): -97.25 (2F, s, 
NCC6H4Fbound), -101.59 (s, NCC6H4Ffree). 
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4.5.2.6 Synthesis of PyH·PF6, PyH·ClO4 and PyH·BF4 
 
 
Pyridinium chloride (0.167 g, 1.44 mmol) and AgPF6 (0.364 g, 2.88 mmol) were mixed 
in C2H4Cl2 and stirred for 2 h in a darkened flask at RT. A white precipitate was filtered 
off using celite and washed with a generous amount of C2H4Cl2. The filtrate was 
concentrated under vacuum to give a white solid (3.7 mg, 1.4%). The poor yield was 
due to the poor solubility of PyH·PF6 in organic solvents with the majority being filtered 
off with AgCl. 1H NMR (400 MHz, acetone-d6+D2O): 6.15 (2H, d, J = 6.0 Hz, HA), 5.96 (1H, 
m, HC), 5.44 (2H, m, HC); 19F NMR (376 MHz, C2D2Cl4): -74.60 (6F, d, JFP = 708.7 Hz, PF6-). 
 
 
PyH·ClO4 was synthesised following the literature procedure by O. Kolodyazhnaya et 




PyH·BF4 was synthesised following a similar procedure to that for PyH·ClO4. To a 
cooled (0 °C) pyridine (7.54 g, 0.095 mol), water (85 mL) solution was charged a 10% 
HBF4 (8.36 g, 0.095 mol) acid solution in water (85 mL). The solution was stirred for 1 
h at 0 °C, before being concentrated to ~5 mL on the rotary evaporator. A precipitate 
was isolated and washed with water, methanol and diethyl ether to give a white 
crystalline product (2.21 g, 14%). 1H NMR (400 MHz, C2D2Cl4): 8.81 (2H, d, J = 5.2 Hz, 
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HA), 8.58 (1H, m, HC), 8.05 (2H, m, HC). 19F NMR (376 MHz, C2D2Cl4): -149.80 (4F, d, JBF = 
19.9 Hz, BF4-). 
4.5.2.7 Synthesis of Λ-[(Ir(ppy)2)3(tcb)3](NTf2)3 
 
 
To Λ-[(Ir(ppy)2Cl)2] (11.1mg, 0.010 mmol) in THF (5 mL) was added AgNTf2 (8.0 mg, 
0.020 mmol) and the solution stirred at RT in a darkened flask for 2 h. The formed AgCl 
was filtered off through celite and the filtrate concentrated under pressure on the 
rotary evaporator. The crude intermediate, [Ir(ppy)2THF2]NTf2, was re-dissolved in 
C2H4Cl2 (1 mL), tcb charged (3.2 mg, 0.010 mmol) and the solution stirred for 4 h at RT. 
The homogeneous mixture was concentrated under pressure and with slow diffusion of 
ether an orange precipitate isolated (13.0 mg, 66%). 1H NMR (500 MHz, C2D2Cl4): (see 
Figure 4.9b). Excess tcb (1.0 mg, 0.006 mmol) was charged to the NMR solution in 
C2D2Cl4 and the 1H NMR re-run. 1H NMR (500 MHz, C2D2Cl4): 9.19 (6H, d, J = 5.7 Hz, HA), 
8.92 (3H, m, HJ), 8.18 (3H, s, Hfree-tcb), 8.14 (6H, d, J4 = 1.5 Hz, HI), 7.94 (12H, m, HC+D), 
7.64 (6H, d, J = 7.1 Hz, HE), 7.43 (6H, m, HB), 7.04 (6H, m, HF), 6.89 (6H, m, HG), 6.15 
(12H, d, J = 7.0 Hz, HH); 19F NMR (376 MHz, C2D2Cl4): -78.49 (36F, s, NTf2-); nESI m/z: 
1120.1 Λ-[(Ir(ppy)2)3(tcb)3](NTf2)2+, 2522.2 Λ-[(Ir(ppy)2)3(tcb)3](NTf2)21+. 
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4.5.2.8 Synthesis of Δ-[(Ir(ppy)2)3(dcmb)3](NTf2)3 
 
 
To Δ-[(Ir(ppy)2Cl)2] (10.5mg, 0.0098 mmol) in THF (5 mL) was added AgNTf (7.6 mg, 
0.0196 mmol) and the solution stirred at RT in a darkened flask for 2 h. The formed 
AgCl was filtered off through celite and the filtrate concentrated under pressure on the 
rotary evaporator. The crude intermediate was redissolved in C2H4Cl2 (1 mL), tcb 
charged (2.8 mg, 0.0196 mmol) and the solution stirred for 4 h at RT. Precipitation 
occurred with ether diffusion into the reaction mixture from which a pale yellow solid 
was isolated (6.3 mg, 41%). 1H NMR (500 MHz, C2D2Cl4): two species present in a 1.8:1 
ratio (see Figure 4.33). 




To N2 purged THF (10 mL) was added Pd(AcO)2 (22.8 mg, 0.10 mmol) and PPh3 (52.5 
mg, 0.20 mmol). The red reaction mixture was purged a further 3 times and CuI (58.1 
mg, 0.2 mmol), 1,3,5-triethylbenzene (100 mg, 0.67 mmol) and 4-bromobenzonitrile 
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(364 mg, 2.0 mmol) were consecutively added. Et3N (5 mL) was charged and the 
reaction stirred at RT for 1 h and 50 °C for 3 days. After 3 days, the reaction was cooled 
to RT, the solvent removed under vacuum and the organics extracted with DCM from 
an aqueous solution of NH4Cl. The organic washes were combined, washed with bring, 
dried with MgSO4 and concentrated on the rotary evaporator. The product was purified 
using flash silica column chromatography (hexane/DCM) to yield a white precipitate 
(50.1 mg, 17% yield). 1H NMR (400 MHz, CDCl3): 7.72 (3H, s, HA), 7.67 (6H, d, J = 8.4 Hz, 
HC), 7.62 (6H, d, J = 8.4 Hz, HB). The 1H NMR signals were an exact match to those 
reported by Y. Yamaguchi et al. for the same compound.[42] 
 
 
To a previously synthesised stock solution of Λ-[Ir(ppy)2THF2]NTf2 (3.9 mg, 0.0042 
mmol) in C2D2Cl4 was titrated tceb (1.27 mg, 0.0028 mmol) in C2D2Cl4. No single species 
was observed to form by 1H NMR or nESI-MS analysis. 
Synthesis of Λ-[(Ir(ppy)2)6(tceb)4](OTf)6 was attempted in an analogous manner. To a 
stock solution of Λ-[(Ir(ppy)2OTf)2] (1.2 mg, 0.00092 mmol) in C2D2Cl4 was titrated tceb 
(0.56 mg, 0.00123 mmol) in C2D2Cl4. Once again, no single species was observed to form 
by 1H NMR or nESI-MS analysis. 
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4.5.2.10 Synthesis of [Ir(ppz)2(NCC6H4F)2](OTf) 
 
 
[Ir(ppz)2(NCC6H4F)2]OTf was synthesised starting from [(Ir(ppz)2Cl)2] and AgOTf 
following an analogous procedure to [Ir(ppy)2(NCC6H4F)2]OTf above.  
 Starting from rac-[Ir(ppz)2Cl)2] (60.8 mg, 0.059 mmol), [Ir(ppz)2(NCC6H4F)2]OTf was 
synthesised as a yellow solid (51.3 mg, 49.9% yield). 1H NMR (400 MHz, C2D2Cl4 + 10 eq 
NCC6H4F): 8.23 (2H, d, J = 2.5 Hz, HA), 8.11 (2H, d, J = 1.9 Hz, HC), 7.70 (m, HI + HNCC6H4F), 
7.23 (m, HE+J + HNCC6H4F), 7.15 (2H, m, HF), 6.89 (2H, m, HB), 6.83 (2H, m, HG), 6.16 (2H, d, J 
= 7.6 Hz, HH); 19F NMR (376 MHz, C2D2Cl4 + 10 eq NCC6H4F): -77.38 (18F, s, OTf-), -96.60 
(2F, s, NCC6H4Fbound), -101.59 (s, NCC6H4Ffree). 
4.5.2.11 Synthesis of Λ/Δ-[(Ir(ppz)2)6(tcb)4](OTf)6 (Λ/Δ-2·6OTf) 
Synthesis of intermediate [(Λ/Δ-Ir(ppz)2)(L/D-serine)] follows a similar procedure to 
that of R. Urban et. Al.[43] 
 
 
A mixture of rac-[(Ir(ppz)2Cl)2] (138 mg, 0.134 mmol), L-serine (35.2 mg, 0.335 mmol) 
and NaOMe (18.1 mg, 0.335 mmol) in CH3OH (15 mL) were stirred at 40 °C for 16 h. 
The solvent was removed under vacuum and the crude product purified using 
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solubility differences between the two diastereoisomers in CH2Cl2. On washing the 
crude mixture with CH2Cl2, Λ-[Ir(ppz)2(L-serine)] was isolated from the filtrate due to 
its significantly greater solubility in the solvent than Δ-[Ir(ppz)2(L-serine)]. The isolated 
Λ-[Ir(ppz)2(L-serine)] was dissolved in CH3OH (5 mL) and to this was added 1M HCl 
solution (1 mL). The formed precipitate was filtered off, washed with CH3OH and Et2O 
and air dried to give a white solid (16.4 mg, 24% (starting from rac-[(Ir(ppz)2Cl)2]). 1H 
NMR (500 MHz, C2D2Cl4): 8.16 (4H, d, J = 2.7 Hz, HA), 7.82 (4H, d, J = 1.6 Hz, HC), 7.17 
(4H, d, J = 7.8 Hz, HE), 6.90 (4H, m, HF), 6.71 (4H, m, HB), 6.62 (4H, m, HG), 6.04 (4H, d, J = 
7.6 Hz, HH). 
Δ-[(Ir(ppz)2Cl)2] was synthesised following the same procedure as above starting with 
rac-[(Ir(ppz)2Cl)2] (50.1 mg, 0.049 mmol), D-serine (12.9 mg, 0.123 mmol) and NaOMe 




Λ-[(Ir(ppz)2)6(tcb)4](OTf)6 (Λ-2·6OTf) was synthesised following the same procedure 
as for Λ/Δ-1·6OTf starting from Λ-[(Ir(ppz)2Cl)2] (16.2 mg, 0.0158 mmol). Using AgOTf 
(8.1 mg, 0.0316 mmol) and tcb (3.1 mg, 0.020 mmol), a pale yellow solid was obtained 
(3.8 mg, 16%). 1H NMR (500 MHz, C2D2Cl4): 8.55 (12H, d, J = 2.1 Hz, HA), 8.44 (12H, s, 
HI), 8.24 (12H, d, J = 2.7 Hz, HC), 7.20 (12H, d, J = 8.0 Hz, HE), 7.07 (12H, m, HB), 6.97 
(12H, m, HF), 6.74 (12H, m, HG), 6.17 (12H, d, J = 5.7 Hz, HH); 13C NMR (126 MHz, 
C2D2Cl4): 143.0, 142.7, 141.7, 133.2, 127.1, 125.8, 124.6, 123.9, 114.2, 112.5, 111.2, 
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109.1; 19F NMR (376 MHz, C2Cl4D2): -78.27 (12F, bs, OTf-); nESI m/z: 2040.2, Λ-
[2·4OTf]2+. 
Δ-[(Ir(ppz)2)6(tcb)4](OTf)6 (Δ-2·6OTf) was synthesised using Δ-[(Ir(ppz)2Cl)2] (23.2 mg, 
0.0226 mmol), AgOTf (11.6 mg, 0.0452mmol) and tcb (4.6 mg, 0.0301 mmol) in an 
analogous manner to Λ-2·6OTf above. A pale yellow solid was obtained (7 mg, 22%). 
Characterisation was identical to Λ-2·6OTf. 
 
4.5.3 1H DOSY NMR spectra of Λ-1·6X 
The NMR samples were only at a high enough concentration to obtain a 1H DOSY NMR 
spectrum for Λ-1·6OTf (see section 3.5.6) and Λ-1·6BF4 (see section 3.5.17). The 1H 
DOSY spectrum for Λ-1·6ClO4 was obtained by titrating excess Bu4NClO4 to Λ-1·6BF4, 
the 1H NMR spectrum was superimposable with authentic Λ-1·6ClO4. 
 
 
Figure 4.14. 1H DOSY NMR (400 MHz, C2D2Cl4, 298 K) spectrum of Λ-1·6PF6. 
Corresponding log (D / m2 s-1) = -10.00. 






Figure 4.15. 1H DOSY NMR (400 MHz, C2D2Cl4, 298 K) spectrum of Λ-1·6ClO4 obtained 
by titrating 60 eq Bu4NClO4 to Λ-1·6BF4. Corresponding log (D / m2 s-1) = -10.01. 
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Figure 4.16. nESI mass spectra of a) Λ-1·6PF6 and b) Λ-1·6ClO4 with measured (black) 
versus modelled (red) isotopic distribution pattern for each [1·4X]2+ ion (where X = 
PF6- and ClO4-, respectively), 50 µM in C2H4Cl2. 
 
oc0840 DIr6tcb4.PF6 50uM in DCE MS
m/z
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4.5.5 19F DOSY and 19F-1H 2D HOESY NMR spectra of Λ-1·6PF6 
 
 
Figure 4.17. 19F DOSY NMR (376 MHz, C2D2Cl4, 298 K) spectrum of Λ-1·6PF6. 
Corresponding log (D / m2 s-1) = -10.03. 





Figure 4.18. 19F-1H HOESY NMR (376 MHz, C2D2Cl4, 298 K) spectrum of Λ-1·6PF6. 
Cross-peak visible between split PF6- signal at -71.00 and -69.12 and the signal for 
proton HI at 8.17. 
 
4.5.6 Stability measurements of 1·6X (where X = OTf-, PF6-, BF4- or 
ClO4-) 
Λ-1·6OTf (170 µM solution in C2D2Cl4, 0.5 mL) and Δ-1·6OTf (170 µM solution in 
C2D2Cl4, 0.5 mL) were prepared in separate NMR tubes. 1H NMR spectra was recorded 
for both samples prior and 0.5, 6, 24, 48, and 96 h post the combination of the two in a 
single NMR tube. Over time new peaks appeared on the 1H NMR spectra. The 
concentration of homochiral Λ- and Δ-1·6OTf was monitored by relative integration of 
the HI proton signal to the signal for C2HDCl4 (see Figure 4.5a). The experimental data 
of 1/[Λ/Δ-1·6OTf]-1/[Λ/Δ-1·6OTf]0 was plotted against the scrambling time t to give a 
straight line with gradient = observed exchange rate constant kobs (1.52 ×10-2 M-1 s-1) 
and half-life, t1/2 = 1/(kobs×[Λ/Δ-1·6OTf]0) (4.48 days). Stability measurements for 
1·6PF6 (135 µM), 1·6ClO4 (144 µM) and 1·6BF4 (156 µM) were performed following the 
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same procedure as for 1·6OTf, with the scrambling time measurements taken at 
suitable intervals relative to the stability of each system. 
 
 




Figure 4.20. 1/[Λ/Δ-1·6PF6]-1/[Λ/Δ-1·6PF6]0 versus scrambling time t. 
 










Figure 4.22. 1/[Λ/Δ-1·6BF4]-1/[Λ/Δ-1·6BF4]0 versus scrambling time t. 
 
Exploration into the properties of the Ir capsules                                                        Chapter 4                                                           
205 
 
4.5.7 Exchange Spectroscopy (2D-EXSY) investigation into Ir-nitrile 
bond strengths and guest binding within 16+ 
19F 2D-EXSY was used to investigate the kinetics of a) NCC6H4F ligand exchange for 
[Ir(ppy)2(NCC6H4F)2]X (where X = OTf-, PF6-, BF4- and ClO4-), b) PF6- counterion 
exchange between the different environments of capsule Δ-1·6PF6, c) NCC6H4F ligand 
exchange for [Ir(ppz)2(NCC6H4F)2]OTf and d) OTf- counterion exchange between the 
two different environments of capsule Λ-2·6OTf. All spectra were recorded on a Bruker 
400 MHz NMR spectrometer at 298 K with the mixing time, τm, set to either 0.2, 0.4, 0.6, 
0.8 or 1.0 s. Using equation 1 shown below, where IAA, IBB, ICC and IDD are the diagonal 
peak intensities and IAB, IBA, IAC, ICA, IBD and IDB are the cross-peak intensities, r was 
calculated. The values for k were obtained for a) from 1/gradient of the linear plot of 
ln((r+1)/(r-1)) versus τm and for b), c) and d) using equation 2-3. As k is the sum of the 
forward, k1, and backward, k-1, pseudo-first order rate constants, which are presumed 
equal (k1 = k-1), the observed pseudo-first order rate constant, kobs, was determined 
from equation 4. kobs was used in the Eyring equation (equation 5) to determine the 
change in Gibbs free energy, ΔG‡, for the exchange processes. Being first order kinetics 
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4.5.7.1 NCC6H4F ligand exchange for [Ir(ppy)2(NCC6H4F)2]X (where X = OTf-, PF6-, 
BF4- and ClO4-) 
 
 
Figure 4.23. Plot of ln((r+1)/(r-1)) versus mixing time τm for [Ir(ppy)2(NCC6H4F)2]OTf 
in C2D2Cl4 with 10 eq NCC6H4F obtained from 19F EXSY NMR measurements. 
 





Figure 4.24. Plot of ln((r+1)/(r-1)) versus mixing time τm for [Ir(ppy)2(NCC6H4F)2]PF6 





Figure 4.25. Plot of ln((r+1)/(r-1)) versus mixing time τm for [Ir(ppy)2(NCC6H4F)2]ClO4 
in C2D2Cl4 with 10 eq NCC6H4F obtained from 19F EXSY NMR measurements. 
 





Figure 4.26. Plot of ln((r+1)/(r-1)) versus mixing time τm for [Ir(ppy)2(NCC6H4F)2]BF4 
in C2D2Cl4 with 10 eq NCC6H4F obtained from 19F EXSY NMR measurements. 
4.5.7.2 PF6- counterion exchange of Δ-1·6PF6 
 
 
Figure 4.27. Partial 19F 2D-EXSY (376 MHz, C2D2Cl4, 298 K) spectrum of Δ-1·6PF6 with 
excess Bu4NPF6. 




 IAA IAC ICA IBB + ICC IBD IDB IDD kobs / s-1 
ΔG‡ /  
kcal mol-1 
FPF6 0.1100 0.3258 0.2834 1.0000 0.3220 0.3098 0.2432 0.80 17.6 
 
Table 4.3. Kinetic parameters for PF6- counterion exchange for Δ-1·6PF6 in C2D2Cl4. 
 
4.5.7.3 NCC6H4F ligand exchange for [Ir(ppz)2(NCC6H4F)2]OTf 
 
 
Figure 4.28. Partial 19F 2D-EXSY (376 MHz, C2D2Cl4, 298 K) spectrum of 
[Ir(ppz)2(NCC6H4F)2]OTf with 10 eq NCC6H4F. 
 
 IAA IAB  IBA IBB kobs / s-1 
ΔG‡  
/ kcal mol-1 
FNCC6H4F  0.0032 0.0065 1.0000 0.0076 20.3 
 
Table 4.4. Kinetic parameters for NCC6H4F ligand exchange of [Ir(ppz)2(NCC6H4F)2]OTf 
in C2D2Cl4 with 10 eq NCC6H4F. 
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4.5.7.4 OTf- counterion exchange of Λ-2·6OTf 
 
 
Figure 4.29. Partial 19F 2D-EXSY (376 MHz, C2D2Cl4, 273 K) spectrum of Λ-2·6OTf. 
 
 IAA IAB  IBA IBB kobs / s-1 
ΔG‡  
/ kcal mol-1 
FOTf  0.8070 0.6905 1.0000 1.22 15.8 
 
Table. Kinetic parameters for OTf- counterion exchange for Λ-2·6OTf in C2D2Cl4. 
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4.5.8 19F NMR of 1·6OTf in a mixed CD3NO2/C2D2Cl4 solvent system 
 
 
Figure 4.30. 19F NMR (376 MHz, C2D2Cl4, 298 K) spectra of Δ-1·6OTf in a) 1:2 
CD3NO2/C2D2Cl4 and b) neat C2D2Cl4. Green singlet (B) corresponds to encapsulated 
OTf- and red singlet (A) is for free OTf-. 
 
4.5.9 1H DOSY NMR spectrum of Λ-[(Ir(ppy)2)3(tcb)3](NTf2)3 
The hydrodynamic radius of Λ-[(Ir(ppy)2)3(tcb)3](NTf2)3 in C2D2Cl4 was determined 
using 1H DOSY NMR spectroscopy. From the 1H DOSY NMR spectrum (see Figure 4.31), 
the measured diffusion coefficient D was used in the Stokes-Einstein equation (equation 





     (7) 
where kB is the Boltzmann constant, T absolute temperature and η the viscosity of the 
solvent. The viscosity of C2D2Cl4 not being available, that of C2H2Cl4 (1.456 mPa.s)[44] at 
298 K was used instead. The diffusion coefficient and computed Stokes-Einstein radius 
are listed in Table 4.5. 
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 log D D / m2 s-1 Stokes-Einstein radius / Å 
Λ-[(Ir(ppy)2)3(tcb)3](NTf2)3 -9.86 1.38×10-10 10.9 
 
Table 4.5. Diffusion coefficient and computed Stokes-Einstein radius of Λ-




Figure 4.31. 1H DOSY NMR (400 MHz, C2D2Cl4, 298 K) spectrum of Λ-
[(Ir(ppy)2)3(tcb)3](NTf2)3 with 6 eq of tcb added. Corresponding log (D / m2 s-1) = -9.86. 
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4.5.10 Mass spectra and isotopic distribution patterns for Λ-
[(Ir(ppy)2)3(tcb)3](NTf2)3 
Figure 4.32. nESI mass spectra of Λ-[(Ir(ppy)2)3(tcb)3](NTf2)3 with measured (black) 
versus modelled (red) isotopic distribution patterns for Λ-[(Ir(ppy)2)3(tcb)3](NTf2)2+ 
and Λ-[(Ir(ppy)2)3(tcb)3](NTf2)2+ ion, 50 μM in C2H4Cl2. 
 




Figure 4.33. 1H NMR (500 MHz, C2D2Cl4, 298 K) spectra of a) Δ-
[(Ir(ppy)2)3(tcb)3](NTf2)3 with excess tcb and b) Δ-[(Ir(ppy)2)3(dcmb)3](NTf2)3 as the 
major species. The assignments correspond to the lettering shown in section 4.5.2.7 for 
a) and section 4.5.2.8 for b). 
 
OC0852 DIr3tcb3.NTf 10 fold dilut. DCE MS
m/z
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4.5.12 1H and 1H DOSY NMR spectra of Λ-2·6OTf 
 
 
Figure 4.34. 1H NMR (500 MHz, C2D2Cl4, 298 K) spectra of a) Λ-1·6OTf and b) Λ-2·6OTf. 




Figure 4.35. 1H DOSY NMR (400 MHz, C2D2Cl4, 298 K) spectrum of Δ-2·6OTf. 
Corresponding log (D / m2 s-1) = -9.98. 









Figure 4.36. nESI mass spectra of rac-2·6OTf with measured (black) versus modelled 
(red) isotopic distribution pattern for the rac-[2·4OTf]2+ ion, 50 µM in C2H4Cl2. 
 
4.5.14 X-ray crystal structure of Δ-2·6OTf 
Structural data were collected at 93 K using a Rigaku Saturn diffractometer (MM007 
high-flux RA/MoKa radiation, confocal optic). All data collection employed narrow 
frames (0.3-1.0) to obtain at least a full hemisphere of data. Intensities were corrected 
for Lorentz polarisation and absorption effects (multiple equivalent reflections). The 
structures were solved by direct methods, non-hydrogen atoms were refined 
anisotropically with CH protons being refined in riding geometries (SHELXTL) against 
F2. 
oc0790ppzIr6tcb4.OTf in DCE NMR samples MS
m/z













Figure 4.37. Preliminary X-ray crystal structure of Δ-2·6OTf. For clarity, non-
encapsulated OTf- counteranions, solvent molecules and hydrogens have been 
removed. The carbon atoms of ppy are shown in blue, tcb in dark green and OTf- 
carbons in orange, iridium in pink, nitrogen in pale blue, sulfur in yellow, oxygen in red 
and fluorine in pale green. 
 
 
Identification code Δ-2·6OTf 
Empirical formula C150H96F18Ir6N36O18S6 
Formula weight 4378.29 
Temperature 93(1) K 
Wavelength 0.71075 Å 
Crystal system Primitive Monoclinic 
Space group P21 
Unit cell dimensions a = 17.773(5) Å  α = 90° 
 b = 34.303(9) Å  β = 95.828(4)° 
 c = 19.085(5) Å  γ = 90° 
Volume 11575(5) Å3 
Z 2 
Density (calculated) 1.256 g cm-3 
Absorption coefficient 3.565 mm-1 
F(000) 4224 




Table 4.6. Crystal data and structural refinement for Δ-2·6OTf. 
 
4.5.15 19F VT NMR studies of 2·6OTf 
 
Figure 4.38. 19F NMR (376 MHz, C2D2Cl4) spectra of Λ-2·6OTf at a) 273K, b) 298K, c) 
303K and d) 308K. Green peak (B) corresponds to encapsulated OTf- and red peak (A) 
to free OTf-. 
 
Crystal size 0.1 × 0.1 × 0.02 mm 
Theta range for data collection 1.60 to 25.42° 
Index ranges -21<=h<=21, -41<=k<=41, -22<=l<=22 
Reflections collected 117344 
Independent reflections 42060 [R(int) = 0.0757] 
Completeness to theta = 25.42° 99.2% 
Absorption correction Multiscan 
Max. and min. transmission 0.931 and 0.690 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 42060 / 1 / 819 
Goodness-of-fit on F2 1.561 
Final R indices [I>2sigma(I)] R1 = 0.1684 
R indices (all data) wR2 = 0.4363 
Absolute structure parameter 0.089(18) 
Largest diff. peak and hole 6.420 and -2.540 e- Å-3 
Exploration into the properties of the Ir capsules                                                        Chapter 4                                                           
218 
 
4.5.16 Stability measurements for 2·6OTf  
Stability measurements for 2·6OTf (124 µM) were performed following a similar 
procedure to 1·6OTf (see section 4.5.6), with the scrambling time measurements taken 
at 0, 0.5, 3, 6, 24, 48, 72 and 96 h. The experimental data of 1/[Λ/Δ-2·6OTf]-1/[Λ/Δ-
2·6OTf]0 was plotted against the scrambling time t from which kobs and t1/2 were 
calculated (see Table 4.7). 
 
 
Figure 4.39. (1/[Λ/Δ-2·6OTf]-1/[Λ/Δ-2·6OTf]0) versus scrambling time t. 
 
 kobs / M-1s-1 t1/2 / day(s) 
Λ/Δ-2·6OTf 4.89×10-2 1.9 
 
Table 4.7. The observed exchange rate constant, kobs, and half-life, t1/2, values for 
2·6OTf derived from Figure 4.39. 
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4.5.17 Emission Data 
Steady-state luminescence spectra were measured using a Fluoromax (Horiba Jobin 
Yvon) photon-counting spectrofluorometer. Spectra were recorded with a bandpass of 
3 nm for both excitation and emission monochromators and were corrected for 
variation in the excitation lamp intensity and the wavelength-dependence of the 
detector response. The data was further corrected with background subtraction and 
baseline correction. Spectral intensities were determined by integration over entire 
emission peaks bandwidth. Samples were measured in 1,1,2,2-tetrachloroethane (TCE) 
at RT using a fused silica cuvette (Starna Ltd.) with a 10 mm path length. The 
luminescence intensity for each sample was measured at an absorbance between 0.01 
and 0.1, with an excitation wavelength of 413 nm. Emission quantum yields (Ф) were 
determined using [Ru(bipy)3](PF6)2 (Фair = 0.018 in acetonitrile)[45] as reference with 
coumarin 153 (Фair = 0.58 in ethanol)[46] as a second reference to verify the yields. The 
quantum yields were calculated using the expression ФX = ФR(mX/mR)(ηX2/ηR2), where 
X and R denote sample being measured and reference respectively, m is the gradient 
from the plot of integrated luminescence intensity vs. absorbance, which passes 
through (0, 0) and η is the refractive index of the solvent (ηTCE = 1.494, ηacetonitrile = 1.344 
and ηethanol = 1.361)[47]. 
 Emission Max (λmax) / nm Quantum yields (Ф) / % 
Λ-1·6OTf 560 4.1 
Λ-1·6PF6 573 0.6 
Δ-1·6ClO4 577 1.2 
Λ-1·6BF4 545 0.6 
Δ-[(Ir(ppy)2)3(tcb)3](NTf2)3 589 0.6 
Λ-2·6OTf 551 5.7 
 
Table 4.8. Measured quantum yields of Λ-1·6OTf (2 µM), Λ-1·6PF6 (2 µM), Δ-1·6ClO4 (2 
µM), Λ-1·6BF4 (2 µM), Δ-[(Ir(ppy)2)3(tcb)3](NTf2)3 (6 µM with 100 eq of tcb) and Λ-
2·6OTf (2 µM) in C2H2Cl4. 
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Conclusion and Outlook 
The versatility of cyclometalated Pt(II) and Ir(III) 2-phenylatopyridyl moieties in 
directing the self-assembly of multiple aggregates into metallosupramolecular capsules 
has been exposed.  
In Chapter 2, the bias imposed by the trans-influence of the auxiliary 2-
phenylatopyridyl ligands on the binding kinetics of the cis-exchangeable sites on Pt(II) 
was used to self-assemble trigonal prisms under an unusual kinetically controlled 
protocol, where-by the sequence of addition of the ditopic and tritopic pyridyl ligands 
determined the stereo-conformation of the product. This synthetic approach has the 
potential to generate other more complex supramolecular assemblies with shape-
specific cavities that are highly selective in guest binding and can catalyse both regio- 
and stereo-specific reactions. 
In Chapters 3 and 4, 2-phenylatopyridine was also used to labilise the cis-exchangeable 
sites on Ir(III) and together with a tritopic nitrile ligand the synthesis of the first 
photoactive [Ir(ppy)2]-based capsule was achieved. Following the development of a 
novel method to resolve the racemic [(Ir(ppy)2Cl)2] starting material into its 
enantiopure forms, both the homochiral Λ- and Δ-Ir capsules were assembled. The 
octahedral capsules were shown to encapsulate an unusually large number of anions 
that were exchangeable for other anionic guests and, coupled with the luminescent 
properties, ion sensing was demonstrated. The associated counterions were highly 
crucial to the Ir capsules; both in templating their self-assembly and controlling their 
stability. Thus, substituting the anions for neutral guests was not possible nor was the 
synthesis of similar M6L4 assemblies with ‘empty’ cavities. The synthesis of photo-
active assemblies with accessible internal space is of particular interest in the field of 
host-guest chemistry and photo-catalysis. Several projects are currently underway in 
the Lusby group, exploring the catalytic potential of alternative cyclometalated Ir-based 
systems. The use of other more kinetically robust ligands with the [Ir(ppy)]+ moiety as 
well as appending the light harvesting unit to the periphery of alternative conjugated 
metallosupramolecular capsules is currently being pursued. Making these systems 
water soluble will also be addressed in future work. 
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In the more remote future, metallosupramolecular assemblies have the potential to be 
used as enzyme-like environmentally benign microreactors powered by light energy to 
catalyse selective and stereo-specific reactions. Or within the medicinal world, as site-
specific drug delivery systems and biosensors. 
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.A kinetically controlled approach …
… to metallosupramolecular assembly has been demonstrated by P. J. Lusby and co-
workers in their Communication on page 4194 ff. By exploiting asymmetric cyclo-
metalated platinum corner units that possess both labile and nonlabile cis-coordination
sites, trigonal prismatic stereoisomeric architectures have been selectively prepared by




Sequential, Kinetically Controlled Synthesis of Multicomponent
Stereoisomeric Assemblies**
Oleg Chepelin, Jakub Ujma, Perdita E. Barran,* and Paul J. Lusby*
The reversibility of noncovalent and metal–ligand interac-
tions has widely been exploited to synthesize a plethora of
supramolecular and coordination-based assemblies under
thermodynamic control.[1] Occasionally, entrapment in local
energy minima leads to the formation of metastable products,
which are often converted into lower-energy products upon
prolonged reaction times.[2] In contrast, self-assembled prod-
ucts in nature almost always arise according to the most
expedient reaction pathway, that is, the kinetically selected.[3]
Herein we demonstrate a kinetically controlled approach to
self-assembly, in which the sequence of addition[4] of molec-
ular structural units leads to the stereoselective formation of
metallosupramolecular isomers.
The use of platinum(II) (and other third-row transition
metals) is particularly well-suited to a kinetic approach to
self-assembly, not just because Pt–ligand bonds can be
kinetically inert, but also because the metal ion can be
conveniently tuned to produce a vast range of different
ligand-exchange labilities. For instance, assemblies that utilize
bis(phosphine) ligands as corner protecting groups often
readily assemble at room temperature,[5] while those that
exploit neutral N-donor bidentate ligands, such as ethylene
diamine, typically require several hours at elevated temper-
ature to reach equilibrium.[6] Furthermore, the mechanism of
labilization, that is, the trans effect, is such that it is possible
for a single metal center to possess cis exchangeable sites with
dramatically different kinetic properties. We have recently
prepared a metallosupramolecular trigonal prism that pos-
sesses an unsymmetrical cyclometalated C
_
N corner protect-
ing group, which was assembled in two steps by treating
[L1Pt(dmso)] (where H2L
1 = 2,6-diphenylpyridine) sequen-
tially with 4,4’-bipy and tpt.3CSA (Scheme 1, steps a and b).[7]
The isolation of a single isomeric product from a possible
fourteen products, as indicated by the 1H NMR spectrum of
the hexa-PF6 salt (see the Supporting Information, Fig-
ure S1a), led us to ask, was this selectivity a result of each
Pt center possessing one labile and one inert exchangeable
site, or was the selectivity thermodynamic in origin?
To answer this question, the sequence in which 4,4’-bipy
and tpt were added to [L1Pt(dmso)] was reversed. [L1Pt-
(dmso)] was first treated with a third of an equivalent of tpt at
room temperature in CH2Cl2 to give [(L
1Pt)3(tpt)] (Scheme 1,
step c), which was then treated with 4,4’-bipy·2CSA, and after
metathesis with NH4PF6, the hexa-PF6 salt was isolated in
99% yield (Scheme 1, step d). The 1H NMR spectrum of this
product (see the Supporting Information, Figure S1b) also
indicated the formation of a single species, yet there were
clear differences between the spectra of the two isomers, in
particular, for resonances HA-E. The product from route 1 was
assigned as cis-[(HL1Pt)6(4,4’-bipy)3(tpt)2](PF6)6, in which the
tpt ligand is coordinated cis to the nitrogen of the 2,6-
diphenylpyridine ligand, and the product from route 2 was
assigned as trans-[(HL1Pt)6(4,4’-bipy)3(tpt)2](PF6)6, in which
the tpt ligand is coordinated trans to the nitrogen of the 2,6-
diphenylpyridine ligand. This absolute assignment was made
on the basis that a) the resonance of the ortho proton of tpt
(HC) is more deshielded in the trans-to-nitrogen coordination
site in comparison to the ortho proton 4,4’-bipy (HB), and b)
the large and small relative separations between the reso-
nances of HA and HB, and between the resonances of HC and
HD.
Scheme 1. Sequence-specific control over the formation of metallosu-
pramolecular stereochemical isomers. a) 4,4’-bipy, CH2Cl2, RT, 18 h,
77%; b) (i) tpt·3CSA, CH2Cl2, RT, 1 h; (ii) NH4PF6, 97%; c) tpt, CH2Cl2,
18 h, 85%; d) (i) 4,4’-bipy·2CSA, CH2Cl2, RT, 3 h; (ii) NH4PF6, 99 %.
bipy= bipyridine, CSA = camphorsulfonic acid, dmso = dimethylsulfox-
ide, tpt = tris(4-pyridyl)triazine.
[*] O. Chepelin, J. Ujma, Dr. P. E. Barran, Dr. P. J. Lusby
EaSTCHEM School of Chemistry, University of Edinburgh
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To corroborate the structure assignment of the isomers in
solution, analysis was undertaken using nanoelectrospray
mass spectrometry (nESI). While samples of the presumed cis
and trans isomers both showed peaks that matched the
predicted isotope pattern for the intact 3 + and 2 + charged
cages (1360 and 2114 m/z, respectively), their collision-
induced dissociation (CID) pathways differed significantly.
For instance, MS–MS experiments showed that with increas-
ing kinetic energy, the isolated intact 3 + charged cage
[[(HL1Pt)6(4,4’-bipy)3(tpt)2](PF6)3]
3+ of the cis isomer initially
fragments to give ions at 1308 and 1464 m/z, which then
fragment further to a dominant species at 1152 m/z (Fig-
ure 1a). Although the singly charged peak at 1152 m/z
unambiguously corresponds to [[(HL1Pt)2(4,4’-bipy)]PF6]
+,
and thus supports the assignment of the cis isomer, in which
the weaker trans-to-phenylato Pttpt bond undergoes selec-
tive dissociation at lower potential, the peaks at both 1308
(+ 2) and 1464 (+ 1) m/z could correspond to more than one




respectively. However, MS3 experiments of both the species
at 1308 and 1464 m/z showed the predominant appearance of
the + 1 ion at 1152 m/z ([[(HL1Pt)2(4,4’-bipy)]PF6]
+). This
finding suggests that the ions at 1308 and 1464 m/z correspond
to tpt coordinated with two and one [(HL1Pt)2(4,4’-bipy)]
unit(s), respectively, and that initial fragmentation of the cage
results from cleavage of Pttpt bonds from adjacent panels
(Figure 1a, inset). When the isolated 3 + ion from the trans
isomer was subjected to the same CID experiment, a signal at
1308 m/z was also observed at low voltage (Figure 1b), yet the
different charge state (+ 3) indicates that the initial fragmen-
tation involves the loss of a single 4,4’-bipy ligand to give
[[(HL1Pt)6(4,4’-bipy)2(tpt)2](PF6)3]
3+ (Figure 1b, inset). At
higher potential, this peak diminishes with a concomitant
appearance of a + 2 ion at 866 m/z, which unequivocally
corresponds to [(HL1Pt)3(tpt)]
3+. This fits with a preferential,
low-energy dissociation of the weaker Pt-4,4’-bipy bond from
the trans isomer (Figure 1b, inset).
To ascertain whether a kinetic self-assembly strategy
could be used if the labile coordination site isnt initially
masked, we have investigated the sequential addition of tpt
and 4,4’-bipy to both [(L2Pt)2Cl2] and [(L
2Pt)Cl2]NBu4, where
HL2 is the bidentate C
_
N ligand 2-phenylpyridine (Scheme 2).
The 1H NMR spectrum of a mixture of [(L2Pt)2Cl2] and
0.5 equivalents of 4,4’-bipy (Scheme 2, route 1, step a) showed
the appearance of several new peaks after 5 minutes (see the
Supporting Information, Figure S2b); these peaks differed
from those of the [(L2Pt)2Cl2] starting material (see the
Supporting Information, Figure S2a). However, the gradual
disappearance of these initial peaks and the concomitant
appearance of a new set of signals, which converged to a single
species after 24 hours at 45 8C, was observed (see the
Supporting Information, Figure S2c). Based on the relative
chemical shifts, and in particular the significant differences of
HE and HF in the initial and final compounds (which is caused
by shielding by the coordinated 4,4’-bipy ligand), it appears
that trans-[(L2Pt)2(4,4’-bipy)Cl2] is the initial kinetic product,
which rearranges into the thermodynamically (and kineti-
Figure 1. Partial nESI spectra with increasing collisional energy of the
+3 charged intact prism (1360 m/z) to illuminate the CID pathways
(see insets) for a) cis- and b) trans-[(HL1Pt)6(4,4’-bipy)3(tpt)2](PF6)6.
Scheme 2. Kinetically controlled synthesis using an “unmasked” corner
protecting ligand. a) 4,4’-bipy, C2H2Cl4, 45 8C, 24 h; b) (i) AgCSA,
C2H2Cl4, RT, 3 h; (ii) tpt, C2H2Cl4, RT, 24 h; (iii) NH4PF6, 98% (starting
from [(L2Pt)2Cl2]); c) tpt, C2H2Cl4, 45 8C, 24 h; d) (i) AgCSA, C2H2Cl4,
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cally) more-stable cis-[(L2Pt)2(4,4’-bipy)Cl2] (Scheme 2,
route 1, step a).[8] After halide extraction using AgCSA,
treatment with tpt, and then anion exchange with NH4PF6,
cis-[(L2Pt)6(4,4’-bipy)3(tpt)2](PF6)6 was isolated in virtually
quantitative yield (Scheme 2, route 1, step b). The 1H NMR
spectrum of this product (see the Supporting Information,
Figure S2d) again suggested the formation of a single isomer.
When the sequence of addition of 4,4’-bipy and tpt to
[(L2Pt)2Cl2] was switched (Scheme 2, route 2) a single, yet
different product was obtained. A comparison of the 1H NMR
spectra of the two isomers showed significant differences (see
Supporting Information, Figure S2d and S2e), particularly in
resonances HA–F.
The nESI mass spectra of cis and trans-[(L2Pt)6(4,4’-
bipy)3(tpt)2](PF6)6 showed identical peaks at 1208 and 1884 m/
z, which matched the predicted isotope patterns for the intact
+ 3 and + 2 charged prisms, respectively (not shown).
However, in contrast to the analogous experiments with cis
and trans-[(HL1Pt)6(4,4’-bipy)3(tpt)2](PF6)6, the CID of the cis
and trans isomers of [(L2Pt)6(4,4’-bipy)3(tpt)2](PF6)6 showed
mainly peaks that did not correspond to any sensible
combinations of L2Pt, 4,4’-bipy, tpt, and PF6. Instead, the
dominant CID pathway for both cis and trans-[[(L2Pt)6(4,4’-
bipy)3(tpt)2](PF6)3]
3+ involves fluoride abstraction from the
PF6 counteranions. With the cis isomer, the disappearance of
the 1208 m/z peak is initially accompanied by a dominant
species at 1093 m/z, which corresponds to the formula
[[(L2Pt)4(4,4’-bipy)2(tpt)F]PF6]
2+ (Figure 2a). In an analogous
manner to cis isomer of [(HL1Pt)6(4,4’-bipy)3(tpt)2](PF6)6, it
appears that the initial fragmentation pathway involves the
cleavage of the weaker Pttpt bonds from adjacent panels
(also supported by a smaller intensity ion at 1311 m/z, which
corresponds to [[(L2Pt)2(4,4’-bipy)(tpt)]PF6]
+), a route that is
either promoted or stabilized by abstraction of fluoride from
one of the PF6 counteranions (Figure 2a, inset). MS
3 experi-
ments show that the disappearance of this 1093 m/z ion results
from the dissociation into a low-intensity ion at 873 m/z,
which matches [(L2Pt)2(4,4’-bipy)F]
+, and subsequent MS4
experiments show that this fragments into a singly charged
ion at 505 m/z, by loss of the neutral [(L2Pt)F] from
[(L2Pt)2(4,4’-bipy)F]
+. For the trans isomer, the fragmentation
pathway appears to first involve loss of a single 4,4’-bipy,
again either promoted or stabilized by fluoride abstraction
from the counter anion, to give [[(L2Pt)6(4,4’-bipy)2(tpt)2F]-
(PF6)2]
3+ (1114 m/z), which subsequently looses another 4,4’-
bipy by a fluoride promoted/stabilized route to produce
[[(L2Pt)6(4,4’-bipy)(tpt)2F2](PF6)2]
3+ (1020 m/z). Again, the
selective loss of 4,4’-bipy ligands from the weaker trans-to-
phenylato coordination sites supports the formation of trans-
[(L2Pt)6(4,4’-bipy)3(tpt)2](PF6)6.
The four metallosupramolecular stereochemical isomers
do not undergo isomerization, or reassemble to generate
other assemblies (e.g. Pt4 squares or Pt6(tpt)4 cages) at room
temperature in solution.[9] We attribute this stability to the
unlabile PtN bonds trans to the nitrogen donors of HL1/L2 ;
although these bonds form readily at room temperature (or
just above in the case of L2) from the corresponding solvato/
halide complexes, the activation barrier for de-coordination is
such that this step is essentially irreversible under ambient
conditions. Therefore the sequence in which the N-donor
bridging ligands are added to the starting platinum complexes
determines the stereochemical outcome of the reaction. In
this regard, the synthesis of these metallosupramolecular
isomers combines elements of covalent (irreversible) syn-
thesis and noncovalent (reversible) thermodynamically con-
trolled assembly. It could also be expected that the isomers
would show some thermodynamic bias towards either the cis
or the trans form, however, heating samples of either cis or
trans-[(HL1/L2Pt)6(4,4’-bipy)3(tpt)2](PF6)6 at 80 8C for
24 hours results in a complex mixture with no obvious
preference for a single species. This is perhaps unsurprising
as to gain greater than 95% selectivity for a single species, an
energy difference greater than 1.74 kcal mol1 would be
required. This is in marked contrast to the sequential,
kinetically controlled syntheses described herein; these
syntheses give greater than 95% selectivity for single
stereochemical isomers, thus highlighting the potential bene-
fits of exploiting differences in rates of assembly, rather than
simply considering ground-state energies, for the preparation
of multicomponent systems.
The vast difference in labilities of cis exchangeable
platinum coordination sites have been exploited to selectively
synthesize multicomponent stereoisomeric assemblies using
a template-free, sequential, kinetically controlled approach.
We anticipate that this approach to noncovalent, and in
particular coordination driven self-assembly will facilitate the
generation of multicomponent, ultimately functional systems.
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Figure 2. Partial nESI mass spectra with increasing collisional energy
of the + 3 charged intact prism (1208 m/z) to illuminate the fluoride-
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Shapes of supramolecular cages by ion mobility mass spectrometrywz
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Mass spectrometry and drift tube ion mobility mass spectrometry
have been used to analyse several isobaric, multicomponent cages
yielding information on three dimensional structure, interactions
and dynamics of assembly in the gas phase.
Unambiguous characterisation of supramolecular and polynuclear
coordination-based assemblies presents a significant challenge.
Such analysis is crucial to understanding structure–activity relation-
ships with respect to a myriad of applications, such as sensing,
catalysis and drug delivery. In the absence of X-ray crystallographic
data, irrefutable evidence for the precise configuration and
conformation of complex 3D architectures is difficult to obtain
solely fromNMR spectroscopic methods. In recent years the use of
nano-electrospray ionisation (n-ESI) coupled with mass spectro-
metry has allowed analysis of intact biological non-covalent
assemblies (for example pre-fibrillar amyloid clusters,1 or hetero-
genic protein complexes2) as well as inorganic supramolecular
self-assemblies.3,4 Mass spectrometry based methods can provide
detailed information of the stoichiometry of complexes, as well as
on structural integrity via the use of collisional activation.
Ion Mobility Mass Spectrometry (IM-MS) is increasingly
utilised for structural analysis of ions following n-ESI.5 In drift
tube based IM-MS (DT IM-MS), ions are allowed to drift
through a cell of defined length filled with an inert buffer gas
under the influence of a weak electric field and their arrival
time at a subsequent detector is recorded. An ion will undergo
many collisions in the drift cell and its mobility (K) in the cell is
given by the ratio of the drift velocity (nd) to the applied
electric field (E). K is related to the temperature (T) dependent
collision cross section (O) of the ion according to a modified









where z is the charge on the ion, and N0 is the number gas
density. Coupling ion mobility (IM) with mass spectrometry
(MS) has produced the hybrid technique (IM-MS) where both
the m/z and the ‘shape’ of the molecular ion can be determined.
IM-MS has risen to prominence in its study of large intact
non-covalent biological systems but recent work has shown that
it also can be applied to supramolecular inorganic systems.7
Schalley and co-workers applied IM-MS to distinguish
between isobaric catenane and octalactam macrocycles.7a
The Bowers group, have utilized DT IM-MS techniques to
study various polyhedral oligomeric silsequioxanes polymers
(POSS)7b and recently also metallosupramolecular cage systems.7c
Chan et al. applied the travelling wave version of IM-MS to
examine isobaric complexes and conformations of a hexacadmium
macrocycle using a Synapt G2 platform.7d and recently Thiel et al.
used IM-MS to distinguish between structural isomers of hybrid
Mn-Anderson clusters.8
We have applied DT IM-MS to examine isobaric self assembled
trigonal prismatic cage isomers of two related systems ((HL1Pt)
and (L2Pt); Fig. 1). These are species which differ only in the
relative orientation (cis or trans) of the bidentate cyclometallated
ligand with respect to the other components.
Remarkably, DT IM-MS is able to readily distinguish these
isomers, despite, in the case of the (L2Pt) system, the isomers
only really differing in the relative position of N and C atoms.
Under identical n-ESI conditions, each of the cages produces a
distinctive mass spectrum, with differing intensities of intact
Fig. 1 Isobaric self-assembled systems examined by IM-MS and their
cartoon representations. Each cage consists of tpt and 4,40-bipy groups
bridged by (a) cis-(HL1Pt); (b) trans-(HL1Pt); (c) cis-(L2Pt); (d) trans-
(L2Pt); corner groups. Corner block shape represents ligand type.
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species as well as different fragments ions, suggesting both
differing gas-phase stabilities and diagnostic isomer-specific
fragmentation pathways. Our peak assignment procedure is
outlined in supplementary data (Fig. S1w).
Focusing first on the cis and trans isomers of (HL1Pt), their
n-ESI mass spectra reveal differences in the inherent stability
of each isomer (Fig. 2a and b). For both, intact cages are
present as ions of the general form [M-nPF6]
6-n+, where loss of
counterions allows positively charged ions to be observed; peaks
at 1361 m/z and 2113 m/z corresponding to the [M-3PF6]
3+, and
[M-2PF6]
2+ species respectively. The cis isomer of (HL1Pt)
(Fig. 2a) appears more resistant to dissociation during the nESI
desolvation process than the corresponding trans isomer.
For both isomers of (HL1Pt), some ‘in-source’ fragmentation is
observed, resulting in spectra that are both diagnostic and
informative on the relative stabilities of the molecular ions from
these isobaric species. For the (L2Pt) cages we also observe a
different mass spectrum for the cis and trans forms (Fig. 2c and d).
Again the relative intensities of intact cages and fragments are
different for each molecular species.
Using DT-IM-MS we have measured rotationally averaged
collision cross sections (CCS), on all the intact cages. Our
analysis allows us to determine the shape with respect to
number of counter ions present. Fig. 3 shows arrival time
distributions (ATDs) obtained for the two charge states of
each of the (HL1Pt) cage isobarimers following mobility based
separation. For the most dominant intact cage in the mass
spectrum, [M-3PF6], the ATDs for the cis-(HL
1Pt) and trans-
(HL1Pt) cage isomers show a single resolvable conformation
(or a smooth distribution of rapidly interconverting conformations)
but with different, distinguishable CCS. With three counter anions,
the cis-(HL1Pt) cage has a smaller CCS in comparison to the trans
isomer (Fig. 3a, Table 1). We associate this difference to
positions of the non-coordinating phenyl groups (Fig. 1) on
two isomeric forms of (HL1Pt) corner group. Moreover, we
anticipate different arrangement of counterions in cis and trans
forms due to both electronic and steric factors.
For the lower charge state ions, [M-2PF6]
2+, both the cis
and trans isomers present two distinct species in the ATDs
(Fig. 3b and c). We assign these as a monomer and a m/z
coincident dimer, separated by ion mobility; since the dimer
[2M-4PF6]
4+ has twice the charge of the monomer, it arrives
earlier. For the cis-(HL1Pt) cage the monomer is the dominant
form with a CCS of 471 Å2, and the earlier arriving dimer with
a CCS of 782 Å2 (Fig. 3b). The relative intensities of these
species are switched for the trans-(HL1Pt) cage (Fig. 3c) now
the dimer dominates, and has a similar CCS as for the cis cage
(770 Å2). The monomer is much lower in intensity and has a
somewhat larger CCS than for the cis cage, (502 Å2).
Although we do not obtain baseline resolution for ions of the
size of the [2M-4PF6]
4+ species, ion mobility easily separates
these species, as well as providing diagnostic size information.
A similar benefit of IM-MS analysis has been previously reported
by Chen et al. on a hexacadmium metallocycle system.7d
Interestingly, additional counterions reduce the CCS. The
cis-(HL1Pt) cage [M-2PF6]
2+ species is slightly smaller than
that measured for [M-3PF6]
3+, for the corresponding trans-
isomer a much more significant difference in size is noted
between the [M-2PF6]
2+ and the [M-3PF6]
3+, 503 Å2 versus
572 Å2 (Fig. 1a and b, Table 1). We attribute this either to an
opening of the cage for the more abundant [M-3PF6]
3+ or a
rearrangement of counterions involving more efficient packing.
The former is a more likely explanation, which is supported by
the very small signal for the monomeric species of trans-(HL1Pt)
cage (Fig. 3c), which suggest that the fully closed intact species
is not stable as a monomer in the gas-phase, also borne out by
the more extensive in-source fragmentation for the trans isomer
(Fig. 2b). Dimers for both isomers provide identical CCS so the
packing arrangement of these must result in a similar gas phase
shape, albeit one that is favoured by the trans isomer.
Similar IM-MS analysis has been performed for isomers of
the (L2Pt) system. This presents in three charge states, all of
which, as expected, exhibit smaller CCS values than the
corresponding values for the (HL1Pt) structures. As already
discussed for the (HL1Pt) system, the more counter ions
present, the smaller the measured CCS (Table 1).
The decrease in CCS on addition of counterions can be
attributed to the effect of a larger number of favourable coulombic
Fig. 2 Nano-ESI mass spectra of the cage systems: (a) cis-(HL1Pt);
(b) trans-(HL1Pt); (c) cis-(L2Pt); (d) trans-(L2Pt).
Fig. 3 ATDs for the (HL1Pt) cages: (a) ATDs for trans and cis
isomers for [M-3PF6]
3+ at 1361 m/z; (b) and (c) presents ATDs
for the cis and trans isomers respectively, for the peak attributed to
[M-2PF6]
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interactions, to the cationic cage systems. The more counterions
that are present, the greater the chance for ion pairs to form which
will restrict and compact the structures. Contrary to the (HL1Pt)
cages isomers, the cis and trans isomeric forms of (L2Pt) are
isoteric and therefore structural/shape differences between the
naked cages without counter anions should be minimal (Fig. 1).
Nevertheless, our IM-MS results show prominent differences in
the mobility for certain charge states. As with (HL1Pt) cages, the
trans isomer for each charge state has larger CCS than the cis form
(Figure S2w), probably due to placement of counterions, in turn
afforded by the steric differences. The [M-4PF6]
4+ ion of the cis
isomer also presents two distinct species in its ATD (Figure S2aw),
which we interpret as closed cage and an open, more extended
structure. The corresponding trans ion presents only one
distinguishable species in its ATD at the +4 charge state
suggesting an increased stability towards fragmentation.
As was observed for the (HL1Pt) system, the lowest observed
charge states give bimodal ATDwhich we interpret as monomeric
and dimeric species. In contrast to the (HL1Pt) system in which
the trans isomer shows highest propensity to dimerize, with (L2Pt)
both the cis and trans form roughly equal proportions of dimer
and monomer, although the CCS in the dimeric form appears to
be quite different.
As well as exploring intact cages IM-MS analysis has also
been applied to fragment species (Scheme 1 and supplementary
data Table S1w). CID experiments9b indicate that fragmentation
of the (L2Pt) system proceeds via abstraction of fluoride from
the PF6
 counterion.
Here we observe such species from in-source fragmentation.
In the case of the cis isomer we observe a significant increase in
CCS upon fluoride abstraction (425Å2 to 475Å2), consistent
with an increase in conformational flexibility. Contrary, in the
trans isomer, fluoride abstraction occurs together with loss of
4-40-bipy. This does not seem to affect the contracted geometry,
CCS values of intact cage and 1114 m/z fragment differ only
marginally (479 Å2 to 468 Å2). Again, this is rationalised by
different trans-effects at metal centres of isobaric species.
While the (HL1Pt) system has slightly larger CCS than the (L2Pt)
system, statistical uncertainties in CCSs of (L2Pt) are often larger
(Table 1). From this, we can speculate that the conformational
dynamics of the two systems are different. The (HL1Pt) system
appears restricted whereas the (L2Pt) cages are certainly more
dynamic. This may be related to the positioning of the PF6
counterions with respect to the Pt centres. For (HL1Pt), the
non-coordinating phenyl group masks Pt from the counterion,
thus preventing fluoride abstraction. No analogous effects
were observed in solution studies.
DT IM-MS has been used to investigate three-dimensional
structures of metallosupramolecular stereochemical isomers.
Despite the increasing use of commercial travelling wave based
ion-mobility instrumentation, there is not yet a suitable set of
calibrants for inorganic macromolecular species from which to
provide accurate CCS from arrival time data. DT IM-MS data
such as that shown here (Table 1, Table S1w), will start to
address this. We have shown how this technique can be used to
distinguish isobaric species, which has potential for checking
the progress of isomerisation. IM-MS analysis has revealed how
subtle structural differences significantly alter the stabilities of
these species, highlighting the benefit of this analytical method.
In the absence of X-ray crystallographic data, often difficult to
obtain for self-assembling systems, IM-MS provides diagnostic
structural information. Insights from the combination of n-ESI
and IM-MS will be used to inform future supramolecular
synthetic strategies.
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Table 1 Average experimental collision cross sections for the intact
cages. Each value is the average of at least three measurements
accompanied by the statistical uncertainty. (see experimental section
and supplementary information)








cis-(HL1Pt) — 503  4 471  4 770  20
trans-(HL1Pt) — 572  5 502  4 782  9
cis-(L2Pt) 443  8
692  15
425  8 425  3 626  29
trans-(L2Pt) 467  12 479  4 431  7 708  18
Scheme 1 Fragmentation pathways from CID experiments correlated
with CCS values of fragments of [M-3PF6]
3+ ion for cis (a) and trans
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ABSTRACT: The first molecular capsule based on an
[Ir(ppy)2]
+ unit (ppy = 2-phenylatopyridine) has been
prepared. Following the development of a method to
resolve rac-[(Ir(ppy)2Cl)2] into its enantiopure forms,
homochiral Ir6L4 octahedra where obtained with the
tritopic 1,3,5-tricyanobenzene. Solution studies and X-ray
diffraction show that these capsules encapsulate four of the
six associated counteranions and that these can be
exchanged for other anionic guests. Initial photophysical
studies have shown that an ensemble of weakly
coordinating ligands can lead to luminescence not present
in comparable mononuclear systems.
The combination of transition metal ions and geometricallycomplementary, multitopic bridging organic ligands has
led to the preparation of numerous molecular capsules and
cages.1 These assemblies possess well-defined internal cavities
that promote the ingress of guest molecules so that interesting
functions, such as catalysis or the stabilization of reactive
species, may be observed.1,2 By and large, the transition metal
ions within these systems have played solely a structural role,
offering advantages such as predictable, well-defined coordina-
tion preferences and bond strength.3 However, transition
metals and their complexes often possess many other notable
features, such as interesting photophysical properties; arguably
the most well-known class are the poly(pyridyl) complexes of
ruthenium(II),4 while more recently, analogous cyclometalated
C^N iridium(III) complexes have found widespread use as
luminescent biological probes5 and as dopants in organic light-
emitting devices.6 Although Newkome has described the
synthesis of several very elegant metallocycles which feature
[Ru(terpy)2]
2+ connections,7 the use Ru poly(pyridyl) or
cyclometalated Ir complexes as structural components in
metallosupramolecular assemblies, in particular polyhedral
architectures, remains rare.7,8 Herein, we report the first
molecular capsule based on an [Ir(ppy)2]
+ (ppy = 2-
phenylatopyridine) motif and demonstrate that incorporation
of this unit into a multimetallic array leads to a significant
luminescence enhancement with respect to a comparable
mononuclear complex, thus paving the way to capsules with
light-harvesting function and the development of devices with
emergent luminescent properties.
It was initially envisaged that [Ir(ppy)2]
+ could be used in an
analogous fashion to cis-protected square planar complexes,
such as [Pd(en)]2+ or [Pt(dppp)]2+,9 and that the ppy ligands,
arranged in a C,C-cis-N,N-trans orientation, would sufficiently
labilize the exchangeable sites to facilitate self-assembly.10
Targeting an M6L4 octahedron,
11 at first we chose to explore
the reaction of tris(4-pyridyl)triazine with the known iridium
compound, [Ir(ppy)2(CH3CN)2]OTf. As no evidence could be
gathered for the formation of the intact architecture, we
decided to instead investigate the self-assembly of the same Ir
starting material with 1,3,5-tricyanobenzene (tcb). While it was
anticipated that acetonitrile substitution from [Ir-
(ppy)2(CH3CN)2]OTf by tcb to generate the M6L4 assembly
should be entropically, if not enthalpically, favored, initial
experiments suggested only partial displacement. Instead, what
is presumed to be [(Ir(ppy)2OTf)2],
12 prepared by treating
[(Ir(ppy)2Cl)2] with silver triflate in C2H4Cl2, was reacted with
tcb in the same solvent (Scheme 1, step a). While the product
gave a relatively complex 1H NMR spectrum (see the
Supporting Information, Figure S1a), nanoelectrospray ioniza-
tion mass spectrometry (n-ESI-MS) showed an intense 2+ peak
at 2106 m/z (see Figure S2a), which matched the predicted
isotope pattern for [1·4OTf]2+. A 1H DOSY NMR spectrum of
the product also showed that the multiple aromatic signals
possessed similar diffusion coefficients (see Figure S3a). This
led us to postulate that 1·6OTf is formed as a complex mixture
of diastereoisomers13 when the synthesis commences from
racemic [(Ir(ppy)2Cl)2] (Scheme 1, route 1), and thus tcb does
not efficiently transmit stereochemical information between
adjacent metal centers.14
To eliminate the problem of mixed stereoisomer formation,
we have developed a preparative method to resolve rac-
[(Ir(ppy)2Cl)2] into its enantiopure forms,
15 which involves
chromatographic resolution of serine complexes (Scheme 1,
steps b and c).16 We have found that the most efficient method
to obtain both enantiomers (which, as expected, exhibit mirror
image circular dichroism (CD) spectra; see Figure S4) is to
resolve with both D- and L-serine, as the similarity in Rf values
on silica ensures that only the faster-running diastereoisomer
can be obtained in significant quantities. Both enantiomers
crystallize in the chiral space group P212121 upon diethyl ether
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diffusion into saturated dichloromethane solutions; the solid-
state structures (see Figure S5) reveal that the compound
isolated following resolution with D-serine is Λ-[(Ir(ppy)2Cl)2],
and that from L-serine is Δ-[(Ir(ppy)2Cl)2] (Scheme 1, steps b
and c).17
When the self-assembly was commenced from either Λ- or
Δ-[(Ir(ppy)2Cl)2] (Scheme 1, routes 2 and 3), a precipitate
was observed shortly after the addition of tcb to what are
presumed to be Δ- and Λ-[(Ir(ppy)2OTf)2], which was then
isolated after a few hours of stirring at room temperature. We
were delighted that the 1H NMR spectra of the two products
not only were indistinguishable (see Figure S1b,c) but also
clearly showed single species with the number and ratio of tcb-
to-ppy signals consistent with the sole formation of Λ- and Δ-1.
CD confirmed that the two compounds were enantiomers (see
Figure S4). The mass spectra also showed essentially a single
species at 2106 m/z, which corresponds to the doubly charged
[1·4OTf]2+ (see Figure S2b,c). The surprising lack of other
charge states in the mass spectra of Λ- and Δ-1·6OTf prompted
us to look at the 19F NMR spectra (see Figure S6a), which
showed two distinct signals at −77.45 and −79.04 ppm in a
ratio of 1:2, respectively. Addition of excess NBu4OTf resulted
in an increase in the intensity of the peak at −77.45 ppm (see
Figure S6b), strongly suggesting that the peak at −79 ppm is
due to encapsulated triflates. Other NMR techniques (HOESY
and DOSY; see Figures S7 and S8) confirm this assignment and
thus support the solution structure [4OTf⊂Δ-1]·2OTf. Further
EXSY NMR experiments have shown that the exo and endo
triflates are in slow exchange and that the activation barrier for
this process is 18 kcal mol−1 (see Figure S9).
Corroboration of the capsule’s structure (Figure 1) was
obtained from X-ray diffraction (XRD) using single crystals
grown from benzene diffusion into a saturated dichloroethane
solution of Δ-1·6OTf.17,18 The solid-state structure supports
the solution structure, [4OTf⊂Δ-1]2+, showing triflates located
in each of the octahedron “windows”. For two encapsulated
triflates (with S labels 3 and 4), the S−C axis points toward the
center of these vacant windows (or, if viewed as a truncated
tetrahedron, toward the vertex), forming a series of close
contacts between the triflate oxygens and the hydrogen atoms
attached to tcb and the ortho pyridyl positions. The other
encapsulated anions (with S labels 1 and 6) are positioned in a
slightly more “side-on” fashion, with the cage forming short
contacts between two of the oxygen atoms and one of the
fluorines. It seems probable that, in solution, these two distinct
triflate co-conformations participate in a low-energy exchange
process, thus explaining the presence of a single “encapsulated”
signal in the 19F NMR spectrum at room temperature.
To explore whether the structure and, in particular, the
encapsulated anions are preserved under MS conditions, ion-
mobility measurements have been undertaken.19 For the ions at
2106 m/z, both samples gave superimposable arrival time
distributions, consistent with a single species/conformation
(see Figure S10). The observed rotationally averaged collision
cross sections for Λ- and Δ-1 were found to be 551 and 543 Å2,
respectively, virtually within error of each other. To validate
these, ion-mobility simulations have been carried out using
structures derived from the XRD data. The values calculated
using either the exact hard-spheres scattering or trajectory
method, 555 and 551 Å2, respectively, agree remarkably well
with the experimental data, suggesting that the counteranions
remain within the capsule upon ionization into the gas phase.
Examples of metallocapsules which encapsulate multiple
species of the same charge are very rare.20 Clearly, the strong
Coulombic attraction between the positively charged Ir vertices
and negative counteranions, alongside the series of CH···X (X
Scheme 1. Synthesis of Heterochiral and Homochiral
Hexanuclear Iridium Assembliesa
aConditions: (a) (i) AgOTf, C2H4Cl2, RT, 2 h; (ii) tcb, C2H4Cl2, RT,
4 h, 48% (starting from rac-[(Ir(ppy)2Cl)2]). (b) (i) D-Serine,
NaOMe, MeOH, 313 K, 16 h; (ii) 1 M HCl, MeOH, RT, 10 min, 50%
(from rac-[(Ir(ppy)2Cl)2]). (c) L-Serine, NaOMe, MeOH, 313 K, 16
h; (ii) 1 M HCl, MeOH, RT, 10 min, 37% (from rac-[(Ir(ppy)2Cl)2]).
(d) (i) AgOTf, C2H4Cl2, RT, 2 h; (ii) tcb, C2H4Cl2, RT, 5 h, 57%
(starting from Λ-[(Ir(ppy)2Cl)2]). (e) (i) AgOTf, C2H4Cl2, RT, 2 h;
(ii) tcb, C2H4Cl2, RT, 4 h, 68% (starting from Δ-[(Ir(ppy)2Cl)2]).
Figure 1. X-ray crystal structures of [4OTf⊂Δ-1]2+. Color code: Ir,
magenta; C(ppy), dark blue; C(tcb), dark green; C(OTf), gray; N,
light blue; O, red; S, yellow; F, light green.
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= O, F) hydrogen bonds (vide supra), is enough to overcome
the repulsion between same-charge ions. It could also be that
the CF3 groups, which are “meshed” together within the center
of the cavity (C−C distances between encapsulated OTf
counteranions range from 4.93 to 6.05 Å, with an average
distance of 5.55 Å), act to insulate this charge. To probe
further, we have calculated the capsule’s occupancy. Based on
an irregular hexadecahedron model (see Supporting Informa-
tion for details), the volume of the empty cavity has been
calculated to be 506 Å3, of which the triflate counteranions
occupy 280 Å3, which equates to 55% filled cavity space, in line
with previous observations made by Rebek.21
Held under a standard long-wavelength UV lamp, tetra-
chloroethane (TCE) solutions of Λ- and Δ-1·6OTf luminesce
orange (Figure 2, inset). As most literature Ir complexes are
luminescent, the significance of the capsules’ photophysical
properties only becomes apparent when compared against the
representative mononuclear bis(benzonitrile) complex, [Ir-
(ppy)2(PhCN)2]OTf.
22 Placed next to the samples of Λ- and
Δ-1 under UV light (Figure 2, inset), there is no visible
luminescence from [Ir(ppy)2(PhCN)2]OTf in the same solvent
(at equivalent [Ir]). The absorption and emission spectra of
these samples confirm these visual observations (Figure 2).
Even with a vast excess of benzonitrile, [Ir(ppy)2(PhCN)2]OTf
is only weakly luminescent (Figure 2). The emission of Λ- and
Δ-1·6OTf is also broadened and red-shifted with respect to
[Ir(ppy)2(PhCN)2]OTf (in the presence of excess benzoni-
trile), signifying increased charge-transfer character of the
emitting state. While the quantum yields for Λ- and Δ-1·6OTf,
found to be 0.04 in air-equilibrated TCE (see the Supporting
Information), are comparable to those for many cyclometalated
Ir complexes under similar ambient conditions,23 these often
utilize either bidentate or strongly coordinating (and high
ligand strength) monodentate ligands.24 As far as we are aware,
this is the first time a collection of weakly coordinating ligands
has been used to inhibit nonradiative ligand dissociation
pathways.25 Interestingly, the emission intensity of Λ- and Δ-
1·6OTf increases only marginally (by a factor of 1.1) when the
samples are thoroughly degassed, in contrast to many other
such Ir complexes,23 suggesting that the metallosupramolecular
architecture may also in some way inhibit collisional O2
quenching.23b Alternatively, the presence of four desolvated
anions located within the cavity of the capsule may provide
such an efficient, alternative nonradiative decay pathway (e.g.,
via electron transfer) that the capsule is insensitive to the
presence of O2.
A preliminary investigation into the host−guest chemistry of
[4OTf⊂Δ/Λ-1]2+ indicates that the encapsulated triflates can
be exchanged for other anionic species. When NBu4PF6 is
titrated into a sample of [4OTf⊂Δ-1]·2OTf in C2D2Cl4, 19F
NMR spectroscopy (see Figure S12) shows multiple OTf and
PF6 signals at low [PF6], indicative of mixed PF6−OTf host−
guest complexes. At equimolar anionic concentrations,
encapsulated OTf has mostly been displaced. This process
has also been monitored by 1H NMR spectroscopy (see Figure
S13), which shows that while the overall symmetry is preserved,
the proton signals closest to the anion binding sites (the tcb
hydrogen atom and the ortho and meta pyridyl sites) are
noticeably shifted. Similar experiments with NBu4BF4 and
NBu4CF3BF3, and additional titrations into Λ-1·6BF4 (see
Figures S14−S23), have ascertained that the overall affinity of
perfluorinated anions for the cavity of [Δ/Λ-1]6+ follows the
sequence PF6 > OTf ≈ CF3BF3 > BF4.
21c While at present we
are unable to rationalize this affinity, due to the fast exchange of
some of the anionic species (even at low temperatures),
additional DOSY measurements show that the cage remains
intact following guest exchange. We have also ascertained that
there is communication between the luminescent properties of
[Δ/Λ-1]6+ and the cavity-bound guests, as evidenced by
changes to the emission spectra during anion titration
experiments (see the Supporting Information). As well as
showing that [Δ/Λ -1]6+ acts as a luminescent anion sensor,
this also suggests that it may be possible to tune luminescent
properties of multimetallic Ir assemblies through supra-
molecular means rather than via conventional covalent
modification. Our initial attempts to expand host−guest
chemistry to neutral organic species have so far been hampered
by the low solubility/stability of Λ/Δ-1 in more polar solvents.
In summary, the first molecular capsule based on an
[Ir(ppy)2]
+ unit has been assembled using a multitopic nitrile
ligand and enantiopure Ir starting materials. This incorporation
leads to luminescence not present in a comparable mono-
nuclear complex. In addition, we have shown that the same
capsule is capable of binding multiple same-charge species and
that these can be swapped for other anionic guests. We are
currently exploring further aspects of this system, in particular
how guest-binding features and photophysical properties relate,
and whether the light-harvesting properties can be exploited in
relation to potential substrate binding.
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Figure 2. Absorption and emission (excitation at 413 nm) spectra of
Λ- and Δ-1·6OTf. Λ = black line; Δ = red line; TCE, 2 μM. For
comparison, the spectra of the mononuclear [Ir(ppy)2(PhCN)2]OTf
are also shown (Ir only = green line; Ir + 3000 equiv PhCN = blue
line; TCE, 12 μM). Inset: Photographs of (i) Λ-1·6OTf, (ii) Δ-
1·6OTf, and (iii) [Ir(ppy)2(PhCN)2]OTf in NMR tubes held (a) in
ambient lighting and (b) under a long-wavelength UV lamp.
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